data_2dcr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dcr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.223 -0.302 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 69' ' ' ASN . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 68' ' ' ASP . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 . . . . . 0 C--O 1.22 -0.481 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.569 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.41 0.148 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.409 ' HB ' HE21 ' A' ' 10' ' ' GLN . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.409 HE21 ' HB ' ' A' ' 9' ' ' VAL . 21.8 mm-40 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.493 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.43 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.491 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.41 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.43 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.552 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.427 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.45 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.566 0.222 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.627 ' HG ' ' NE2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.627 ' NE2' ' HG ' ' A' ' 43' ' ' SER . 2.8 pm0 -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.429 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.453 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.47 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.427 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.522 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 96' ' ' THR . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.522 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 121.026 0.441 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.414 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.488 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.365 0.603 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.426 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 98' ' ' LYS . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 96' ' ' THR . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.449 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.434 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.414 ' H ' ' CD1' ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.905 0.86 . . . . 0.0 112.754 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.424 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.83 94.19 3.57 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.809 1.805 . . . . 0.0 110.397 -165.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -160.39 170.17 21.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.698 1.999 . . . . 0.0 106.429 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.93 171.34 48.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.8 m -91.51 172.67 8.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.113 0.565 . . . . 0.0 109.56 165.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 p -71.12 175.82 4.94 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.91 0.884 . . . . 0.0 109.473 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.54 -153.16 22.73 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.941 -1.1 . . . . 0.0 111.586 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 68.61 9.32 7.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.448 2.299 . . . . 0.0 114.305 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' H ' ' A' ' 69' ' ' ASN . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.406 ' H ' ' HB3' ' A' ' 68' ' ' ASP . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.03 174.51 47.19 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.62 -11.22 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.646 2.898 . . . . 0.0 113.93 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.5 t -86.04 87.31 7.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.67 1.188 . . . . 0.0 107.887 -170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.7 p -74.0 99.28 3.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.085 1.754 . . . . 0.0 111.113 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.023 170.44 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -59.9 107.09 0.57 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -110.09 -57.03 2.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -168.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.77 -103.6 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.7 m 53.16 30.77 10.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.894 1.278 . . . . 0.0 111.926 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.8 m -105.21 -7.21 19.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.337 1.055 . . . . 0.0 112.566 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.51 110.71 1.62 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 -130.98 3.56 4.41 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.788 1.235 . . . . 0.0 112.756 -168.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.569 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.569 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.6 177.43 48.27 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.24 -10.57 29.1 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.626 2.884 . . . . 0.0 116.28 -168.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -160.83 164.09 31.61 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.468 1.485 . . . . 0.0 110.188 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 m -147.28 163.93 34.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.921 2.088 . . . . 0.0 108.762 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.15 -5.46 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -69.98 168.95 14.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.156 0.889 . . . . 0.0 111.49 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -131.46 1.29 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -20.01 30.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.666 1.233 . . . . 0.0 111.938 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m 59.78 20.22 9.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.39 1.876 . . . . 0.0 111.868 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.89 90.6 1.38 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -168.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -111.16 14.34 21.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.404 1.482 . . . . 0.0 110.869 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' HB ' HE21 ' A' ' 10' ' ' GLN . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.409 HE21 ' HB ' ' A' ' 9' ' ' VAL . 21.8 mm-40 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.493 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.46 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.493 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.95 175.36 13.93 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.71 4.59 3.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.127 2.551 . . . . 0.0 114.046 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 t -128.29 86.52 2.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.494 1.497 . . . . 0.0 108.909 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.46 101.11 6.28 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -179.567 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m 53.84 21.55 2.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 114.817 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -129.25 174.18 9.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.24 1.016 . . . . 0.0 110.21 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.11 6.7 13.46 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.849 1.69 . . . . 0.0 112.791 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -60.0 134.84 57.42 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.818 1.309 . . . . 0.0 108.773 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -144.88 159.93 42.12 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.45 1.1 . . . . 0.0 109.746 -170.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.52 147.68 48.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.963 0.792 . . . . 0.0 111.134 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.77 16.37 5.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.984 1.314 . . . . 0.0 111.257 -164.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.43 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.491 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.41 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.43 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.434 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.71 175.42 15.18 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.57 2.04 8.57 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.575 2.85 . . . . 0.0 113.824 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -150.71 157.61 43.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.092 0.86 . . . . 0.0 110.327 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.1 p -138.46 177.65 7.72 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.518 1.927 . . . . 0.0 108.04 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 CA-C-O 118.376 -1.235 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -145.82 4.23 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -114.5 -16.39 11.91 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.99 9.16 9.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 159.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.44 175.06 9.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 121.309 2.554 . . . . 0.0 112.434 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -138.66 -14.3 1.25 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -165.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.4 124.09 0.92 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 105.788 -2.925 . . . . 0.0 105.788 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -138.42 24.81 2.69 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.731 1.213 . . . . 0.0 109.119 -147.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.552 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.552 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.427 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.19 177.41 16.38 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -87.66 22.52 0.89 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 125.181 3.921 . . . . 0.0 112.12 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.2 t -176.29 160.64 2.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.476 1.91 . . . . 0.0 107.681 -171.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.7 m -147.62 122.76 10.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.908 0.483 . . . . 0.0 110.567 -153.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 C-N-CA 125.146 1.355 . . . . 0.0 111.284 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -78.95 -26.16 43.56 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.82 169.95 16.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.704 0.802 . . . . 0.0 110.222 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.15 -67.15 0.96 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t 42.05 53.71 4.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.699 1.599 . . . . 0.0 111.071 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.5 t -163.3 141.16 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.36 1.464 . . . . 0.0 107.355 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.89 -92.05 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 54.2 20.68 2.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.112 2.165 . . . . 0.0 113.728 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.45 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.45 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.52 170.73 46.76 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.55 -40.43 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.633 2.222 . . . . 0.0 111.959 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 m -79.54 130.75 35.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.0 m -136.0 163.29 30.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.261 2.224 . . . . 0.0 107.272 168.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -170.451 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -142.91 1.74 1.3 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -163.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.13 175.71 7.25 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.138 1.375 . . . . 0.0 110.536 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 176.05 38.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 172.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -146.33 70.57 1.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -139.84 -178.99 5.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.809 1.243 . . . . 0.0 109.354 -171.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.14 142.15 8.99 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -106.93 5.24 28.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -162.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.448 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.448 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.0 163.62 23.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.97 27.22 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.09 3.194 . . . . 0.0 111.617 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m -125.96 87.33 2.66 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.251 1.42 . . . . 0.0 107.55 -166.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.66 111.04 20.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.37 1.068 . . . . 0.0 108.599 -169.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.2 -1.889 . . . . 0.0 110.673 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -115.29 -66.88 1.04 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.072 0.936 . . . . 0.0 109.258 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -56.08 -40.39 73.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.277 0.944 . . . . 0.0 110.537 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.29 174.42 8.62 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.484 0.491 . . . . 0.0 112.116 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -138.83 169.25 18.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 p -150.11 -56.63 0.18 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.726 2.011 . . . . 0.0 108.927 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.31 1.65 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.78 11.07 6.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.021 1.328 . . . . 0.0 111.092 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.627 ' HG ' ' NE2' ' A' ' 44' ' ' GLN . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.627 ' NE2' ' HG ' ' A' ' 43' ' ' SER . 2.8 pm0 -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.429 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.429 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.8 177.25 18.89 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 -33.36 9.43 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.718 2.945 . . . . 0.0 111.574 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -126.64 95.82 4.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.099 0.96 . . . . 0.0 108.494 -156.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -42.97 124.82 3.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.741 2.816 . . . . 0.0 110.895 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.471 0 CA-C-O 118.396 -1.225 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -127.34 -79.76 0.59 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.133 0.966 . . . . 0.0 108.867 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 123.81 21.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.519 1.127 . . . . 0.0 109.181 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.04 174.21 42.93 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.935 0.779 . . . . 0.0 112.555 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t 69.45 6.55 5.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.461 2.304 . . . . 0.0 114.908 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.81 163.29 1.46 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.431 1.492 . . . . 0.0 114.023 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.57 57.76 0.32 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 126.169 1.843 . . . . 0.0 111.159 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -75.8 22.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.87 2.468 . . . . 0.0 115.766 -153.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.453 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.47 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.08 165.66 40.82 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.09 18.68 1.14 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.792 2.328 . . . . 0.0 115.033 -161.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 m -132.51 152.03 51.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.766 1.166 . . . . 0.0 108.464 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -159.78 121.51 3.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.48 0 CA-C-O 119.239 -0.756 . . . . 0.0 111.277 177.539 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -64.27 -9.19 15.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -150.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 m -132.56 1.44 3.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.484 1.038 . . . . 0.0 112.407 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.98 114.62 4.55 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -104.42 0.07 28.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.879 0.872 . . . . 0.0 112.585 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t -151.15 -169.24 3.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.901 1.28 . . . . 0.0 108.429 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.85 49.85 3.03 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -123.79 15.42 9.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.468 1.107 . . . . 0.0 112.89 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.427 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.427 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.35 174.71 19.53 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.73 91.12 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.284 3.323 . . . . 0.0 110.089 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 t -149.13 163.41 37.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.532 1.533 . . . . 0.0 108.719 -167.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.2 p -151.97 149.16 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.712 0.687 . . . . 0.0 111.486 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.326 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -70.89 -26.96 63.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.625 1.17 . . . . 0.0 110.875 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.33 160.64 21.3 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.253 1.021 . . . . 0.0 108.886 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.63 159.07 28.23 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m -128.57 -40.28 1.59 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.877 1.271 . . . . 0.0 108.75 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m 46.1 68.86 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.788 2.435 . . . . 0.0 111.668 165.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.6 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 61.04 17.98 8.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.684 1.193 . . . . 0.0 112.408 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD22 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.413 ' CD2' HD22 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.522 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 98' ' ' LYS . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 96' ' ' THR . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.522 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.66 166.12 32.14 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.17 -21.24 12.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.45 2.1 . . . . 0.0 113.647 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.9 m -85.68 173.01 10.41 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.509 1.504 . . . . 0.0 111.258 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.4 p -142.18 163.13 33.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.653 0.781 . . . . 0.0 110.164 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 N-CA-C 107.286 -2.325 . . . . 0.0 107.286 174.676 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.086 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -93.7 -14.8 25.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.466 1.633 . . . . 0.0 112.657 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -134.19 129.32 35.61 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.506 1.523 . . . . 0.0 106.929 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.14 159.21 14.89 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.245 0.926 . . . . 0.0 110.855 -163.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 t -143.46 -43.09 0.28 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.921 1.288 . . . . 0.0 109.899 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -145.48 173.87 11.65 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.313 1.045 . . . . 0.0 110.388 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.65 -136.45 12.16 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.754 -2.138 . . . . 0.0 107.754 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.11 26.68 12.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.047 1.339 . . . . 0.0 110.61 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.21 160.74 15.51 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.96 -21.41 27.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.35 2.034 . . . . 0.0 113.062 -168.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 t -109.87 134.75 51.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -171.57 -173.94 1.3 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 129.443 3.097 . . . . 0.0 106.899 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.734 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.01 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -94.96 -59.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.751 0.82 . . . . 0.0 109.95 -167.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -160.0 177.11 11.08 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.313 1.845 . . . . 0.0 107.812 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 156.2 24.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.277 0.941 . . . . 0.0 111.921 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -87.86 66.02 8.57 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.637 1.175 . . . . 0.0 112.134 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -79.05 59.54 2.72 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.035 1.734 . . . . 0.0 110.434 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.69 -34.36 19.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.518 1.056 . . . . 0.0 111.262 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 54.06 26.98 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.857 1.663 . . . . 0.0 113.163 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.431 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 160.0 26.76 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.74 86.24 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.554 2.836 . . . . 0.0 111.074 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 p -120.7 -174.66 2.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.005 1.722 . . . . 0.0 109.06 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.9 m -143.75 46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.66 -1.275 . . . . 0.0 108.202 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 -167.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.822 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -134.6 110.12 9.1 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -167.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -166.03 -170.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.56 0.744 . . . . 0.0 110.852 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -164.8 22.32 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.92 1.248 . . . . 0.0 112.234 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -132.15 29.34 4.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.191 1.796 . . . . 0.0 111.036 -167.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t 57.31 42.56 24.89 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.886 -1.134 . . . . 0.0 110.209 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.45 75.68 0.21 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -131.82 22.65 4.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.718 1.207 . . . . 0.0 110.34 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.414 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.488 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.548 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.488 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.67 164.2 22.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 -38.95 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.406 2.07 . . . . 0.0 112.59 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 t -86.26 148.49 25.61 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 p -144.95 168.83 19.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -163.707 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -140.73 121.42 14.31 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.467 1.134 . . . . 0.0 109.444 -171.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t -90.48 -75.95 0.45 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.79 162.25 26.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.07 1.319 . . . . 0.0 111.255 -175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.468 1.107 . . . . 0.0 108.403 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -147.64 138.08 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.941 1.297 . . . . 0.0 107.621 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.18 76.99 0.93 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -130.38 30.11 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.688 1.595 . . . . 0.0 110.202 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.527 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.426 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.412 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.476 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.9 -172.64 54.42 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -85.56 -5.54 9.09 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.548 3.498 . . . . 0.0 115.159 -169.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.2 t -155.55 169.44 24.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.006 0.922 . . . . 0.0 109.09 -168.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -113.11 161.91 16.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.46 1.504 . . . . 0.0 108.712 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -140.96 -3.79 1.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.79 1.236 . . . . 0.0 112.308 -164.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -75.39 -169.24 0.95 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.104 0.962 . . . . 0.0 110.566 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -69.33 0.22 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 39.61 65.76 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 111.686 166.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 m -66.2 157.81 30.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.956 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 38.79 67.84 0.52 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.129 2.299 . . . . 0.0 113.521 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -83.68 20.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.156 0.982 . . . . 0.0 111.941 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HB3' ' CD1' ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.44 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' C ' ' H ' ' A' ' 98' ' ' LYS . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.421 ' H ' ' C ' ' A' ' 96' ' ' THR . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.36 174.86 18.66 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.32 -8.33 15.1 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.6 2.867 . . . . 0.0 113.918 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.98 156.55 37.9 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.072 1.349 . . . . 0.0 108.088 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.0 p -150.59 169.0 22.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.675 0.39 . . . . 0.0 111.322 -167.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.984 176.039 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 m -134.04 -70.91 0.51 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -53.42 137.95 34.47 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 168.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.68 -72.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -171.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -146.93 161.4 40.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.678 1.239 . . . . 0.0 109.022 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -75.61 -3.94 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.674 0.789 . . . . 0.0 112.948 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 103.73 2.32 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -119.21 11.71 12.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.317 1.058 . . . . 0.0 111.515 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.449 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.449 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.415 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.87 171.77 28.52 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -15.45 34.09 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.659 2.24 . . . . 0.0 112.069 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -74.98 90.7 2.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.275 1.43 . . . . 0.0 108.892 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -60.99 150.55 33.17 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 164.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -176.009 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -58.42 -34.13 70.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -72.38 170.23 14.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 110.817 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.55 -93.9 1.7 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 m -138.09 150.64 47.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.422 1.111 . . . . 0.0 111.292 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.73 156.82 38.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.931 1.693 . . . . 0.0 110.021 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -77.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 163.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 55.15 16.62 1.66 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.546 1.138 . . . . 0.0 113.473 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.414 ' CD1' ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.434 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.414 ' H ' ' CD1' ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.46 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.434 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.438 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.423 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.7 173.0 13.66 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -83.65 -4.16 10.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.836 2.357 . . . . 0.0 113.708 -166.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 t -131.96 147.82 52.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.505 1.522 . . . . 0.0 109.292 -165.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.0 m -144.09 -178.15 5.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.309 1.844 . . . . 0.0 109.21 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.294 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -168.556 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.612 0 CA-C-O 119.48 -0.622 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -68.11 -54.28 19.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 150.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 p -67.61 158.36 32.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 167.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.32 -80.07 0.04 OUTLIER Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 p -66.04 -174.56 0.25 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.116 1.366 . . . . 0.0 111.655 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -142.3 9.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 112.535 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 163.81 28.19 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -145.07 21.48 1.58 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.521 1.128 . . . . 0.0 110.894 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.406 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.26 171.32 29.03 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.58 3.32 5.49 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.757 2.305 . . . . 0.0 112.667 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -72.86 164.18 27.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.035 0.921 . . . . 0.0 110.195 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.71 153.9 46.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 157.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -176.065 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.905 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -78.4 149.9 33.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.927 0.87 . . . . 0.0 110.766 -165.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.5 p -118.34 -17.44 9.47 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 127.325 2.25 . . . . 0.0 111.495 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.61 8.62 87.59 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.075 -174.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.6 m -47.75 105.19 0.07 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.2 p -152.99 -159.07 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.649 1.58 . . . . 0.0 108.39 -175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.1 -97.79 1.43 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 44.79 34.34 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.845 2.058 . . . . 0.0 112.754 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.453 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.424 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.42 169.58 26.81 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.67 -1.73 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.945 3.097 . . . . 0.0 116.879 -162.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.73 157.17 46.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 121.292 1.86 . . . . 0.0 110.21 170.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.3 t -142.06 171.96 13.34 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 109.431 -166.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.239 -1.312 . . . . 0.0 109.972 -169.819 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.223 -0.302 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 9' ' ' VAL . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 107' ' ' VAL . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 63' ' ' ILE . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.75 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HD3' HD12 ' A' ' 58' ' ' LEU . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 50' ' ' VAL . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 67' ' ' LEU . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.438 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 31' ' ' LEU . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 . . . . . 0 C--O 1.22 -0.481 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 HG21 ' A' ' 107' ' ' VAL . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 63' ' ' ILE . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.587 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 50' ' ' VAL . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 101' ' ' VAL . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 32' ' ' LEU . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.41 0.148 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.761 HD21 HD23 ' A' ' 39' ' ' LEU . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 63' ' ' ILE . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.499 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 96' ' ' THR . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 62' ' ' PHE . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.44 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 16.4 m170 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.475 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 39' ' ' LEU . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 HD13 ' A' ' 63' ' ' ILE . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.436 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.654 HD13 HG22 ' A' ' 50' ' ' VAL . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.547 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.436 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 63' ' ' ILE . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 50' ' ' VAL . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 83' ' ' LEU . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' O ' HD12 ' A' ' 83' ' ' LEU . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.631 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 39' ' ' LEU . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 39' ' ' LEU . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 32' ' ' LEU . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 63' ' ' ILE . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.461 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.462 HD13 HG22 ' A' ' 50' ' ' VAL . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.511 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 13' ' ' LEU . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 9' ' ' VAL . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 96' ' ' THR . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.461 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 9' ' ' VAL . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 39' ' ' LEU . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' HD22 ' A' ' 103' ' ' LEU . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 32' ' ' LEU . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 63' ' ' ILE . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.536 ' CH2' HG22 ' A' ' 102' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 HG22 ' A' ' 50' ' ' VAL . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' CD2' HD22 ' A' ' 95' ' ' LEU . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' HD13 ' A' ' 83' ' ' LEU . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 80' ' ' SER . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 73' ' ' LEU . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.536 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.707 ' HB3' HD12 ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.454 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 32' ' ' LEU . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.566 0.222 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.518 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.454 HD23 HG21 ' A' ' 107' ' ' VAL . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 63' ' ' ILE . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.444 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 50' ' ' VAL . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 95' ' ' LEU . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 73' ' ' LEU . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG23 ' H ' ' A' ' 101' ' ' VAL . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 32' ' ' LEU . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 9' ' ' VAL . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.772 HG22 HD13 ' A' ' 63' ' ' ILE . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.487 HG11 ' CG1' ' A' ' 101' ' ' VAL . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 102' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 58' ' ' LEU . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.772 HD13 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 ' CG1' HG11 ' A' ' 53' ' ' VAL . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.594 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HB3' HG11 ' A' ' 107' ' ' VAL . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 39' ' ' LEU . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 63' ' ' ILE . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CH2' HG22 ' A' ' 102' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.584 HD13 HG22 ' A' ' 50' ' ' VAL . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.495 ' CD2' HD22 ' A' ' 95' ' ' LEU . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 73' ' ' LEU . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 31' ' ' LEU . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 83' ' ' LEU . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CD2' HD23 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 39' ' ' LEU . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 39' ' ' LEU . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 63' ' ' ILE . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 101' ' ' VAL . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.653 HD13 HG22 ' A' ' 50' ' ' VAL . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.58 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.58 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB2' HD13 ' A' ' 83' ' ' LEU . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.448 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 101' ' ' VAL . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.406 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 32' ' ' LEU . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 50' ' ' VAL . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 HD23 ' A' ' 83' ' ' LEU . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 52' ' ' SER . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD21 HD23 ' A' ' 39' ' ' LEU . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.498 ' O ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.801 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 63' ' ' ILE . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB3' HG11 ' A' ' 28' ' ' VAL . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.624 HD13 HG22 ' A' ' 50' ' ' VAL . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.445 HD23 HG12 ' A' ' 9' ' ' VAL . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 101' ' ' VAL . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 121.026 0.441 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 83' ' ' LEU . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.429 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.85 HD21 HD23 ' A' ' 39' ' ' LEU . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 63' ' ' ILE . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' HG22 ' A' ' 102' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 50' ' ' VAL . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 83' ' ' LEU . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' HD12 ' A' ' 13' ' ' LEU . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.63 HG22 ' CH2' ' A' ' 55' ' ' TRP . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.365 0.603 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 52' ' ' SER . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 39' ' ' LEU . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 32' ' ' LEU . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 HD13 ' A' ' 63' ' ' ILE . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 95' ' ' LEU . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.528 ' CD2' HG23 ' A' ' 101' ' ' VAL . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.727 HD13 HG22 ' A' ' 50' ' ' VAL . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.6 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 80' ' ' SER . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' HG13 ' A' ' 101' ' ' VAL . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.438 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' HD3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' HD11 ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 63' ' ' ILE . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD22 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' HD3' HD22 ' A' ' 58' ' ' LEU . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.508 HD13 HG22 ' A' ' 50' ' ' VAL . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.423 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' HD12 ' A' ' 13' ' ' LEU . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 37' ' ' ASP . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' HD22 ' A' ' 32' ' ' LEU . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 63' ' ' ILE . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.524 ' CD2' HG23 ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.515 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD2' HD22 ' A' ' 95' ' ' LEU . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 13' ' ' LEU . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.665 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' HG12 ' A' ' 101' ' ' VAL . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 9' ' ' VAL . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 107' ' ' VAL . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD21 HD23 ' A' ' 39' ' ' LEU . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG22 HD13 ' A' ' 63' ' ' ILE . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.605 ' CH2' HG22 ' A' ' 102' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.632 ' H ' HD11 ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 50' ' ' VAL . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 13' ' ' LEU . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.605 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.732 ' HB3' HD12 ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.477 HG21 HD23 ' A' ' 32' ' ' LEU . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG13 ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 23' ' ' ILE . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 52' ' ' SER . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 39' ' ' LEU . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 32' ' ' LEU . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' HG11 ' A' ' 28' ' ' VAL . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.438 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 50' ' ' VAL . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.559 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.438 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HB3' HD12 ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.905 0.86 . . . . 0.0 112.754 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 107' ' ' VAL . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG22 HD13 ' A' ' 63' ' ' ILE . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HG22 ' A' ' 50' ' ' VAL . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG21 HD23 ' A' ' 32' ' ' LEU . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.83 94.19 3.57 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.809 1.805 . . . . 0.0 110.397 -165.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -160.39 170.17 21.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.698 1.999 . . . . 0.0 106.429 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.93 171.34 48.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.8 m -91.51 172.67 8.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.113 0.565 . . . . 0.0 109.56 165.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 p -71.12 175.82 4.94 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.91 0.884 . . . . 0.0 109.473 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.54 -153.16 22.73 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.941 -1.1 . . . . 0.0 111.586 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 68.61 9.32 7.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.448 2.299 . . . . 0.0 114.305 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 9' ' ' VAL . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 107' ' ' VAL . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 63' ' ' ILE . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.75 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HD3' HD12 ' A' ' 58' ' ' LEU . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 50' ' ' VAL . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.486 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 67' ' ' LEU . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.438 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 31' ' ' LEU . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.03 174.51 47.19 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.62 -11.22 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.646 2.898 . . . . 0.0 113.93 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.5 t -86.04 87.31 7.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.67 1.188 . . . . 0.0 107.887 -170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.7 p -74.0 99.28 3.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.085 1.754 . . . . 0.0 111.113 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.023 170.44 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -59.9 107.09 0.57 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -110.09 -57.03 2.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -168.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.77 -103.6 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.7 m 53.16 30.77 10.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.894 1.278 . . . . 0.0 111.926 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.8 m -105.21 -7.21 19.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.337 1.055 . . . . 0.0 112.566 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.51 110.71 1.62 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 -130.98 3.56 4.41 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.788 1.235 . . . . 0.0 112.756 -168.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 HG21 ' A' ' 107' ' ' VAL . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 63' ' ' ILE . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.587 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 50' ' ' VAL . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 101' ' ' VAL . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 32' ' ' LEU . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.6 177.43 48.27 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.24 -10.57 29.1 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.626 2.884 . . . . 0.0 116.28 -168.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -160.83 164.09 31.61 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.468 1.485 . . . . 0.0 110.188 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 m -147.28 163.93 34.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.921 2.088 . . . . 0.0 108.762 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.15 -5.46 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -69.98 168.95 14.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.156 0.889 . . . . 0.0 111.49 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -131.46 1.29 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -20.01 30.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.666 1.233 . . . . 0.0 111.938 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m 59.78 20.22 9.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.39 1.876 . . . . 0.0 111.868 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.89 90.6 1.38 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -168.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -111.16 14.34 21.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.404 1.482 . . . . 0.0 110.869 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.761 HD21 HD23 ' A' ' 39' ' ' LEU . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 63' ' ' ILE . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.499 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 96' ' ' THR . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.52 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 62' ' ' PHE . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.44 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 16.4 m170 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.95 175.36 13.93 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.71 4.59 3.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.127 2.551 . . . . 0.0 114.046 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 t -128.29 86.52 2.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.494 1.497 . . . . 0.0 108.909 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.46 101.11 6.28 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -179.567 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m 53.84 21.55 2.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 114.817 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -129.25 174.18 9.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.24 1.016 . . . . 0.0 110.21 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.11 6.7 13.46 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.849 1.69 . . . . 0.0 112.791 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -60.0 134.84 57.42 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.818 1.309 . . . . 0.0 108.773 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -144.88 159.93 42.12 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.45 1.1 . . . . 0.0 109.746 -170.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.52 147.68 48.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.963 0.792 . . . . 0.0 111.134 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.77 16.37 5.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.984 1.314 . . . . 0.0 111.257 -164.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.475 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 39' ' ' LEU . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 HD13 ' A' ' 63' ' ' ILE . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.436 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.654 HD13 HG22 ' A' ' 50' ' ' VAL . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.436 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.71 175.42 15.18 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.57 2.04 8.57 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.575 2.85 . . . . 0.0 113.824 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -150.71 157.61 43.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.092 0.86 . . . . 0.0 110.327 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.1 p -138.46 177.65 7.72 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.518 1.927 . . . . 0.0 108.04 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 CA-C-O 118.376 -1.235 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -145.82 4.23 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -114.5 -16.39 11.91 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.99 9.16 9.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 159.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.44 175.06 9.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 121.309 2.554 . . . . 0.0 112.434 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -138.66 -14.3 1.25 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -165.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.4 124.09 0.92 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 105.788 -2.925 . . . . 0.0 105.788 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -138.42 24.81 2.69 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.731 1.213 . . . . 0.0 109.119 -147.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 63' ' ' ILE . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 50' ' ' VAL . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 83' ' ' LEU . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.19 177.41 16.38 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -87.66 22.52 0.89 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 125.181 3.921 . . . . 0.0 112.12 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.2 t -176.29 160.64 2.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.476 1.91 . . . . 0.0 107.681 -171.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.7 m -147.62 122.76 10.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.908 0.483 . . . . 0.0 110.567 -153.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 C-N-CA 125.146 1.355 . . . . 0.0 111.284 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -78.95 -26.16 43.56 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.82 169.95 16.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.704 0.802 . . . . 0.0 110.222 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.15 -67.15 0.96 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t 42.05 53.71 4.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.699 1.599 . . . . 0.0 111.071 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.5 t -163.3 141.16 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.36 1.464 . . . . 0.0 107.355 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.89 -92.05 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 54.2 20.68 2.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.112 2.165 . . . . 0.0 113.728 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' O ' HD12 ' A' ' 83' ' ' LEU . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.631 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 39' ' ' LEU . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 39' ' ' LEU . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 32' ' ' LEU . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 63' ' ' ILE . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.461 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.462 HD13 HG22 ' A' ' 50' ' ' VAL . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 13' ' ' LEU . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 9' ' ' VAL . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 96' ' ' THR . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.461 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.52 170.73 46.76 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.55 -40.43 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.633 2.222 . . . . 0.0 111.959 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 m -79.54 130.75 35.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.0 m -136.0 163.29 30.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.261 2.224 . . . . 0.0 107.272 168.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -170.451 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -142.91 1.74 1.3 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -163.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.13 175.71 7.25 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.138 1.375 . . . . 0.0 110.536 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 176.05 38.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 172.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -146.33 70.57 1.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -139.84 -178.99 5.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.809 1.243 . . . . 0.0 109.354 -171.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.14 142.15 8.99 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -106.93 5.24 28.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -162.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 ' H ' HG23 ' A' ' 9' ' ' VAL . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 39' ' ' LEU . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' HD22 ' A' ' 103' ' ' LEU . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 32' ' ' LEU . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 63' ' ' ILE . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.536 ' CH2' HG22 ' A' ' 102' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 HG22 ' A' ' 50' ' ' VAL . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' CD2' HD22 ' A' ' 95' ' ' LEU . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' HD13 ' A' ' 83' ' ' LEU . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 80' ' ' SER . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 64.7 m80 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 73' ' ' LEU . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.536 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.707 ' HB3' HD12 ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.454 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 32' ' ' LEU . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.0 163.62 23.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.97 27.22 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.09 3.194 . . . . 0.0 111.617 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m -125.96 87.33 2.66 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.251 1.42 . . . . 0.0 107.55 -166.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.66 111.04 20.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.37 1.068 . . . . 0.0 108.599 -169.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.2 -1.889 . . . . 0.0 110.673 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -115.29 -66.88 1.04 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.072 0.936 . . . . 0.0 109.258 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -56.08 -40.39 73.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.277 0.944 . . . . 0.0 110.537 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.29 174.42 8.62 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.484 0.491 . . . . 0.0 112.116 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -138.83 169.25 18.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 p -150.11 -56.63 0.18 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.726 2.011 . . . . 0.0 108.927 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.31 1.65 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.78 11.07 6.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.021 1.328 . . . . 0.0 111.092 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.518 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.454 HD23 HG21 ' A' ' 107' ' ' VAL . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 44' ' ' GLN . 0.2 OUTLIER -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 63' ' ' ILE . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.444 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 50' ' ' VAL . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 95' ' ' LEU . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 73' ' ' LEU . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG23 ' H ' ' A' ' 101' ' ' VAL . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 32' ' ' LEU . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.8 177.25 18.89 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 -33.36 9.43 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.718 2.945 . . . . 0.0 111.574 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -126.64 95.82 4.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.099 0.96 . . . . 0.0 108.494 -156.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -42.97 124.82 3.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.741 2.816 . . . . 0.0 110.895 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.471 0 CA-C-O 118.396 -1.225 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -127.34 -79.76 0.59 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.133 0.966 . . . . 0.0 108.867 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 123.81 21.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.519 1.127 . . . . 0.0 109.181 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.04 174.21 42.93 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.935 0.779 . . . . 0.0 112.555 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t 69.45 6.55 5.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.461 2.304 . . . . 0.0 114.908 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.81 163.29 1.46 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.431 1.492 . . . . 0.0 114.023 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.57 57.76 0.32 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 126.169 1.843 . . . . 0.0 111.159 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -75.8 22.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.87 2.468 . . . . 0.0 115.766 -153.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 9' ' ' VAL . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.772 HG22 HD13 ' A' ' 63' ' ' ILE . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.487 HG11 ' CG1' ' A' ' 101' ' ' VAL . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 102' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 58' ' ' LEU . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.772 HD13 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 ' CG1' HG11 ' A' ' 53' ' ' VAL . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.08 165.66 40.82 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.09 18.68 1.14 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.792 2.328 . . . . 0.0 115.033 -161.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 m -132.51 152.03 51.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.766 1.166 . . . . 0.0 108.464 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -159.78 121.51 3.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.48 0 CA-C-O 119.239 -0.756 . . . . 0.0 111.277 177.539 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -64.27 -9.19 15.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -150.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 m -132.56 1.44 3.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.484 1.038 . . . . 0.0 112.407 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.98 114.62 4.55 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -104.42 0.07 28.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.879 0.872 . . . . 0.0 112.585 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t -151.15 -169.24 3.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.901 1.28 . . . . 0.0 108.429 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.85 49.85 3.03 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -123.79 15.42 9.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.468 1.107 . . . . 0.0 112.89 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.594 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HB3' HG11 ' A' ' 107' ' ' VAL . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 39' ' ' LEU . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 63' ' ' ILE . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CH2' HG22 ' A' ' 102' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.584 HD13 HG22 ' A' ' 50' ' ' VAL . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.508 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.495 ' CD2' HD22 ' A' ' 95' ' ' LEU . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 73' ' ' LEU . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 31' ' ' LEU . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.35 174.71 19.53 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.73 91.12 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.284 3.323 . . . . 0.0 110.089 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 t -149.13 163.41 37.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.532 1.533 . . . . 0.0 108.719 -167.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.2 p -151.97 149.16 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.712 0.687 . . . . 0.0 111.486 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.326 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -70.89 -26.96 63.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.625 1.17 . . . . 0.0 110.875 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.33 160.64 21.3 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.253 1.021 . . . . 0.0 108.886 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.63 159.07 28.23 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m -128.57 -40.28 1.59 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.877 1.271 . . . . 0.0 108.75 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m 46.1 68.86 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.788 2.435 . . . . 0.0 111.668 165.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.6 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 61.04 17.98 8.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.684 1.193 . . . . 0.0 112.408 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 83' ' ' LEU . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CD2' HD23 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 39' ' ' LEU . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 39' ' ' LEU . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 63' ' ' ILE . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 101' ' ' VAL . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.653 HD13 HG22 ' A' ' 50' ' ' VAL . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.58 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.58 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB2' HD13 ' A' ' 83' ' ' LEU . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.448 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 101' ' ' VAL . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.406 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 32' ' ' LEU . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.66 166.12 32.14 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.17 -21.24 12.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.45 2.1 . . . . 0.0 113.647 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.9 m -85.68 173.01 10.41 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.509 1.504 . . . . 0.0 111.258 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.4 p -142.18 163.13 33.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.653 0.781 . . . . 0.0 110.164 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 N-CA-C 107.286 -2.325 . . . . 0.0 107.286 174.676 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.086 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -93.7 -14.8 25.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.466 1.633 . . . . 0.0 112.657 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -134.19 129.32 35.61 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.506 1.523 . . . . 0.0 106.929 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.14 159.21 14.89 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.245 0.926 . . . . 0.0 110.855 -163.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 t -143.46 -43.09 0.28 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.921 1.288 . . . . 0.0 109.899 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -145.48 173.87 11.65 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.313 1.045 . . . . 0.0 110.388 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.65 -136.45 12.16 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.754 -2.138 . . . . 0.0 107.754 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.11 26.68 12.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.047 1.339 . . . . 0.0 110.61 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 50' ' ' VAL . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.21 160.74 15.51 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.96 -21.41 27.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.35 2.034 . . . . 0.0 113.062 -168.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 t -109.87 134.75 51.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -171.57 -173.94 1.3 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 129.443 3.097 . . . . 0.0 106.899 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.734 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.01 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -94.96 -59.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.751 0.82 . . . . 0.0 109.95 -167.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -160.0 177.11 11.08 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.313 1.845 . . . . 0.0 107.812 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 156.2 24.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.277 0.941 . . . . 0.0 111.921 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -87.86 66.02 8.57 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.637 1.175 . . . . 0.0 112.134 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -79.05 59.54 2.72 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.035 1.734 . . . . 0.0 110.434 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.69 -34.36 19.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.518 1.056 . . . . 0.0 111.262 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 54.06 26.98 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.857 1.663 . . . . 0.0 113.163 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 HD23 ' A' ' 83' ' ' LEU . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 52' ' ' SER . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD21 HD23 ' A' ' 39' ' ' LEU . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.498 ' O ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.801 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 63' ' ' ILE . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB3' HG11 ' A' ' 28' ' ' VAL . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.624 HD13 HG22 ' A' ' 50' ' ' VAL . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.445 HD23 HG12 ' A' ' 9' ' ' VAL . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.466 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 101' ' ' VAL . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 160.0 26.76 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.74 86.24 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.554 2.836 . . . . 0.0 111.074 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 p -120.7 -174.66 2.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.005 1.722 . . . . 0.0 109.06 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.9 m -143.75 46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.66 -1.275 . . . . 0.0 108.202 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 -167.655 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.822 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -134.6 110.12 9.1 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -167.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -166.03 -170.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.56 0.744 . . . . 0.0 110.852 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -164.8 22.32 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.92 1.248 . . . . 0.0 112.234 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -132.15 29.34 4.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.191 1.796 . . . . 0.0 111.036 -167.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t 57.31 42.56 24.89 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.886 -1.134 . . . . 0.0 110.209 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.45 75.68 0.21 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -131.82 22.65 4.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.718 1.207 . . . . 0.0 110.34 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 83' ' ' LEU . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.429 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.85 HD21 HD23 ' A' ' 39' ' ' LEU . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 63' ' ' ILE . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' HG22 ' A' ' 102' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 50' ' ' VAL . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 83' ' ' LEU . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' HD12 ' A' ' 13' ' ' LEU . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.63 HG22 ' CH2' ' A' ' 55' ' ' TRP . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.67 164.2 22.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 -38.95 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.406 2.07 . . . . 0.0 112.59 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 t -86.26 148.49 25.61 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 p -144.95 168.83 19.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -163.707 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -140.73 121.42 14.31 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.467 1.134 . . . . 0.0 109.444 -171.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t -90.48 -75.95 0.45 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.79 162.25 26.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.07 1.319 . . . . 0.0 111.255 -175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.468 1.107 . . . . 0.0 108.403 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -147.64 138.08 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.941 1.297 . . . . 0.0 107.621 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.18 76.99 0.93 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -130.38 30.11 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.688 1.595 . . . . 0.0 110.202 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 52' ' ' SER . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 39' ' ' LEU . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 32' ' ' LEU . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 HD13 ' A' ' 63' ' ' ILE . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 95' ' ' LEU . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.528 ' CD2' HG23 ' A' ' 101' ' ' VAL . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.727 HD13 HG22 ' A' ' 50' ' ' VAL . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.6 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 80' ' ' SER . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' HG13 ' A' ' 101' ' ' VAL . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.9 -172.64 54.42 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -85.56 -5.54 9.09 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.548 3.498 . . . . 0.0 115.159 -169.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.2 t -155.55 169.44 24.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.006 0.922 . . . . 0.0 109.09 -168.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -113.11 161.91 16.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.46 1.504 . . . . 0.0 108.712 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -140.96 -3.79 1.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.79 1.236 . . . . 0.0 112.308 -164.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -75.39 -169.24 0.95 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.104 0.962 . . . . 0.0 110.566 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -69.33 0.22 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 39.61 65.76 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 111.686 166.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 m -66.2 157.81 30.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.956 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 38.79 67.84 0.52 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.129 2.299 . . . . 0.0 113.521 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -83.68 20.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.156 0.982 . . . . 0.0 111.941 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.438 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' HD3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' HD11 ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 63' ' ' ILE . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD22 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' HD3' HD22 ' A' ' 58' ' ' LEU . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.508 HD13 HG22 ' A' ' 50' ' ' VAL . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.512 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.423 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' HD12 ' A' ' 13' ' ' LEU . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.36 174.86 18.66 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.32 -8.33 15.1 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.6 2.867 . . . . 0.0 113.918 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.98 156.55 37.9 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.072 1.349 . . . . 0.0 108.088 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.0 p -150.59 169.0 22.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.675 0.39 . . . . 0.0 111.322 -167.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.984 176.039 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 m -134.04 -70.91 0.51 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -53.42 137.95 34.47 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 168.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.68 -72.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -171.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -146.93 161.4 40.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.678 1.239 . . . . 0.0 109.022 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -75.61 -3.94 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.674 0.789 . . . . 0.0 112.948 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 103.73 2.32 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -119.21 11.71 12.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.317 1.058 . . . . 0.0 111.515 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 37' ' ' ASP . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' HD22 ' A' ' 32' ' ' LEU . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 63' ' ' ILE . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.524 ' CD2' HG23 ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.515 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD2' HD22 ' A' ' 95' ' ' LEU . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 13' ' ' LEU . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.665 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' HG12 ' A' ' 101' ' ' VAL . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.87 171.77 28.52 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -15.45 34.09 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.659 2.24 . . . . 0.0 112.069 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -74.98 90.7 2.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.275 1.43 . . . . 0.0 108.892 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -60.99 150.55 33.17 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 164.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -176.009 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -58.42 -34.13 70.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -72.38 170.23 14.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 110.817 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.55 -93.9 1.7 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 m -138.09 150.64 47.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.422 1.111 . . . . 0.0 111.292 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.73 156.82 38.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.931 1.693 . . . . 0.0 110.021 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -77.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 163.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 55.15 16.62 1.66 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.546 1.138 . . . . 0.0 113.473 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 9' ' ' VAL . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 107' ' ' VAL . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD21 HD23 ' A' ' 39' ' ' LEU . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG22 HD13 ' A' ' 63' ' ' ILE . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.605 ' CH2' HG22 ' A' ' 102' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.632 ' H ' HD11 ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 50' ' ' VAL . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 13' ' ' LEU . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.605 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.732 ' HB3' HD12 ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.477 HG21 HD23 ' A' ' 32' ' ' LEU . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.7 173.0 13.66 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -83.65 -4.16 10.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.836 2.357 . . . . 0.0 113.708 -166.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 t -131.96 147.82 52.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.505 1.522 . . . . 0.0 109.292 -165.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.0 m -144.09 -178.15 5.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.309 1.844 . . . . 0.0 109.21 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.294 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -168.556 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.612 0 CA-C-O 119.48 -0.622 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -68.11 -54.28 19.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 150.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 p -67.61 158.36 32.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 167.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.32 -80.07 0.04 OUTLIER Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 p -66.04 -174.56 0.25 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.116 1.366 . . . . 0.0 111.655 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -142.3 9.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 112.535 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 163.81 28.19 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -145.07 21.48 1.58 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.521 1.128 . . . . 0.0 110.894 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG13 ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 23' ' ' ILE . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 52' ' ' SER . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 39' ' ' LEU . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 32' ' ' LEU . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' HG11 ' A' ' 28' ' ' VAL . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.438 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 50' ' ' VAL . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.559 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.438 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HB3' HD12 ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.26 171.32 29.03 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.58 3.32 5.49 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.757 2.305 . . . . 0.0 112.667 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -72.86 164.18 27.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.035 0.921 . . . . 0.0 110.195 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.71 153.9 46.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 157.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -176.065 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.905 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -78.4 149.9 33.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.927 0.87 . . . . 0.0 110.766 -165.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.5 p -118.34 -17.44 9.47 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 127.325 2.25 . . . . 0.0 111.495 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.61 8.62 87.59 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.075 -174.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.6 m -47.75 105.19 0.07 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.2 p -152.99 -159.07 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.649 1.58 . . . . 0.0 108.39 -175.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.1 -97.79 1.43 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 44.79 34.34 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.845 2.058 . . . . 0.0 112.754 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 107' ' ' VAL . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG22 HD13 ' A' ' 63' ' ' ILE . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HG22 ' A' ' 50' ' ' VAL . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CD ' ' H ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG21 HD23 ' A' ' 32' ' ' LEU . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.42 169.58 26.81 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.67 -1.73 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.945 3.097 . . . . 0.0 116.879 -162.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.73 157.17 46.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 121.292 1.86 . . . . 0.0 110.21 170.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.3 t -142.06 171.96 13.34 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 109.431 -166.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.239 -1.312 . . . . 0.0 109.972 -169.819 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 C--O 1.223 -0.302 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 9' ' ' VAL . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 107' ' ' VAL . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 63' ' ' ILE . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.75 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HD3' HD12 ' A' ' 58' ' ' LEU . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 50' ' ' VAL . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.486 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 67' ' ' LEU . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.438 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 31' ' ' LEU . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 . . . . . 0 C--O 1.22 -0.481 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 HG21 ' A' ' 107' ' ' VAL . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 63' ' ' ILE . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.587 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 50' ' ' VAL . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.487 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 101' ' ' VAL . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 32' ' ' LEU . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 . . . . . 0 C--O 1.224 -0.271 0 CA-C-O 120.41 0.148 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.761 HD21 HD23 ' A' ' 39' ' ' LEU . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.761 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 63' ' ' ILE . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.499 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 96' ' ' THR . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 62' ' ' PHE . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.44 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 56.2 m-70 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 121.008 0.432 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.475 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 39' ' ' LEU . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 HD13 ' A' ' 63' ' ' ILE . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.436 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.654 HD13 HG22 ' A' ' 50' ' ' VAL . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.547 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.436 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 C--O 1.22 -0.472 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 63' ' ' ILE . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 50' ' ' VAL . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 83' ' ' LEU . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.502 ' O ' HD12 ' A' ' 83' ' ' LEU . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.631 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 39' ' ' LEU . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 39' ' ' LEU . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 32' ' ' LEU . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 63' ' ' ILE . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.461 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.462 HD13 HG22 ' A' ' 50' ' ' VAL . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 13' ' ' LEU . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 9' ' ' VAL . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 96' ' ' THR . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.461 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 . . . . . 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 9' ' ' VAL . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 39' ' ' LEU . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' HD22 ' A' ' 103' ' ' LEU . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 32' ' ' LEU . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 63' ' ' ILE . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.536 ' CH2' HG22 ' A' ' 102' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 HG22 ' A' ' 50' ' ' VAL . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.496 ' CD2' HD22 ' A' ' 95' ' ' LEU . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' HD13 ' A' ' 83' ' ' LEU . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 80' ' ' SER . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 73' ' ' LEU . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.536 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.707 ' HB3' HD12 ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.454 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 32' ' ' LEU . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.566 0.222 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.518 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.454 HD23 HG21 ' A' ' 107' ' ' VAL . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.496 ' H ' ' CD ' ' A' ' 44' ' ' GLN . 2.8 pm0 -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 63' ' ' ILE . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.444 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 50' ' ' VAL . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 95' ' ' LEU . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 73' ' ' LEU . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.46 HG23 ' H ' ' A' ' 101' ' ' VAL . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 32' ' ' LEU . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 9' ' ' VAL . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.772 HG22 HD13 ' A' ' 63' ' ' ILE . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.487 HG11 ' CG1' ' A' ' 101' ' ' VAL . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 102' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 58' ' ' LEU . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.772 HD13 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 ' CG1' HG11 ' A' ' 53' ' ' VAL . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.594 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HB3' HG11 ' A' ' 107' ' ' VAL . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 39' ' ' LEU . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 63' ' ' ILE . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CH2' HG22 ' A' ' 102' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.584 HD13 HG22 ' A' ' 50' ' ' VAL . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.495 ' CD2' HD22 ' A' ' 95' ' ' LEU . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 73' ' ' LEU . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.599 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 31' ' ' LEU . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 83' ' ' LEU . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CD2' HD23 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 39' ' ' LEU . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 39' ' ' LEU . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 63' ' ' ILE . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 101' ' ' VAL . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.653 HD13 HG22 ' A' ' 50' ' ' VAL . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.58 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.58 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB2' HD13 ' A' ' 83' ' ' LEU . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.448 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 101' ' ' VAL . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.406 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 32' ' ' LEU . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.534 0.683 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 50' ' ' VAL . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 HD23 ' A' ' 83' ' ' LEU . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.416 ' CE1' HD13 ' A' ' 31' ' ' LEU . 14.0 m-70 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 52' ' ' SER . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 20' ' ' HIS . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.801 HD21 HD23 ' A' ' 39' ' ' LEU . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.498 ' O ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.801 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 63' ' ' ILE . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB3' HG11 ' A' ' 28' ' ' VAL . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.624 HD13 HG22 ' A' ' 50' ' ' VAL . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.445 HD23 HG12 ' A' ' 9' ' ' VAL . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.466 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 101' ' ' VAL . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 CA--C 1.535 0.391 0 CA-C-O 121.026 0.441 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 83' ' ' LEU . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.429 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.85 HD21 HD23 ' A' ' 39' ' ' LEU . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 63' ' ' ILE . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' HG22 ' A' ' 102' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 50' ' ' VAL . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 83' ' ' LEU . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' HD12 ' A' ' 13' ' ' LEU . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.63 HG22 ' CH2' ' A' ' 55' ' ' TRP . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.365 0.603 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 52' ' ' SER . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 39' ' ' LEU . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 32' ' ' LEU . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 HD13 ' A' ' 63' ' ' ILE . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 95' ' ' LEU . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.528 ' CD2' HG23 ' A' ' 101' ' ' VAL . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.727 HD13 HG22 ' A' ' 50' ' ' VAL . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 80' ' ' SER . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' HG13 ' A' ' 101' ' ' VAL . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.438 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' HD3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' HD11 ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 63' ' ' ILE . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.525 HD22 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' HD3' HD22 ' A' ' 58' ' ' LEU . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.508 HD13 HG22 ' A' ' 50' ' ' VAL . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.423 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' HD12 ' A' ' 13' ' ' LEU . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.644 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 111.515 0.191 . . . . 0.0 111.515 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 37' ' ' ASP . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' HD22 ' A' ' 32' ' ' LEU . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 63' ' ' ILE . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.524 ' CD2' HG23 ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.515 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD2' HD22 ' A' ' 95' ' ' LEU . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 13' ' ' LEU . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.665 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' HG12 ' A' ' 101' ' ' VAL . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 9' ' ' VAL . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 107' ' ' VAL . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.586 HD21 HD23 ' A' ' 39' ' ' LEU . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.685 HG22 HD13 ' A' ' 63' ' ' ILE . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.605 ' CH2' HG22 ' A' ' 102' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.632 ' H ' HD11 ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 50' ' ' VAL . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 13' ' ' LEU . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.605 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.732 ' HB3' HD12 ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.477 HG21 HD23 ' A' ' 32' ' ' LEU . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.869 0.366 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.408 HG13 ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 23' ' ' ILE . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 52' ' ' SER . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 39' ' ' LEU . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 32' ' ' LEU . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' HG11 ' A' ' 28' ' ' VAL . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.438 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 50' ' ' VAL . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.559 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.438 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HB3' HD12 ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 121.905 0.86 . . . . 0.0 112.754 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 107' ' ' VAL . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG22 HD13 ' A' ' 63' ' ' ILE . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HG22 ' A' ' 50' ' ' VAL . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.463 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.404 HG21 HD23 ' A' ' 32' ' ' LEU . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.855 0 CA-C-O 119.21 -0.772 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -130.83 94.19 3.57 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.809 1.805 . . . . 0.0 110.397 -165.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.7 p -160.39 170.17 21.57 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 126.698 1.999 . . . . 0.0 106.429 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.93 171.34 48.15 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 171.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.8 m -91.51 172.67 8.35 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.113 0.565 . . . . 0.0 109.56 165.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 p -71.12 175.82 4.94 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.91 0.884 . . . . 0.0 109.473 168.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 166.54 -153.16 22.73 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.941 -1.1 . . . . 0.0 111.586 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 68.61 9.32 7.25 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 127.448 2.299 . . . . 0.0 114.305 167.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 9' ' ' VAL . 6.4 t -55.79 -54.35 27.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 124.658 1.183 . . . . 0.0 109.135 -172.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -84.7 -6.85 59.38 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.004 0.922 . . . . 0.0 110.815 -170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.3 mttt -64.16 161.92 36.22 Favored Pre-proline 0 C--O 1.237 0.399 0 O-C-N 121.137 -0.977 . . . . 0.0 109.381 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.37 162.33 27.54 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 120.699 0.933 . . . . 0.0 110.115 168.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.4 tt -60.42 -31.95 70.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.34 171.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -77.0 0.17 22.19 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -125.39 22.28 7.76 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.82 1.248 . . . . 0.0 110.693 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -71.85 -178.7 2.4 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.532 0.682 . . . . 0.0 110.061 169.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.58 -43.78 3.79 Favored 'General case' 0 C--O 1.224 -0.242 0 C-N-CA 126.68 1.992 . . . . 0.0 110.758 176.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.6 p-90 -79.62 -5.06 54.27 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.697 1.599 . . . . 0.0 113.401 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -84.03 87.97 7.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -70.61 -45.42 65.31 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.733 -175.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.1 -147.56 18.91 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 108.251 -1.94 . . . . 0.0 108.251 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.66 103.59 2.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 124.347 1.059 . . . . 0.0 109.36 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.17 146.02 60.27 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.407 1.083 . . . . 0.0 108.165 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.16 168.88 22.88 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.324 2.682 . . . . 0.0 111.82 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -68.96 -27.61 65.88 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.093 -1.63 . . . . 0.0 112.949 178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.48 -37.82 68.35 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-N 118.893 0.77 . . . . 0.0 110.784 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -61.45 -33.55 73.93 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 123.494 0.718 . . . . 0.0 110.345 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.6 t -42.31 -62.74 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.244 0 C-N-CA 124.411 1.084 . . . . 0.0 109.777 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.75 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.45 -16.06 63.77 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -171.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -72.67 -32.33 65.75 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.88 0.872 . . . . 0.0 110.351 170.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB3' HG11 ' A' ' 107' ' ' VAL . 33.2 mt -86.76 -43.74 12.31 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 125.107 1.363 . . . . 0.0 110.743 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.7 mt -81.19 136.31 35.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 t -132.19 -27.71 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 122.866 0.467 . . . . 0.0 110.726 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -105.55 142.04 35.98 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.4 p -62.13 105.53 0.6 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 125.59 -20.59 6.47 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-O 116.865 -2.075 . . . . 0.0 114.477 -171.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.3 128.56 36.94 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -130.95 159.92 36.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.534 1.133 . . . . 0.0 110.125 170.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.22 163.38 33.02 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.887 2.075 . . . . 0.0 108.614 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.1 t -114.62 132.14 64.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -128.35 163.2 25.35 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.072 1.349 . . . . 0.0 109.52 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -101.52 152.14 21.13 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.988 0.915 . . . . 0.0 109.981 169.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -70.31 -167.26 0.16 Allowed 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.278 1.831 . . . . 0.0 109.789 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -83.93 52.16 2.22 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.832 1.253 . . . . 0.0 109.618 -171.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.11 10.43 64.37 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.364 1.459 . . . . 0.0 113.159 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -93.18 144.42 25.3 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 69.8 mm-40 -76.45 49.5 0.6 Allowed 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 119.181 0.9 . . . . 0.0 110.896 -176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -139.48 119.87 13.92 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 126.117 1.767 . . . . 0.0 108.227 -164.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -88.59 162.58 16.28 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.92 -1.491 . . . . 0.0 110.096 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.602 HG22 HD13 ' A' ' 63' ' ' ILE . 24.8 t -137.99 136.9 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 126.509 1.924 . . . . 0.0 105.935 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 22.4 tp -90.79 126.82 36.13 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 126.913 2.085 . . . . 0.0 107.394 170.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.98 112.09 12.63 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -169.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.9 p -144.91 137.56 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.091 1.356 . . . . 0.0 111.178 -159.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.0 tp -96.2 118.66 33.22 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.444 -1.687 . . . . 0.0 106.444 -170.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.445 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 4.1 t-105 -137.77 127.76 25.73 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 52.73 41.65 31.56 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.771 0.796 . . . . 0.0 111.375 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.14 30.08 75.26 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 125.023 1.297 . . . . 0.0 112.822 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD12 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tm? -144.3 110.25 5.0 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -172.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.75 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 89.1 Cg_endo -70.1 92.19 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.29 3.327 . . . . 0.0 109.599 177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.402 ' HD3' HD12 ' A' ' 58' ' ' LEU . 17.2 mmt-85 -62.42 157.79 19.21 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -135.54 114.59 12.21 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -121.24 129.65 53.28 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.602 HD13 HG22 ' A' ' 50' ' ' VAL . 6.0 mm -58.87 135.2 23.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.3 mm -60.05 135.64 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 170.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.486 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -47.37 161.47 0.08 Allowed 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 129.668 3.187 . . . . 0.0 110.687 176.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t 173.4 124.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.545 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.3 OUTLIER -124.63 -48.7 1.79 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.041 1.336 . . . . 0.0 110.273 -178.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -142.68 -83.09 0.18 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -161.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -145.49 25.45 1.35 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.825 2.45 . . . . 0.0 109.2 174.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.412 ' HB2' HD21 ' A' ' 67' ' ' LEU . 5.2 mt -130.54 -173.97 3.22 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 126.581 1.952 . . . . 0.0 108.644 -171.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -142.91 126.34 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.545 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -137.8 128.19 26.37 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.862 1.665 . . . . 0.0 108.848 -176.42 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.7 tp -123.98 -40.34 2.3 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.442 1.019 . . . . 0.0 113.326 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -117.84 -67.51 0.99 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.14 -129.92 6.59 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.552 2.025 . . . . 0.0 110.675 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.98 175.23 5.3 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 117.557 0.678 . . . . 0.0 112.534 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.66 164.51 19.87 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 123.988 0.804 . . . . 0.0 112.924 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -132.06 159.28 72.81 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 125.117 1.367 . . . . 0.0 109.461 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.53 -14.82 34.0 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.551 3.501 . . . . 0.0 114.154 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.602 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.5 m -136.3 150.65 48.99 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -175.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 61.0 mt -63.79 -49.24 77.06 Favored Pre-proline 0 N--CA 1.451 -0.379 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 172.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 20.9 Cg_endo -64.12 -30.35 65.42 Favored 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 121.144 1.444 . . . . 0.0 112.956 -172.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.602 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -67.25 -38.82 85.8 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 123.39 0.676 . . . . 0.0 109.734 177.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.81 -41.74 78.24 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 123.711 0.804 . . . . 0.0 110.22 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.7 mm -53.12 -43.43 48.84 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.427 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.29 -40.4 81.78 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 120.17 1.35 . . . . 0.0 110.769 -171.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -76.41 -3.14 35.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.99 -42.79 8.46 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.519 1.127 . . . . 0.0 110.757 162.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.72 -41.2 72.2 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 125.249 1.42 . . . . 0.0 111.002 -168.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.72 -16.43 53.94 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.356 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -100.53 -22.68 14.91 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 68.02 31.44 5.52 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.46 1.104 . . . . 0.0 109.906 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -65.77 143.21 98.47 Favored Pre-proline 0 CA--C 1.538 0.484 0 O-C-N 121.862 -0.524 . . . . 0.0 110.932 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.29 131.34 13.86 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 123.765 2.977 . . . . 0.0 112.098 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 33.2 mt -67.74 -30.34 69.8 Favored 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 124.66 1.184 . . . . 0.0 112.194 -176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.2 t -153.62 151.39 29.66 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 172.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -63.81 0.05 0.93 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.988 1.315 . . . . 0.0 112.133 170.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -115.41 -6.03 12.3 Favored 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 66.0 m -145.16 -7.9 0.62 Allowed 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 50.51 26.46 10.12 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 126.51 2.005 . . . . 0.0 115.527 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 16.4 t -55.77 139.25 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 C-N-CA 124.846 1.258 . . . . 0.0 107.739 170.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.1 151.35 35.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 120.027 1.285 . . . . 0.0 108.068 169.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 19.6 mt -76.74 136.96 39.05 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.232 1.013 . . . . 0.0 109.12 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.438 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 52.2 m-70 -138.06 -57.28 0.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -125.24 143.74 50.8 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 121.447 -0.783 . . . . 0.0 109.053 -166.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -116.77 117.76 30.65 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 31' ' ' LEU . 61.2 t -67.12 118.5 56.4 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 173.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -73.24 146.54 40.69 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 121.339 1.359 . . . . 0.0 111.297 171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.4 t -135.09 -0.16 2.79 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.642 2.377 . . . . 0.0 111.801 172.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.03 174.51 47.19 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.069 0.842 . . . . 0.0 111.3 -172.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -89.62 -11.22 3.45 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.646 2.898 . . . . 0.0 113.93 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.5 t -86.04 87.31 7.4 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.67 1.188 . . . . 0.0 107.887 -170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.7 p -74.0 99.28 3.25 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.085 1.754 . . . . 0.0 111.113 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 117.86 -1.522 . . . . 0.0 111.023 170.44 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.751 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.0 m -59.9 107.09 0.57 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 172.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.7 t -110.09 -57.03 2.25 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -168.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.77 -103.6 1.08 Allowed Glycine 0 C--N 1.337 0.601 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.7 m 53.16 30.77 10.31 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.894 1.278 . . . . 0.0 111.926 -172.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.8 m -105.21 -7.21 19.15 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.337 1.055 . . . . 0.0 112.566 -176.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 127.51 110.71 1.62 Allowed Glycine 0 C--N 1.333 0.385 0 N-CA-C 107.736 -2.145 . . . . 0.0 107.736 -169.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.5 mp0 -130.98 3.56 4.41 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 124.788 1.235 . . . . 0.0 112.756 -168.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 t -50.01 -54.65 7.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 126.406 1.882 . . . . 0.0 109.568 -169.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -79.82 -5.71 55.95 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.74 0.816 . . . . 0.0 111.897 -168.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.08 161.25 57.55 Favored Pre-proline 0 N--CA 1.464 0.232 0 O-C-N 120.971 -1.081 . . . . 0.0 109.947 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.5 162.44 24.24 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.824 1.016 . . . . 0.0 109.894 171.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.7 tt -56.37 -36.18 68.54 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.849 171.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -74.0 5.28 4.4 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -133.91 17.47 3.85 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.036 1.335 . . . . 0.0 110.982 177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.0 mm-40 -73.45 174.39 8.26 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.43 0.692 . . . . 0.0 110.234 171.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 -47.73 3.71 Favored 'General case' 0 C--O 1.221 -0.424 0 C-N-CA 124.46 1.104 . . . . 0.0 108.361 -174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.2 p-90 -69.9 -7.35 39.63 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 123.665 0.786 . . . . 0.0 112.687 176.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -80.89 106.2 12.72 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -102.39 3.55 37.97 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 81.14 -162.89 44.7 Favored Glycine 0 N--CA 1.434 -1.494 0 CA-C-O 123.809 1.783 . . . . 0.0 108.9 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.44 75.98 2.5 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.008 -1.096 . . . . 0.0 111.933 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -95.82 143.12 25.57 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 125.172 1.389 . . . . 0.0 108.994 175.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.02 164.16 36.53 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 124.486 3.457 . . . . 0.0 112.507 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -64.89 -25.05 67.72 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.605 -1.309 . . . . 0.0 113.161 177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.66 -44.64 85.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.91 -25.63 61.12 Favored 'General case' 0 C--O 1.219 -0.549 0 C-N-CA 123.934 0.894 . . . . 0.0 111.754 -169.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -44.83 -62.88 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.227 0 C-N-CA 125.087 1.355 . . . . 0.0 110.734 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.693 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.64 -19.95 66.0 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.469 1.031 . . . . 0.0 112.225 -169.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -72.82 -26.81 61.62 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.541 1.136 . . . . 0.0 111.17 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.84 -42.4 10.66 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.677 1.191 . . . . 0.0 110.974 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 HG21 ' A' ' 107' ' ' VAL . 12.6 mt -80.56 136.48 36.28 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -177.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 44.7 t -130.04 -27.29 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.649 1.113 . . . . 0.0 112.571 -175.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -116.67 146.63 42.61 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 p -55.29 114.55 1.84 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 167.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.36 8.26 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-O 116.997 -2.002 . . . . 0.0 114.654 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -59.47 126.18 26.59 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 175.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -128.2 160.61 31.55 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.442 1.097 . . . . 0.0 109.958 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.67 162.1 36.34 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.859 1.664 . . . . 0.0 108.16 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.7 t -108.97 124.99 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 28.9 ptt85 -124.81 -179.45 4.53 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.998 1.719 . . . . 0.0 108.802 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -112.55 161.43 16.77 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.08 0.854 . . . . 0.0 111.126 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -68.04 -173.65 0.4 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.603 1.561 . . . . 0.0 109.891 173.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -87.22 79.65 8.51 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 120.884 -1.135 . . . . 0.0 109.288 -172.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.03 -16.44 8.77 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.866 1.222 . . . . 0.0 113.309 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.84 153.03 42.18 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 118.674 1.237 . . . . 0.0 109.834 173.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -90.16 54.75 2.87 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 124.989 1.315 . . . . 0.0 107.814 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -140.05 129.25 23.77 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -86.11 161.38 18.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 122.346 1.069 . . . . 0.0 110.47 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 63' ' ' ILE . 5.5 t -135.66 126.72 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 105.286 -2.116 . . . . 0.0 105.286 -175.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -80.74 137.43 36.27 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 165.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.9 m -140.85 129.02 22.17 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 120.393 -1.442 . . . . 0.0 107.984 170.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -143.13 137.01 26.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.326 1.45 . . . . 0.0 108.446 -167.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.8 113.51 21.4 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.587 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 14.2 t-105 -125.49 103.47 7.9 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.6 t70 57.04 47.06 18.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 122.222 1.011 . . . . 0.0 110.634 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.4 -2.58 87.75 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 126.014 1.769 . . . . 0.0 113.303 176.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -117.4 106.53 46.6 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 118.769 1.284 . . . . 0.0 108.582 -172.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.693 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 72.2 Cg_endo -65.92 91.85 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 124.73 3.62 . . . . 0.0 110.759 174.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 -61.17 164.95 4.75 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.941 1.697 . . . . 0.0 109.934 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -144.08 75.35 1.46 Allowed 'General case' 0 C--O 1.237 0.433 0 O-C-N 121.309 -0.87 . . . . 0.0 110.822 -176.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.505 ' CZ ' HG21 ' A' ' 101' ' ' VAL . 56.2 m-85 -83.42 127.97 34.13 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 50' ' ' VAL . 18.5 mm -64.21 140.6 19.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 170.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.3 mm -64.82 142.56 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 123.055 1.407 . . . . 0.0 108.077 171.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.86 168.28 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 127.885 2.474 . . . . 0.0 109.472 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.8 t 179.34 136.09 0.1 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 105.706 -1.961 . . . . 0.0 105.706 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.487 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.31 -66.86 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.212 1.005 . . . . 0.0 110.264 178.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -139.55 -57.31 0.58 Allowed 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.6 0.76 . . . . 0.0 110.031 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -134.4 11.68 3.81 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.172 1.389 . . . . 0.0 112.191 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 mt -144.43 -172.11 3.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.108 0.963 . . . . 0.0 109.45 -161.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -142.8 126.09 16.56 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 175.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -140.19 130.34 25.01 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 121.475 1.943 . . . . 0.0 109.991 -177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.7 tp -115.14 -72.17 0.71 Allowed 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 120.398 1.453 . . . . 0.0 112.166 -171.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -87.32 -52.84 5.16 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 123.766 0.827 . . . . 0.0 109.011 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.82 -130.35 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 124.761 1.172 . . . . 0.0 111.409 -168.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -77.05 179.28 6.35 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.536 1.134 . . . . 0.0 112.025 -177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -123.8 150.06 16.93 Favored Glycine 0 C--N 1.338 0.655 0 C-N-CA 123.353 0.501 . . . . 0.0 113.552 -169.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -123.25 156.7 63.01 Favored Pre-proline 0 CA--C 1.522 -0.122 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -173.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -68.09 -17.49 45.7 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 124.054 3.169 . . . . 0.0 112.857 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.9 m -135.01 150.39 50.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.155 1.382 . . . . 0.0 107.301 -172.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 53.3 mt -60.81 -51.18 81.36 Favored Pre-proline 0 N--CA 1.452 -0.367 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 169.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.5 Cg_endo -63.15 -36.9 55.21 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 120.185 1.102 . . . . 0.0 110.872 -173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.0 mp -75.32 -1.43 23.61 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 117.143 -1.408 . . . . 0.0 112.271 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.66 -35.05 9.62 Favored 'General case' 0 C--N 1.338 0.08 0 CA-C-N 120.255 1.389 . . . . 0.0 112.595 162.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 25.6 mm -50.13 -44.63 22.74 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.464 0 C-N-CA 123.517 0.727 . . . . 0.0 111.626 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.3 -40.85 94.33 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 120.279 1.4 . . . . 0.0 109.736 -175.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.77 -0.89 19.74 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.5 1.12 . . . . 0.0 112.791 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.2 mt -101.85 -42.67 6.06 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 123.93 0.892 . . . . 0.0 111.228 159.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -31.65 63.45 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 124.258 1.023 . . . . 0.0 111.164 -167.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.8 t -76.71 -36.67 57.04 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 177.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -91.76 -32.92 15.21 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -160.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.408 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.9 OUTLIER 76.37 36.08 0.41 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 127.395 2.278 . . . . 0.0 110.364 179.105 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -64.83 148.27 97.48 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 124.288 1.035 . . . . 0.0 111.489 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 49.6 Cg_endo -68.11 150.6 77.35 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 122.506 2.138 . . . . 0.0 110.538 172.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.9 mt -86.74 -36.41 18.65 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.005 0.922 . . . . 0.0 111.543 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.3 t -162.31 148.88 13.28 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 120.624 -1.297 . . . . 0.0 108.674 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.74 -29.06 58.92 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 125.346 1.458 . . . . 0.0 111.46 171.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.5 mmpt? -70.46 -8.87 54.34 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.469 ' HB3' HG23 ' A' ' 101' ' ' VAL . 59.7 m -140.7 -62.46 0.49 Allowed 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 119.297 0.953 . . . . 0.0 111.461 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.54 28.25 30.31 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.302 0.954 . . . . 0.0 112.05 -164.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.587 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.4 t -57.25 150.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.271 0 CA-C-O 116.856 -1.545 . . . . 0.0 109.791 163.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.54 158.09 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 119.993 1.27 . . . . 0.0 108.007 167.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 33.0 mt -77.88 135.04 37.84 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 120.747 -1.22 . . . . 0.0 108.756 174.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -135.67 -38.84 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 118.216 -0.897 . . . . 0.0 112.14 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -146.48 150.03 34.79 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 120.563 1.528 . . . . 0.0 109.841 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.56 126.38 51.86 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.087 0.858 . . . . 0.0 109.293 -174.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 HD23 ' A' ' 32' ' ' LEU . 44.7 t -73.68 125.0 90.81 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 118.185 -0.912 . . . . 0.0 108.694 175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.27 120.23 4.03 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.151 2.567 . . . . 0.0 111.971 175.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 10.9 t -74.02 -30.67 62.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.814 1.646 . . . . 0.0 110.848 171.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.6 177.43 48.27 Favored Glycine 0 CA--C 1.534 1.251 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -151.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -67.24 -10.57 29.1 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.626 2.884 . . . . 0.0 116.28 -168.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -160.83 164.09 31.61 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 120.468 1.485 . . . . 0.0 110.188 -174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.3 m -147.28 163.93 34.84 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.921 2.088 . . . . 0.0 108.762 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.03 0 N-CA-C 106.847 -2.501 . . . . 0.0 106.847 174.036 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.486 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.15 -5.46 0.68 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.59 0.756 . . . . 0.0 112.13 -175.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.2 t -69.98 168.95 14.28 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.156 0.889 . . . . 0.0 111.49 -171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.19 -131.46 1.29 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -171.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.68 -20.01 30.95 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.666 1.233 . . . . 0.0 111.938 174.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 m 59.78 20.22 9.03 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.39 1.876 . . . . 0.0 111.868 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.89 90.6 1.38 Allowed Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -168.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -111.16 14.34 21.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 125.404 1.482 . . . . 0.0 110.869 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' O ' HD12 ' A' ' 83' ' ' LEU . 3.0 t -49.88 -47.31 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 C-N-CA 125.437 1.495 . . . . 0.0 109.817 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -84.81 -10.94 56.69 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -170.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 mmtt -59.68 164.99 4.77 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 123.731 0.813 . . . . 0.0 110.115 175.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -64.12 161.07 35.18 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 N-CA-C 109.092 -1.157 . . . . 0.0 109.092 170.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.7 tt -59.17 -35.95 74.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 119.219 -0.419 . . . . 0.0 110.622 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 31.9 p80 -71.51 -3.57 21.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -170.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -121.56 10.45 10.42 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.728 1.211 . . . . 0.0 111.134 178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -72.74 165.04 25.59 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.831 0.824 . . . . 0.0 110.049 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -50.86 4.43 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 125.044 1.338 . . . . 0.0 109.245 -168.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 8.0 p-90 -64.03 -10.02 19.46 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.109 1.363 . . . . 0.0 112.303 171.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -78.81 102.12 7.98 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -88.84 -1.35 58.05 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 119.256 0.935 . . . . 0.0 112.981 179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.24 -101.18 2.74 Favored Glycine 0 C--N 1.342 0.881 0 O-C-N 119.947 -1.721 . . . . 0.0 109.166 176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.17 135.28 52.47 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.565 2.346 . . . . 0.0 109.061 158.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 156.18 72.67 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 125.855 1.662 . . . . 0.0 107.207 168.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -66.26 172.88 8.21 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.676 2.917 . . . . 0.0 112.053 172.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -67.5 -44.99 77.14 Favored 'General case' 0 CA--C 1.51 -0.566 0 O-C-N 119.466 -2.021 . . . . 0.0 109.777 169.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.46 -39.08 67.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 119.057 -0.496 . . . . 0.0 111.988 -168.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -69.26 -24.58 64.0 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.921 1.289 . . . . 0.0 112.398 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -53.86 -57.47 5.51 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 123.296 0.638 . . . . 0.0 110.652 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.53 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.92 -7.69 30.5 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -172.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.03 -40.46 53.41 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 124.125 0.97 . . . . 0.0 110.15 166.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.76 -39.93 69.65 Favored 'General case' 0 N--CA 1.457 -0.104 0 C-N-CA 124.719 1.208 . . . . 0.0 109.846 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.761 HD21 HD23 ' A' ' 39' ' ' LEU . 2.2 mt -102.74 119.54 39.01 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 39.7 t -112.37 -34.42 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 124.103 0.961 . . . . 0.0 108.885 171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.3 m80 -100.91 143.28 31.25 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -168.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.0 p -68.53 85.55 0.29 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.246 1.818 . . . . 0.0 110.627 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.52 -24.25 1.21 Allowed Glycine 0 CA--C 1.509 -0.341 0 CA-C-O 117.758 -1.579 . . . . 0.0 114.395 -169.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.428 ' HB3' HD22 ' A' ' 32' ' ' LEU . 1.0 OUTLIER -64.98 130.83 44.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.4 p90 -135.61 154.04 51.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.758 1.623 . . . . 0.0 110.515 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.761 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.52 163.01 34.34 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.066 1.746 . . . . 0.0 108.272 171.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.0 t -108.76 129.14 63.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -130.89 168.88 16.56 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 124.268 1.027 . . . . 0.0 110.579 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 23.3 tt0 -105.55 146.73 29.22 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.9 t -61.13 162.86 6.76 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.995 1.718 . . . . 0.0 110.588 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -73.13 100.0 2.94 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.167 0.508 . . . . 0.0 109.767 177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.23 -0.23 59.87 Favored Glycine 0 CA--C 1.524 0.625 0 C-N-CA 125.473 1.511 . . . . 0.0 114.901 169.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 23.1 mmtm -87.88 176.36 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 168.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -115.75 65.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 105.662 -1.977 . . . . 0.0 105.662 168.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -140.61 129.9 23.75 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 104.898 -2.26 . . . . 0.0 104.898 -177.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -86.49 158.83 19.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.44 1.591 . . . . 0.0 110.397 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 63' ' ' ILE . 3.1 t -134.5 132.91 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.0 tp -77.44 144.99 37.41 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 167.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.19 116.52 14.57 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 155.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 p -125.9 141.24 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 126.78 2.032 . . . . 0.0 108.054 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 24.5 tp -88.34 116.31 26.47 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.499 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 10.1 t-105 -138.46 141.72 39.47 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 53.81 24.35 4.39 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.614 1.166 . . . . 0.0 111.907 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.67 13.27 83.69 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 120.894 -1.129 . . . . 0.0 113.565 -175.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.8 120.44 26.68 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 119.208 1.504 . . . . 0.0 108.006 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.53 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.2 Cg_endo -66.29 89.58 0.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.226 1.95 . . . . 0.0 110.278 172.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -60.48 156.45 16.15 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.269 1.428 . . . . 0.0 109.846 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -141.86 66.49 1.35 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 122.063 0.935 . . . . 0.0 110.051 -172.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 96' ' ' THR . 33.1 m-85 -74.43 131.15 40.82 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 173.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.522 HD13 HG22 ' A' ' 50' ' ' VAL . 10.9 mm -64.42 140.3 19.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 171.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.4 mm -65.75 142.06 17.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 106.379 -1.712 . . . . 0.0 106.379 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.52 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.11 161.92 0.76 Allowed 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 127.125 2.17 . . . . 0.0 108.41 174.349 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.75 136.36 0.18 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 166.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.79 -118.95 0.27 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -75.62 -60.47 2.3 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.38 1.072 . . . . 0.0 109.628 -174.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -145.76 7.83 1.11 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.82 1.248 . . . . 0.0 111.417 178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.15 176.01 5.65 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.643 1.177 . . . . 0.0 108.837 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -135.36 129.92 34.14 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.87 129.31 17.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 120.817 1.644 . . . . 0.0 110.801 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tp -114.81 -70.23 0.81 Allowed 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 119.645 1.111 . . . . 0.0 112.422 -168.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -87.24 -55.82 3.64 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.31 -137.35 6.25 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 126.381 1.944 . . . . 0.0 110.926 -171.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.97 172.66 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.371 1.468 . . . . 0.0 112.658 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 164.15 14.71 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 123.088 0.375 . . . . 0.0 113.326 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -128.94 154.62 80.27 Favored Pre-proline 0 N--CA 1.462 0.165 0 C-N-CA 123.772 0.829 . . . . 0.0 109.273 170.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.48 -13.63 35.68 Favored 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 124.925 3.75 . . . . 0.0 114.375 -176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -135.9 149.43 48.97 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 59.0 mt -63.15 -48.03 84.44 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-O 117.543 -1.218 . . . . 0.0 107.802 169.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 26.0 Cg_endo -61.91 -29.48 82.35 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.262 1.486 . . . . 0.0 112.491 -175.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.6 mp -81.34 6.18 15.11 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 126.073 1.749 . . . . 0.0 112.418 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tp -110.64 -25.12 10.13 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 165.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 37.0 mm -55.95 -48.43 78.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 CA-C-N 118.238 0.472 . . . . 0.0 110.438 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -65.43 -42.17 92.73 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 125.488 1.515 . . . . 0.0 109.479 -171.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -70.31 -10.6 59.46 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 118.089 -0.957 . . . . 0.0 111.64 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.91 -32.63 10.89 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 120.888 1.676 . . . . 0.0 112.415 167.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.6 -41.36 60.59 Favored 'General case' 0 CA--C 1.514 -0.419 0 C-N-CA 124.529 1.132 . . . . 0.0 109.99 -174.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.1 t -75.28 -24.83 57.59 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.626 -0.43 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 70.1 p -102.84 -21.66 13.99 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 124.564 1.145 . . . . 0.0 109.783 -165.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 66.53 34.95 5.73 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.75 1.22 . . . . 0.0 109.919 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -67.07 143.11 97.64 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.136 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 77.2 Cg_endo -73.81 129.94 14.04 Favored 'Trans proline' 0 N--CA 1.442 -1.504 0 C-N-CA 124.665 3.577 . . . . 0.0 112.516 175.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 18.7 mt -74.34 -30.58 62.08 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 124.017 0.927 . . . . 0.0 112.504 -176.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 62' ' ' PHE . 5.9 t -156.03 153.38 29.36 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.31 -14.73 62.71 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.116 0.967 . . . . 0.0 110.168 173.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.45 -21.48 61.23 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 117.194 -1.384 . . . . 0.0 113.768 178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 36.1 m -149.18 -15.77 0.29 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 -172.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.9 32.17 48.2 Favored Glycine 0 CA--C 1.526 0.76 0 CA-C-O 118.795 -1.003 . . . . 0.0 112.557 -173.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.499 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.5 t -52.7 137.17 12.91 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 117.107 -1.425 . . . . 0.0 107.823 170.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -124.38 165.19 21.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 119.871 1.214 . . . . 0.0 107.984 172.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.0 mt -92.97 133.98 35.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.44 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 56.2 m-70 -131.61 -47.82 0.97 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 118.102 -0.952 . . . . 0.0 110.796 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -139.09 144.92 38.94 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.187 1.358 . . . . 0.0 111.606 -165.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -122.58 113.8 19.76 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 123.837 0.855 . . . . 0.0 109.854 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 t -65.76 123.31 84.42 Favored Pre-proline 0 N--CA 1.464 0.236 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.28 110.24 3.03 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.478 2.119 . . . . 0.0 111.596 172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 t -63.82 -50.75 67.7 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 159.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.95 175.36 13.93 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 107.684 -2.166 . . . . 0.0 107.684 -172.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.71 4.59 3.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.127 2.551 . . . . 0.0 114.046 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.5 t -128.29 86.52 2.47 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 120.494 1.497 . . . . 0.0 108.909 -173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.46 101.11 6.28 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 N-CA-C 107.06 -2.416 . . . . 0.0 107.06 -179.567 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.629 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 m 53.84 21.55 2.82 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.368 1.467 . . . . 0.0 114.817 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.7 m -129.25 174.18 9.83 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.24 1.016 . . . . 0.0 110.21 178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.11 6.7 13.46 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 125.849 1.69 . . . . 0.0 112.791 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.5 t -60.0 134.84 57.42 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.818 1.309 . . . . 0.0 108.773 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.6 m -144.88 159.93 42.12 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.45 1.1 . . . . 0.0 109.746 -170.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.52 147.68 48.87 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 123.963 0.792 . . . . 0.0 111.134 -174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.77 16.37 5.27 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.984 1.314 . . . . 0.0 111.257 -164.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.6 t -55.45 -42.28 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 125.677 1.591 . . . . 0.0 111.08 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -79.58 -9.91 59.71 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 122.625 0.37 . . . . 0.0 110.965 -173.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 mttt -70.2 161.99 72.3 Favored Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 121.465 -0.772 . . . . 0.0 110.31 172.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -63.06 166.7 13.82 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.867 1.711 . . . . 0.0 110.699 173.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -59.33 -34.06 71.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.657 172.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -77.6 1.24 20.25 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -171.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -114.45 8.78 16.62 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.096 1.358 . . . . 0.0 111.813 171.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -76.52 154.45 34.58 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 122.294 1.045 . . . . 0.0 110.015 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.4 OUTLIER -90.32 -51.42 5.44 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 125.521 1.528 . . . . 0.0 107.841 -167.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.475 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 15.1 p-90 -64.19 -11.07 27.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 126.174 1.79 . . . . 0.0 112.36 170.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -78.57 100.93 7.15 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.395 0.998 . . . . 0.0 108.933 173.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -90.04 8.96 29.92 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.544 1.138 . . . . 0.0 112.436 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.01 -101.94 2.23 Favored Glycine 0 C--N 1.337 0.585 0 O-C-N 119.765 -1.835 . . . . 0.0 108.944 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.07 124.21 27.2 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.12 2.968 . . . . 0.0 107.634 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.36 148.76 38.72 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.78 155.93 43.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.85 3.034 . . . . 0.0 111.814 174.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -56.4 -27.37 56.21 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.794 -1.191 . . . . 0.0 113.774 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.09 -33.33 61.63 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 118.821 0.737 . . . . 0.0 111.16 -174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -66.28 -31.4 72.19 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.436 0.694 . . . . 0.0 110.706 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.5 t -46.78 -61.91 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 125.111 1.365 . . . . 0.0 110.992 -175.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.513 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -68.54 -12.01 60.69 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.258 0.936 . . . . 0.0 113.038 -168.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -76.07 -36.41 58.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.565 0.746 . . . . 0.0 110.889 168.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.3 mt -71.21 -48.37 51.81 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.549 HD21 HD23 ' A' ' 39' ' ' LEU . 13.0 mt -83.68 137.14 33.92 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -170.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -122.44 -43.53 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 123.471 0.708 . . . . 0.0 109.739 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -113.55 153.81 28.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.492 0.663 . . . . 0.0 109.546 -171.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.0 p -59.49 118.87 6.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.91 -22.06 9.3 Favored Glycine 0 C--N 1.33 0.214 0 CA-C-O 117.701 -1.611 . . . . 0.0 113.481 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -60.86 128.62 37.42 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 125.487 1.515 . . . . 0.0 107.07 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -137.49 161.28 36.81 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.611 1.164 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -143.14 169.51 17.47 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 125.527 1.531 . . . . 0.0 108.363 168.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.2 t -116.9 137.06 52.03 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 163.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -138.33 164.94 28.0 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.249 1.42 . . . . 0.0 107.439 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -87.41 170.38 11.43 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 125.288 1.435 . . . . 0.0 109.741 174.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 t -59.17 -168.21 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.884 1.674 . . . . 0.0 111.608 165.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.3 pm0 -86.35 21.32 2.11 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 120.821 -1.174 . . . . 0.0 111.158 171.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.48 53.45 0.12 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.838 1.208 . . . . 0.0 112.146 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -137.2 179.55 6.33 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.669 1.588 . . . . 0.0 108.638 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -91.64 28.62 1.71 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.336 1.054 . . . . 0.0 110.662 173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -113.2 135.69 53.55 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 104.799 -2.297 . . . . 0.0 104.799 -172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -102.83 157.28 17.07 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.776 0.798 . . . . 0.0 109.064 168.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.654 HG22 HD13 ' A' ' 63' ' ' ILE . 97.6 t -125.6 136.36 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 128.842 2.857 . . . . 0.0 105.143 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.4 tp -85.4 146.26 27.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 166.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.4 m -141.44 117.33 10.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 163.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.26 135.43 59.61 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 125.782 1.633 . . . . 0.0 108.63 -177.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 17.2 tp -81.83 117.06 21.81 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.436 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.4 t-105 -135.1 135.87 41.52 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.4 t70 62.01 14.1 6.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 174.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.88 28.65 54.1 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 124.398 0.999 . . . . 0.0 112.036 -172.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -137.19 114.62 9.86 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.513 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -66.08 94.41 0.29 Allowed 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.199 2.599 . . . . 0.0 108.262 172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 21.9 mmt180 -59.0 162.81 3.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -140.37 99.06 3.56 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -110.5 136.08 50.18 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.654 HD13 HG22 ' A' ' 50' ' ' VAL . 3.4 mm -63.43 144.39 14.65 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.4 mm -63.95 141.61 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.547 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.3 OUTLIER -48.23 162.91 0.08 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.562 2.745 . . . . 0.0 111.459 176.177 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.6 t 178.56 133.4 0.08 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.45 -62.52 0.83 Allowed 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 118.357 0.526 . . . . 0.0 110.786 172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -135.46 -59.66 0.77 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 118.732 0.696 . . . . 0.0 109.383 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -140.76 19.27 2.33 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.912 1.285 . . . . 0.0 110.835 174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.4 mt -142.8 169.95 16.62 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 125.299 1.439 . . . . 0.0 109.556 -166.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -129.33 121.4 27.41 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.42 143.21 48.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 120.127 1.331 . . . . 0.0 108.852 177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tp -125.13 -36.91 2.47 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 120.434 1.47 . . . . 0.0 113.813 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -125.4 -70.05 0.76 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.73 -160.36 28.26 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.967 2.222 . . . . 0.0 111.308 173.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -66.36 163.18 18.73 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.027 0.931 . . . . 0.0 112.605 -176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -85.5 162.55 36.38 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 123.967 0.794 . . . . 0.0 112.991 -174.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -130.58 159.86 68.91 Favored Pre-proline 0 CA--C 1.529 0.172 0 C-N-CA 124.2 1.0 . . . . 0.0 110.184 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.07 -13.3 21.3 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 124.537 3.491 . . . . 0.0 113.536 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.425 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 39.8 m -135.51 151.33 50.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.379 1.472 . . . . 0.0 107.407 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 51.7 mt -63.82 -49.66 74.72 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 171.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 10.9 Cg_endo -58.61 -34.8 99.11 Favored 'Trans proline' 0 C--N 1.353 0.764 0 CA-C-N 120.737 1.299 . . . . 0.0 113.164 -176.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.13 -38.38 90.94 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -28.75 57.88 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 118.671 0.669 . . . . 0.0 110.699 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -55.24 -50.99 60.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -66.07 -39.54 90.14 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.624 -172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -73.89 -5.95 44.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 117.94 -1.029 . . . . 0.0 111.446 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.99 -32.55 10.9 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 120.942 1.701 . . . . 0.0 113.053 161.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.64 -41.68 37.54 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 124.445 1.098 . . . . 0.0 110.516 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.0 t -84.74 -7.56 59.17 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.2 0.6 . . . . 0.0 110.502 -177.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -106.28 -32.42 8.18 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 70.76 67.85 0.18 Allowed 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 126.744 2.018 . . . . 0.0 107.552 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -118.72 152.8 51.89 Favored Pre-proline 0 C--O 1.235 0.331 0 N-CA-C 117.76 2.504 . . . . 0.0 117.76 -177.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 48.1 Cg_endo -70.29 140.08 39.89 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 123.804 3.003 . . . . 0.0 111.996 -172.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.7 mt -88.06 -21.48 24.71 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.1 t -159.86 143.12 14.07 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -57.56 -23.03 48.31 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 123.252 0.621 . . . . 0.0 110.538 169.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mmpt? -77.24 -13.66 59.9 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 115.256 1.576 . . . . 0.0 115.256 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 41.7 t -147.68 -23.15 0.37 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.984 1.265 . . . . 0.0 112.5 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.8 25.58 69.25 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 120.14 -1.6 . . . . 0.0 114.007 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.436 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 25.1 t -53.31 142.32 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 117.091 -1.433 . . . . 0.0 108.803 167.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.93 146.62 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 17.6 mt -71.55 137.85 48.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -143.18 -41.64 0.3 Allowed 'General case' 0 C--O 1.237 0.436 0 CA-C-O 118.481 -0.771 . . . . 0.0 113.017 -174.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -144.25 141.36 29.79 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 119.25 0.932 . . . . 0.0 110.381 -176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -108.55 122.92 48.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 9.7 t -62.27 120.85 62.22 Favored Pre-proline 0 C--N 1.334 -0.106 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 164.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 93.6 Cg_endo -76.72 116.86 4.36 Favored 'Trans proline' 0 N--CA 1.438 -1.771 0 CA-C-N 119.653 0.912 . . . . 0.0 111.102 162.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.9 t -73.14 -50.18 24.12 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 163.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.71 175.42 15.18 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 108.407 -1.877 . . . . 0.0 108.407 -161.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -83.57 2.04 8.57 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.575 2.85 . . . . 0.0 113.824 -171.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -150.71 157.61 43.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 119.092 0.86 . . . . 0.0 110.327 -174.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.1 p -138.46 177.65 7.72 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 126.518 1.927 . . . . 0.0 108.04 177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.709 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 178.192 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.762 0 CA-C-O 118.376 -1.235 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.4 m -145.82 4.23 0.98 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.4 m -114.5 -16.39 11.91 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 59.99 9.16 9.81 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 118.376 2.11 . . . . 0.0 118.376 159.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.44 175.06 9.46 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 121.309 2.554 . . . . 0.0 112.434 -169.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.9 p -138.66 -14.3 1.25 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -165.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.4 124.09 0.92 Allowed Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 105.788 -2.925 . . . . 0.0 105.788 -177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -138.42 24.81 2.69 Favored 'General case' 0 C--O 1.22 -0.472 0 C-N-CA 124.731 1.213 . . . . 0.0 109.119 -147.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.6 t -49.83 -53.24 10.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.341 0 C-N-CA 125.975 1.71 . . . . 0.0 109.291 -169.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -79.47 -7.69 58.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.218 0.607 . . . . 0.0 112.361 -169.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -59.88 163.64 7.23 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.105 0.562 . . . . 0.0 110.095 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -60.66 165.1 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.301 1.334 . . . . 0.0 109.281 168.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.9 tt -61.22 -35.04 76.12 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -71.24 -4.37 25.36 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -172.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -113.83 4.16 15.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 119.133 0.879 . . . . 0.0 110.954 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -72.11 162.0 30.09 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 121.975 0.893 . . . . 0.0 110.449 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.71 -51.43 4.1 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 125.021 1.328 . . . . 0.0 109.491 -166.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.8 p-90 -65.44 -8.85 21.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 125.202 1.401 . . . . 0.0 112.461 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -80.92 93.17 6.26 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -78.16 -43.43 28.72 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.664 -0.647 . . . . 0.0 111.118 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.72 -153.34 17.76 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 108.431 -1.868 . . . . 0.0 108.431 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.66 80.36 8.79 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.775 1.23 . . . . 0.0 111.031 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.91 147.57 34.5 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.989 1.315 . . . . 0.0 109.231 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.54 156.75 49.5 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.608 2.872 . . . . 0.0 111.939 174.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -59.59 -26.42 65.41 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.34 -1.475 . . . . 0.0 114.549 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.89 -40.35 68.94 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 123.526 0.516 . . . . 0.0 110.151 -175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -62.87 -34.3 77.08 Favored 'General case' 0 C--O 1.221 -0.419 0 C-N-CA 124.039 0.935 . . . . 0.0 110.222 -173.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 86.1 t -38.32 -63.51 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.416 0 C-N-CA 125.196 1.398 . . . . 0.0 110.78 172.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.565 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.84 -8.48 48.82 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -167.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -86.75 -28.62 22.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.986 1.714 . . . . 0.0 110.489 171.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 mt -86.61 -42.39 13.5 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.434 1.494 . . . . 0.0 109.948 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.4 mt -80.51 141.93 34.68 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 174.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.9 t -132.81 -38.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 118.008 0.367 . . . . 0.0 110.868 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -115.49 158.2 22.92 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.4 p -66.23 123.67 20.57 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 119.403 -0.919 . . . . 0.0 108.615 177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 119.9 -25.25 7.61 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 117.258 -1.857 . . . . 0.0 114.542 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.08 128.59 37.89 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -136.72 157.16 47.42 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.422 1.089 . . . . 0.0 110.505 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.2 pp -144.78 155.1 43.34 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.507 1.523 . . . . 0.0 109.504 170.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.68 123.66 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -117.51 162.01 18.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.366 1.066 . . . . 0.0 108.187 172.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -87.04 161.02 18.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 166.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -81.16 -171.49 3.26 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.981 1.312 . . . . 0.0 110.492 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm100 -65.01 -88.52 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.591 1.956 . . . . 0.0 110.614 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -105.65 -10.0 31.84 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 124.188 0.899 . . . . 0.0 112.129 175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -73.28 165.38 25.16 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 118.284 1.042 . . . . 0.0 110.141 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -100.34 50.28 0.9 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.631 1.972 . . . . 0.0 107.2 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -134.27 137.19 44.11 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -161.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -95.32 162.08 13.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 122.071 0.939 . . . . 0.0 110.28 177.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.635 HG22 HD13 ' A' ' 63' ' ' ILE . 11.6 t -137.9 125.23 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -175.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.2 tp -82.22 128.57 34.3 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 169.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -127.37 111.4 13.83 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -176.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -139.21 132.6 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.849 1.26 . . . . 0.0 110.461 -170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -83.47 121.28 26.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 125.462 1.505 . . . . 0.0 107.167 -173.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.566 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 1.9 t-105 -136.08 112.57 9.98 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.15 47.42 24.78 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 121.987 0.898 . . . . 0.0 110.241 -174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.06 3.42 75.18 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 125.53 1.538 . . . . 0.0 113.318 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.04 107.1 52.54 Favored Pre-proline 0 N--CA 1.456 -0.134 0 C-N-CA 124.706 1.202 . . . . 0.0 108.311 -174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.565 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.0 Cg_endo -64.4 98.0 0.27 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.768 2.978 . . . . 0.0 108.869 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -67.66 154.65 41.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 171.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.1 p80 -141.56 80.29 1.72 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -88.02 128.97 35.4 Favored 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.635 HD13 HG22 ' A' ' 50' ' ' VAL . 38.5 mm -58.76 132.69 23.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 166.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 16.9 mm -57.91 148.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 122.544 1.164 . . . . 0.0 108.122 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 166.63 4.38 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.7 -177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 t -176.42 138.05 0.3 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 168.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CG ' ' H ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -135.04 -109.6 0.21 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.156 0.582 . . . . 0.0 110.131 168.342 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.4 ' H ' ' CG ' ' A' ' 67' ' ' LEU . 0.4 OUTLIER -78.41 -53.81 6.86 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -169.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -165.1 37.63 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.601 2.36 . . . . 0.0 107.698 175.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.8 mt -146.75 174.14 11.73 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.911 1.284 . . . . 0.0 110.004 -178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -129.41 111.27 12.63 Favored 'General case' 0 C--O 1.222 -0.38 0 C-N-CA 124.338 1.055 . . . . 0.0 109.278 -177.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.09 140.92 46.94 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 121.359 1.89 . . . . 0.0 112.992 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.0 tp -120.38 -60.73 1.65 Allowed 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 116.886 -1.53 . . . . 0.0 110.778 -172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -114.39 -16.1 12.0 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.197 0.908 . . . . 0.0 113.212 169.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.01 -154.56 8.71 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 -164.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -62.73 172.73 1.53 Allowed 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.823 1.311 . . . . 0.0 110.382 169.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.91 163.83 12.93 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 124.813 1.197 . . . . 0.0 110.857 171.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -133.38 162.36 58.16 Favored Pre-proline 0 N--CA 1.464 0.225 0 C-N-CA 125.527 1.531 . . . . 0.0 108.674 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.3 -6.87 19.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 125.084 3.856 . . . . 0.0 114.553 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.53 ' HB2' HD13 ' A' ' 83' ' ' LEU . 2.4 m -138.77 147.65 42.88 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 56.6 mt -61.74 -48.95 88.32 Favored Pre-proline 0 N--CA 1.451 -0.39 0 CA-C-O 116.831 -1.556 . . . . 0.0 108.11 173.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 24.1 Cg_endo -64.5 -33.0 58.62 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 121.746 1.631 . . . . 0.0 111.617 -173.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.53 HD13 ' HB2' ' A' ' 80' ' ' SER . 10.2 mp -66.75 -25.68 66.61 Favored 'General case' 0 C--N 1.337 0.026 0 C-N-CA 124.148 0.979 . . . . 0.0 111.208 -176.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.05 -36.14 15.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.437 1.095 . . . . 0.0 110.328 177.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 19.9 mm -49.74 -42.3 17.73 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 CA-C-O 118.698 -0.668 . . . . 0.0 110.289 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -61.32 -42.11 98.13 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.798 0.726 . . . . 0.0 111.048 -176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -69.7 -11.18 60.65 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 118.356 -0.831 . . . . 0.0 112.451 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.3 -18.72 16.68 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 127.223 2.209 . . . . 0.0 112.076 174.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.74 -29.0 16.27 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.197 0.999 . . . . 0.0 110.226 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.82 0.26 25.89 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -169.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.64 -22.64 6.83 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.608 -1.308 . . . . 0.0 111.208 167.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 74.4 35.87 0.68 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 125.44 1.496 . . . . 0.0 109.575 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -65.31 145.96 99.01 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 123.451 0.7 . . . . 0.0 109.728 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.05 140.7 20.29 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 122.836 2.358 . . . . 0.0 111.245 178.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 16.6 mt -82.3 -24.16 34.81 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.823 1.249 . . . . 0.0 113.2 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.0 t -160.6 142.95 12.82 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -64.88 2.2 0.75 Allowed 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.101 0.961 . . . . 0.0 112.843 167.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.468 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 5.9 mmpt? -90.08 -21.92 22.06 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 120.029 1.286 . . . . 0.0 114.4 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.4 m -147.37 -8.41 0.44 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.23 19.24 38.54 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.618 1.58 . . . . 0.0 114.588 174.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.566 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 4.6 t -57.56 142.01 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 125.308 1.443 . . . . 0.0 108.936 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -132.75 154.35 39.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-N 120.083 1.31 . . . . 0.0 108.137 173.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.6 mt -77.54 139.42 39.57 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.467 1.03 . . . . 0.0 108.613 176.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.486 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 13.4 m-70 -137.69 -43.34 0.54 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 119.381 -0.342 . . . . 0.0 111.835 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -138.33 140.61 39.57 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 119.002 0.819 . . . . 0.0 109.422 -173.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.52 152.78 21.97 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 123.949 0.899 . . . . 0.0 108.787 175.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.6 t -100.9 117.09 63.19 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -85.6 101.03 0.68 Allowed 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 123.125 2.55 . . . . 0.0 113.894 -176.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -77.17 -29.7 54.56 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.779 0.832 . . . . 0.0 111.378 -173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.19 177.41 16.38 Favored Glycine 0 CA--C 1.537 1.466 0 C-N-CA 127.381 2.42 . . . . 0.0 108.781 -165.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -87.66 22.52 0.89 Allowed 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 125.181 3.921 . . . . 0.0 112.12 173.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 47.2 t -176.29 160.64 2.18 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.476 1.91 . . . . 0.0 107.681 -171.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 7.7 m -147.62 122.76 10.16 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 122.908 0.483 . . . . 0.0 110.567 -153.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.764 0 C-N-CA 125.146 1.355 . . . . 0.0 111.284 -179.937 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.848 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -78.95 -26.16 43.56 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -164.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -164.82 169.95 16.04 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.704 0.802 . . . . 0.0 110.222 -169.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.15 -67.15 0.96 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 107.821 -2.111 . . . . 0.0 107.821 162.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t 42.05 53.71 4.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.699 1.599 . . . . 0.0 111.071 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 46.5 t -163.3 141.16 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.36 1.464 . . . . 0.0 107.355 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.89 -92.05 0.45 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 54.2 20.68 2.69 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 127.112 2.165 . . . . 0.0 113.728 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' O ' HD12 ' A' ' 83' ' ' LEU . 20.6 t -59.03 -47.56 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.166 1.386 . . . . 0.0 109.125 -169.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -83.81 -13.73 53.06 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 122.867 0.467 . . . . 0.0 111.904 -166.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.1 mttm -61.76 165.42 7.73 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.878 1.271 . . . . 0.0 110.964 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -61.29 162.33 20.54 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.575 1.517 . . . . 0.0 110.441 166.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.631 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.2 tt -60.51 -29.96 69.43 Favored 'General case' 0 C--O 1.225 -0.222 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.648 170.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -81.53 5.69 17.14 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -175.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -127.61 18.81 6.8 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.626 1.17 . . . . 0.0 110.938 175.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -69.97 -171.04 0.38 Allowed 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 122.436 1.112 . . . . 0.0 110.751 170.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.5 -49.54 2.75 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.803 1.641 . . . . 0.0 109.602 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -71.82 -2.31 17.25 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.423 1.889 . . . . 0.0 114.157 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -89.62 96.58 10.76 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.76 -1.213 . . . . 0.0 109.179 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -92.53 -1.11 57.19 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.372 1.069 . . . . 0.0 111.127 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.32 -145.23 31.64 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 107.382 -2.287 . . . . 0.0 107.382 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 107.01 2.95 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 126.784 2.034 . . . . 0.0 109.797 178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.3 150.41 66.57 Favored Pre-proline 0 CA--C 1.541 0.613 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.32 169.85 20.54 Favored 'Trans proline' 0 CA--C 1.539 0.729 1 C-N-CA 125.508 4.138 . . . . 0.0 112.971 176.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -62.16 -36.99 83.54 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 120.205 -1.559 . . . . 0.0 111.294 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.76 -37.81 85.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.92 0.327 . . . . 0.0 111.329 -172.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -70.8 -27.88 64.23 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 123.946 0.898 . . . . 0.0 111.608 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 92.8 t -46.71 -63.57 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.431 0 C-N-CA 125.293 1.437 . . . . 0.0 111.129 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.63 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.26 -8.82 49.4 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 119.662 1.119 . . . . 0.0 113.214 -171.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.86 -21.95 40.28 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.892 1.277 . . . . 0.0 111.782 169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD12 HD22 ' A' ' 39' ' ' LEU . 64.1 mt -94.75 -43.63 8.15 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 126.032 1.733 . . . . 0.0 109.212 174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.581 HD21 HD23 ' A' ' 39' ' ' LEU . 7.2 mt -88.86 113.85 24.85 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -113.94 -17.01 8.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 117.676 0.216 . . . . 0.0 110.65 -177.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -132.28 159.37 39.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.083 0.953 . . . . 0.0 109.925 -176.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.91 125.4 24.75 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 117.32 -23.12 9.92 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-O 118.318 -1.268 . . . . 0.0 113.801 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -64.0 134.14 54.45 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.364 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -137.24 159.79 40.9 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.607 1.163 . . . . 0.0 110.633 172.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 HD21 ' A' ' 32' ' ' LEU . 1.2 pp -144.3 167.1 23.25 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.859 2.063 . . . . 0.0 108.998 170.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 99.1 t -124.98 88.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -90.32 162.48 15.14 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 121.812 -0.555 . . . . 0.0 110.369 -173.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -87.11 160.98 18.37 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.44 0.638 . . . . 0.0 110.01 172.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.0 t -63.54 156.79 25.4 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 127.33 2.252 . . . . 0.0 111.387 166.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -75.41 92.15 2.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 170.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.03 17.87 60.45 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 117.83 -1.539 . . . . 0.0 113.624 171.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -127.7 153.85 46.0 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 120.602 2.201 . . . . 0.0 109.278 175.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -78.69 62.22 3.18 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.788 1.235 . . . . 0.0 108.095 170.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -139.3 155.85 47.44 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.286 1.434 . . . . 0.0 108.279 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -117.11 162.75 17.33 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.04 1.336 . . . . 0.0 110.992 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG22 HD13 ' A' ' 63' ' ' ILE . 47.1 t -135.46 125.6 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 C-N-CA 127.597 2.359 . . . . 0.0 106.847 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.5 tp -77.25 120.28 22.07 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 125.003 1.321 . . . . 0.0 108.079 167.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.4 m -117.56 117.88 30.62 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -144.55 135.51 20.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 C-N-CA 124.383 1.073 . . . . 0.0 108.566 -166.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.0 tp -96.91 115.32 27.23 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 124.123 0.969 . . . . 0.0 108.473 -171.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.461 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 13.5 t-105 -135.9 122.45 20.82 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -173.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 56.64 26.28 11.01 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.595 1.158 . . . . 0.0 112.627 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.31 4.05 66.7 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 124.818 1.199 . . . . 0.0 113.622 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -118.99 108.12 41.09 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 119.115 1.458 . . . . 0.0 108.884 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.63 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 67.6 Cg_endo -66.05 90.54 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 124.131 3.22 . . . . 0.0 110.612 166.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -64.36 159.78 20.41 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.635 1.174 . . . . 0.0 108.735 173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 29.4 p80 -141.77 61.13 1.47 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.869 1.268 . . . . 0.0 111.156 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -68.13 128.73 37.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.462 HD13 HG22 ' A' ' 50' ' ' VAL . 3.1 mm -53.89 143.15 6.27 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 O-C-N 121.402 -0.811 . . . . 0.0 108.922 165.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.6 mm -61.92 164.49 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 124.244 1.973 . . . . 0.0 108.935 173.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.511 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -74.81 164.27 26.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.626 -1.296 . . . . 0.0 109.595 178.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t 179.82 131.27 0.09 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 174.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.4 OUTLIER -133.44 -57.35 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.91 0.884 . . . . 0.0 112.257 174.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.73 -59.29 0.51 Allowed 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 118.779 0.718 . . . . 0.0 111.106 177.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -149.11 27.88 0.84 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.92 1.688 . . . . 0.0 109.385 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -142.73 179.75 6.81 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.125 1.37 . . . . 0.0 108.493 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.93 115.59 10.11 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -133.57 138.35 45.98 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 121.44 1.927 . . . . 0.0 111.39 -177.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.4 tp -127.95 -27.09 2.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 120.221 1.373 . . . . 0.0 113.38 -173.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.58 -69.95 0.72 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 166.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.76 -75.59 1.3 Allowed Glycine 0 C--N 1.337 0.597 0 C-N-CA 123.548 0.594 . . . . 0.0 112.538 -160.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.71 177.73 7.29 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 126.744 2.018 . . . . 0.0 110.152 -176.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.72 161.04 14.98 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 124.281 0.943 . . . . 0.0 111.548 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -132.24 160.88 66.1 Favored Pre-proline 0 N--CA 1.465 0.29 0 C-N-CA 124.877 1.271 . . . . 0.0 109.054 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.97 -13.3 31.55 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 124.501 3.468 . . . . 0.0 113.446 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.475 ' HB2' HD13 ' A' ' 83' ' ' LEU . 0.9 OUTLIER -137.56 152.35 49.34 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -174.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 13' ' ' LEU . 76.9 mt -67.15 -48.28 48.94 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-O 118.195 -0.907 . . . . 0.0 109.294 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.7 Cg_endo -66.61 -29.36 43.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 CA-C-N 120.822 1.329 . . . . 0.0 111.388 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD12 ' O ' ' A' ' 9' ' ' VAL . 10.7 mp -68.9 -16.13 63.68 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.108 0.963 . . . . 0.0 110.927 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.22 -39.89 10.29 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.089 0.956 . . . . 0.0 110.623 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.0 mm -49.55 -43.43 18.01 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 CA-C-O 118.616 -0.707 . . . . 0.0 110.997 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -60.57 -46.04 91.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.562 1.074 . . . . 0.0 111.94 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -73.76 -3.24 27.25 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.021 0.928 . . . . 0.0 111.566 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.57 -42.2 8.18 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 125.181 1.392 . . . . 0.0 111.323 162.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.2 -41.1 74.13 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 124.056 0.942 . . . . 0.0 110.844 -168.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 t -87.06 -18.02 31.54 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.914 -175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 77.7 p -93.78 -28.35 15.95 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.429 1.092 . . . . 0.0 110.272 -173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.9 mm-40 66.43 34.11 6.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.517 1.127 . . . . 0.0 110.092 -176.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -67.73 155.24 91.91 Favored Pre-proline 0 C--O 1.235 0.304 0 C-N-CA 124.887 1.275 . . . . 0.0 111.099 175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 87.6 Cg_endo -77.88 156.33 30.86 Favored 'Trans proline' 0 N--CA 1.444 -1.384 0 C-N-CA 122.452 2.101 . . . . 0.0 112.474 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.9 mt -91.81 -21.37 20.7 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 125.517 1.527 . . . . 0.0 112.938 174.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -154.39 141.59 19.47 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 169.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -19.83 15.0 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.681 1.192 . . . . 0.0 112.446 175.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mptt -79.02 -75.89 0.22 Allowed 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 169.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.421 ' H ' HG23 ' A' ' 96' ' ' THR . 4.0 m -79.77 -9.08 59.61 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -153.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 59.0 10.82 9.49 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 127.078 2.275 . . . . 0.0 116.145 169.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.461 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 26.2 t -53.03 143.02 5.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 C-N-CA 127.014 2.126 . . . . 0.0 109.699 177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.3 m -131.34 167.61 25.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 119.4 1.0 . . . . 0.0 108.612 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 23.3 mt -98.77 139.59 34.22 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 125.883 1.673 . . . . 0.0 109.668 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -140.43 -43.88 0.41 Allowed 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.7 tpt180 -133.63 143.55 48.68 Favored 'General case' 0 C--O 1.226 -0.166 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -167.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.71 111.47 16.21 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -59.86 116.22 16.13 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.62 108.25 2.09 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.42 2.08 . . . . 0.0 111.166 -174.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.8 t -88.6 -14.78 36.71 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.876 0.871 . . . . 0.0 111.723 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 83.52 170.73 46.76 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 -157.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.55 -40.43 1.53 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.633 2.222 . . . . 0.0 111.959 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 4.2 m -79.54 130.75 35.68 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.132 0.573 . . . . 0.0 110.347 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.0 m -136.0 163.29 30.64 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 127.261 2.224 . . . . 0.0 107.272 168.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.245 0 N-CA-C 107.095 -2.402 . . . . 0.0 107.095 -170.451 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.522 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -142.91 1.74 1.3 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -163.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.13 175.71 7.25 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.138 1.375 . . . . 0.0 110.536 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.74 176.05 38.24 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 172.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -146.33 70.57 1.22 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.2 m -139.84 -178.99 5.68 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.809 1.243 . . . . 0.0 109.354 -171.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.14 142.15 8.99 Favored Glycine 0 CA--C 1.521 0.425 0 N-CA-C 108.025 -2.03 . . . . 0.0 108.025 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -106.93 5.24 28.09 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -162.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' H ' ' A' ' 9' ' ' VAL . 5.3 t -52.92 -48.75 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 C-N-CA 127.535 2.334 . . . . 0.0 109.936 -167.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -90.34 -9.2 48.62 Favored 'General case' 0 N--CA 1.445 -0.725 0 O-C-N 124.306 1.004 . . . . 0.0 110.942 -170.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.8 mttp -67.36 162.2 57.88 Favored Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 121.265 -0.897 . . . . 0.0 109.627 174.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.71 163.35 18.83 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 120.674 0.916 . . . . 0.0 110.846 169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.09 -32.08 73.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.4 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -82.01 4.61 22.17 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -173.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -121.35 16.78 11.41 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.38 1.072 . . . . 0.0 110.162 170.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -76.3 171.35 14.7 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 122.377 1.084 . . . . 0.0 109.682 173.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -103.76 -47.22 4.29 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 125.313 1.445 . . . . 0.0 108.64 -177.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -67.97 -10.12 50.9 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.427 1.491 . . . . 0.0 113.045 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -83.53 93.19 7.78 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.102 -0.999 . . . . 0.0 108.772 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -78.73 1.22 23.77 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 121.904 -0.498 . . . . 0.0 111.618 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.37 -115.73 4.28 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.83 113.04 25.14 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 127.503 2.321 . . . . 0.0 109.13 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.59 149.4 53.82 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -69.89 -178.33 2.34 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 124.757 3.638 . . . . 0.0 113.245 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 36.2 ptt180 -73.87 -40.39 63.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 118.011 -0.995 . . . . 0.0 112.493 169.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.18 -34.59 77.97 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.596 0.635 . . . . 0.0 111.8 -166.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -64.6 -35.8 82.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.277 1.431 . . . . 0.0 111.464 -178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -46.73 -59.7 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 C-N-CA 126.146 1.778 . . . . 0.0 111.165 -172.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.731 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.14 -11.86 58.43 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -171.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -85.97 -14.67 43.9 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.648 1.179 . . . . 0.0 112.254 171.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 42.1 mt -94.21 -46.0 7.27 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 125.552 1.541 . . . . 0.0 109.27 173.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.411 HD21 HD23 ' A' ' 39' ' ' LEU . 10.8 mt -81.1 135.42 35.8 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -177.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 74.1 t -129.87 -47.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 126.019 1.728 . . . . 0.0 109.143 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -89.38 146.81 24.43 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.017 0.527 . . . . 0.0 109.91 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 p -67.06 87.83 0.15 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 145.31 -22.24 1.89 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-O 117.712 -1.605 . . . . 0.0 114.144 -168.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -60.66 122.81 15.66 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD2' HD22 ' A' ' 103' ' ' LEU . 53.4 p90 -127.87 159.56 34.51 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.105 0.962 . . . . 0.0 110.786 170.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD23 HD21 ' A' ' 32' ' ' LEU . 1.8 pp -141.34 159.03 43.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.539 1.936 . . . . 0.0 108.123 166.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -111.34 130.69 64.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 171.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 25.3 ptt85 -133.38 157.42 45.58 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.781 1.232 . . . . 0.0 108.796 -176.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -81.33 142.92 32.61 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 t -63.77 168.47 4.94 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.985 1.714 . . . . 0.0 109.387 168.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.5 pm0 -72.8 83.28 1.19 Allowed 'General case' 0 CA--C 1.537 0.47 0 O-C-N 120.401 -1.437 . . . . 0.0 111.89 -174.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.04 15.08 79.65 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 124.442 1.02 . . . . 0.0 113.354 171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -98.54 142.03 30.65 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 158.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -73.34 73.27 1.33 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 156.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.37 145.47 37.16 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 167.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -103.9 161.19 14.17 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 123.114 1.435 . . . . 0.0 110.811 177.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.674 HG22 HD13 ' A' ' 63' ' ' ILE . 70.9 t -132.11 132.41 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 128.025 2.53 . . . . 0.0 105.263 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.3 tp -90.01 115.16 27.08 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 126.4 1.88 . . . . 0.0 107.304 166.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -117.17 125.02 50.55 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.66 138.1 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 124.484 1.114 . . . . 0.0 108.71 -166.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 27.5 tp -95.05 121.34 36.58 Favored 'General case' 0 CA--C 1.514 -0.424 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -170.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.536 ' CH2' HG22 ' A' ' 102' ' ' VAL . 24.9 t-105 -141.27 125.14 17.05 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.576 -0.726 . . . . 0.0 109.227 -174.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.3 t0 45.02 47.98 9.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.79 1.281 . . . . 0.0 110.443 -174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.12 3.39 90.58 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 126.459 1.98 . . . . 0.0 114.583 173.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -124.12 113.28 28.12 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 118.628 1.214 . . . . 0.0 110.176 -164.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.731 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 93.3 Cg_endo -71.48 97.98 0.82 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.96 3.107 . . . . 0.0 110.136 175.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 -68.27 169.66 10.1 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.864 0.866 . . . . 0.0 110.684 173.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -147.35 80.19 1.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.481 . . . . 0.0 108.962 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -84.05 128.94 34.89 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.674 HD13 HG22 ' A' ' 50' ' ' VAL . 4.4 mm -64.56 130.76 29.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 170.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.0 mm -55.16 151.23 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.13 0 CA-C-O 123.114 1.435 . . . . 0.0 108.782 176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -69.17 171.23 8.69 Favored 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 113.361 -1.745 . . . . 0.0 109.995 -171.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.0 t -170.1 152.73 4.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 165.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.39 -114.68 0.23 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 149.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -77.32 -47.63 19.49 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 123.479 0.712 . . . . 0.0 111.337 -174.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -156.37 2.9 0.15 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 110.85 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.4 mt -127.09 171.18 11.61 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.472 1.509 . . . . 0.0 108.737 -173.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -129.75 124.95 34.7 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.68 126.4 19.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.423 1.489 . . . . 0.0 109.602 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.496 ' CD2' HD22 ' A' ' 95' ' ' LEU . 18.4 tp -104.55 -37.92 6.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 119.577 1.081 . . . . 0.0 111.593 -171.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -111.7 -60.99 1.77 Allowed 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.98 -93.22 0.9 Allowed Glycine 0 C--N 1.339 0.739 0 C-N-CA 124.738 1.161 . . . . 0.0 112.468 -168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -80.74 162.34 24.14 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 117.237 0.519 . . . . 0.0 112.217 -172.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -115.32 161.81 12.69 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 124.242 0.925 . . . . 0.0 112.205 -172.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -133.18 158.17 76.42 Favored Pre-proline 0 N--CA 1.464 0.271 0 C-N-CA 124.286 1.034 . . . . 0.0 110.614 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.95 -17.29 36.8 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 124.519 3.48 . . . . 0.0 113.929 -178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.407 ' HB2' HD13 ' A' ' 83' ' ' LEU . 7.8 m -137.61 152.87 49.83 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 52.2 mt -60.75 -50.32 85.68 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-O 116.901 -1.523 . . . . 0.0 107.742 169.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.33 -30.79 88.26 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.314 2.009 . . . . 0.0 112.32 -171.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 80' ' ' SER . 1.8 mp -69.88 -22.94 63.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.1 tp -85.49 -29.74 24.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 119.514 1.052 . . . . 0.0 110.664 170.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mm -53.78 -40.41 43.46 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.351 -176.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.35 -42.71 87.69 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 119.924 1.238 . . . . 0.0 112.149 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -69.96 -8.0 45.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.382 -0.818 . . . . 0.0 111.604 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -101.23 -35.05 9.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.886 1.221 . . . . 0.0 111.779 167.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 103' ' ' LEU . 9.8 tp -81.62 -27.17 34.3 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 120.973 -1.079 . . . . 0.0 110.801 -172.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.99 -5.42 57.96 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 117.72 0.237 . . . . 0.0 111.001 176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.3 p -117.58 -27.5 6.3 Favored 'General case' 0 C--N 1.332 -0.195 0 O-C-N 121.114 -0.991 . . . . 0.0 110.425 -172.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.42 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.29 33.72 6.96 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.506 1.123 . . . . 0.0 109.209 -179.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -71.7 152.5 93.48 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.516 1.127 . . . . 0.0 110.826 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 91.9 Cg_endo -79.53 137.12 12.8 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.899 2.399 . . . . 0.0 113.678 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.496 HD22 ' CD2' ' A' ' 73' ' ' LEU . 12.9 mt -69.62 -26.06 64.24 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.4 t -159.54 160.5 34.61 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 126.395 1.878 . . . . 0.0 107.75 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.1 tptm -66.52 -4.4 8.37 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.924 1.69 . . . . 0.0 113.172 168.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -103.5 -20.78 13.92 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 -168.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 28.2 t -137.48 -9.82 1.66 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.788 1.176 . . . . 0.0 112.082 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 52.7 27.52 27.9 Favored Glycine 0 C--N 1.341 0.831 0 C-N-CA 125.492 1.52 . . . . 0.0 112.977 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.453 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 7.0 t -52.83 131.0 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 127.533 2.333 . . . . 0.0 108.12 168.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.536 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.7 m -124.61 150.87 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 O-C-N 124.326 1.016 . . . . 0.0 108.649 174.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.707 ' HB3' HD12 ' A' ' 89' ' ' LEU . 6.2 mt -68.47 140.46 55.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 168.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.454 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -153.21 -30.83 0.13 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 118.911 -0.566 . . . . 0.0 112.043 178.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -151.81 143.06 23.33 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 119.89 1.223 . . . . 0.0 110.989 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 116.6 30.12 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.017 0.927 . . . . 0.0 110.031 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.4 HG21 HD23 ' A' ' 32' ' ' LEU . 42.4 t -64.33 117.11 33.86 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-N 118.763 0.711 . . . . 0.0 109.713 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.403 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 86.7 Cg_endo -75.89 109.07 2.82 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.552 2.168 . . . . 0.0 113.088 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.52 -25.18 21.54 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.407 1.083 . . . . 0.0 111.708 170.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 105.0 163.62 23.96 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.53 1.538 . . . . 0.0 110.463 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -79.97 27.22 0.55 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 124.09 3.194 . . . . 0.0 111.617 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.7 m -125.96 87.33 2.66 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 125.251 1.42 . . . . 0.0 107.55 -166.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.66 111.04 20.68 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.37 1.068 . . . . 0.0 108.599 -169.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.174 0 CA-C-O 117.2 -1.889 . . . . 0.0 110.673 178.826 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.1 m -115.29 -66.88 1.04 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.072 0.936 . . . . 0.0 109.258 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -56.08 -40.39 73.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.277 0.944 . . . . 0.0 110.537 174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.29 174.42 8.62 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.484 0.491 . . . . 0.0 112.116 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -138.83 169.25 18.14 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.271 1.028 . . . . 0.0 111.544 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 p -150.11 -56.63 0.18 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.726 2.011 . . . . 0.0 108.927 -164.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.2 95.31 1.65 Allowed Glycine 0 C--N 1.336 0.571 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 174.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -127.78 11.07 6.63 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.021 1.328 . . . . 0.0 111.092 -170.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 23.6 t -61.06 -48.06 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 125.342 1.457 . . . . 0.0 110.404 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -82.81 -7.17 59.68 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.318 -169.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 mttt -66.93 162.22 55.15 Favored Pre-proline 0 C--O 1.237 0.437 0 C-N-CA 123.82 0.848 . . . . 0.0 109.894 172.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -62.63 163.22 22.0 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 N-CA-C 109.231 -1.104 . . . . 0.0 109.231 169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.518 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.9 tt -57.87 -35.3 70.78 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.498 169.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 16.2 p80 -73.69 5.34 4.06 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -127.32 9.4 6.66 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.869 1.667 . . . . 0.0 112.02 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -66.22 -166.57 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.627 1.171 . . . . 0.0 113.901 -177.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.16 -39.72 3.38 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.526 1.53 . . . . 0.0 110.95 172.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -86.05 4.15 39.3 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.293 2.237 . . . . 0.0 113.979 -177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -92.81 99.68 12.3 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 123.749 0.819 . . . . 0.0 109.29 172.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -83.77 -17.05 42.47 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.118 0.967 . . . . 0.0 110.804 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 95.28 -146.03 18.01 Favored Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.85 89.12 7.68 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 125.128 1.371 . . . . 0.0 111.327 -171.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.32 148.38 40.68 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.721 1.209 . . . . 0.0 110.517 -173.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.56 165.99 29.4 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 124.559 3.506 . . . . 0.0 112.048 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.8 ptt180 -62.97 -28.84 70.36 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.377 -1.452 . . . . 0.0 111.825 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.31 82.75 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.489 0.716 . . . . 0.0 111.729 -172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -66.19 -38.11 87.22 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.733 0.813 . . . . 0.0 110.887 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.2 t -44.31 -62.21 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 125.832 1.653 . . . . 0.0 113.193 -169.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.41 -16.35 63.53 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 120.188 1.358 . . . . 0.0 113.678 -169.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.72 -29.43 62.25 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.263 0.938 . . . . 0.0 110.724 170.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 69.9 mt -83.88 -42.01 16.83 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.823 1.249 . . . . 0.0 109.038 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.454 HD23 HG21 ' A' ' 107' ' ' VAL . 2.5 mt -94.86 114.35 26.2 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 124.604 1.162 . . . . 0.0 108.936 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.92 -31.44 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 124.089 0.956 . . . . 0.0 109.801 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.3 m80 -87.62 136.97 32.73 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 p -68.18 82.68 0.23 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.841 0.857 . . . . 0.0 110.237 173.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 149.38 -19.99 1.19 Allowed Glycine 0 N--CA 1.443 -0.873 0 CA-C-O 117.409 -1.773 . . . . 0.0 113.974 -166.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -60.78 133.86 56.52 Favored 'General case' 0 CA--C 1.515 -0.381 0 C-N-CA 125.867 1.667 . . . . 0.0 108.521 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -137.66 156.79 47.65 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.109 0.964 . . . . 0.0 112.06 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.43 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -149.9 165.23 33.21 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 127.41 2.284 . . . . 0.0 109.09 172.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.86 83.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.686 0.794 . . . . 0.0 108.905 -171.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -85.42 158.69 20.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.682 -0.636 . . . . 0.0 109.32 -170.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -81.32 164.21 22.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.779 0.799 . . . . 0.0 109.864 165.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.13 -178.3 0.16 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.673 1.589 . . . . 0.0 111.513 168.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.496 ' H ' ' CD ' ' A' ' 44' ' ' GLN . 2.8 pm0 -75.76 61.7 1.43 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.764 1.225 . . . . 0.0 110.09 171.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.34 60.81 3.63 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -127.74 -151.14 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 126.088 1.755 . . . . 0.0 106.865 167.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -129.19 42.72 3.26 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -145.8 135.26 23.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.552 1.141 . . . . 0.0 108.208 -164.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -97.23 164.22 12.58 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 122.421 1.105 . . . . 0.0 111.203 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG22 HD13 ' A' ' 63' ' ' ILE . 56.3 t -131.83 124.13 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.02 2.128 . . . . 0.0 105.598 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -72.62 126.87 30.92 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 43.3 m -124.81 108.7 12.22 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 175.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.61 144.63 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.603 1.961 . . . . 0.0 107.582 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 tp -94.08 123.43 37.44 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.444 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.3 t-105 -132.0 114.18 14.29 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.3 t0 48.89 52.28 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.246 1.018 . . . . 0.0 111.773 -171.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.62 25.64 70.42 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 124.63 1.109 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tp -127.39 108.52 21.17 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.786 1.634 . . . . 0.0 106.925 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.489 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 94.6 Cg_endo -70.43 82.76 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.24 2.627 . . . . 0.0 109.987 173.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -60.92 156.57 17.18 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 120.529 -1.357 . . . . 0.0 111.541 171.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -132.48 110.03 10.22 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -120.32 114.24 21.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.579 HD13 HG22 ' A' ' 50' ' ' VAL . 3.5 mm -47.49 136.64 3.39 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 CA-C-N 118.736 0.698 . . . . 0.0 109.436 174.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.7 mm -60.89 145.07 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.522 1.154 . . . . 0.0 108.36 178.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.57 166.21 3.32 Favored 'General case' 0 CA--C 1.509 -0.596 0 C-N-CA 125.86 1.664 . . . . 0.0 109.364 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.2 t -164.95 165.63 20.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 158.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.87 -111.9 0.16 Allowed 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 126.34 1.856 . . . . 0.0 107.923 163.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.3 -65.25 0.98 Allowed 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 169.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -142.57 5.88 1.62 Allowed 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.133 1.373 . . . . 0.0 112.776 -159.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.3 mt -130.83 -179.23 5.18 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 125.986 1.715 . . . . 0.0 107.619 -173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -135.32 124.49 24.48 Favored 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 178.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -138.24 135.09 35.19 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 116.672 -1.633 . . . . 0.0 111.103 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 95' ' ' LEU . 8.2 tp -129.51 -51.54 1.17 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 120.273 1.397 . . . . 0.0 112.988 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -97.9 -69.24 0.77 Allowed 'General case' 0 C--O 1.235 0.304 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.15 -146.15 19.58 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 126.278 1.894 . . . . 0.0 111.185 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -63.22 172.93 1.66 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.317 1.447 . . . . 0.0 113.484 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.62 158.52 43.31 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.985 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -127.79 157.64 72.86 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.519 1.128 . . . . 0.0 108.93 164.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -78.32 -10.22 16.23 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 124.624 3.549 . . . . 0.0 113.577 -177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.8 m -129.52 149.93 51.08 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.518 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.1 mt -63.45 -47.93 82.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 168.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.8 Cg_endo -62.67 -29.68 77.88 Favored 'Trans proline' 0 C--N 1.352 0.727 0 CA-C-N 121.415 1.541 . . . . 0.0 114.028 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.6 mt -63.86 -43.12 97.04 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.715 1.206 . . . . 0.0 111.814 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.39 -40.59 77.28 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 122.728 0.411 . . . . 0.0 110.268 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mm -50.62 -46.71 28.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.389 0 CA-C-O 118.143 -0.932 . . . . 0.0 109.027 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -65.07 -40.0 94.04 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.502 1.047 . . . . 0.0 111.552 -173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 44.2 t60 -77.45 -7.56 56.37 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.428 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 -36.83 13.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 120.377 -1.452 . . . . 0.0 111.615 163.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.4 -44.96 49.69 Favored 'General case' 0 CA--C 1.512 -0.504 0 C-N-CA 123.66 0.784 . . . . 0.0 109.528 -173.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.29 -5.74 56.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.316 0.247 . . . . 0.0 110.952 -172.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 48.4 p -111.64 -27.01 8.72 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.054 1.742 . . . . 0.0 109.784 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 68.58 37.63 2.5 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.377 1.871 . . . . 0.0 109.079 -176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -83.76 155.4 65.04 Favored Pre-proline 0 C--O 1.234 0.254 0 C-N-CA 123.716 0.806 . . . . 0.0 112.619 -175.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 71.4 Cg_endo -81.75 159.13 18.89 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 124.306 3.338 . . . . 0.0 115.485 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 73' ' ' LEU . 39.4 mt -91.69 -29.41 16.86 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.344 1.458 . . . . 0.0 114.397 176.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.2 t -151.61 148.66 28.24 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.614 -1.304 . . . . 0.0 109.186 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 26.0 mmmt -65.64 -14.96 62.27 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 123.779 0.832 . . . . 0.0 113.056 168.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? -77.47 -88.39 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 171.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -86.07 -1.5 57.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 118.068 -0.968 . . . . 0.0 113.566 -160.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 58.0 14.28 16.86 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.283 0.944 . . . . 0.0 115.057 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.46 HG23 ' H ' ' A' ' 101' ' ' VAL . 24.5 t -47.44 123.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 127.309 2.244 . . . . 0.0 111.834 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . 0.268 0.7 OUTLIER -107.07 156.84 7.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 119.824 1.193 . . . . 0.0 110.13 175.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.9 mt -80.8 136.39 36.11 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 120.954 -1.091 . . . . 0.0 108.433 171.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.445 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 2.4 m-70 -142.37 -36.16 0.41 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 118.581 -0.723 . . . . 0.0 111.219 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -146.39 143.24 28.92 Favored 'General case' 0 C--O 1.222 -0.376 0 CA-C-N 119.972 1.26 . . . . 0.0 110.4 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.04 132.88 53.77 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG21 HD23 ' A' ' 32' ' ' LEU . 97.3 t -79.47 111.61 22.23 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -90.62 104.22 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.67 2.247 . . . . 0.0 112.904 -170.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 32.5 t -94.53 -12.92 26.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.928 1.691 . . . . 0.0 112.748 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.8 177.25 18.89 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.606 -0.997 . . . . 0.0 110.606 -174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.19 -33.36 9.43 Favored 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.718 2.945 . . . . 0.0 111.574 -176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 19.1 m -126.64 95.82 4.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.099 0.96 . . . . 0.0 108.494 -156.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -42.97 124.82 3.3 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.741 2.816 . . . . 0.0 110.895 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.765 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 179.788 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.471 0 CA-C-O 118.396 -1.225 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -127.34 -79.76 0.59 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.133 0.966 . . . . 0.0 108.867 176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.1 m -68.6 123.81 21.88 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.519 1.127 . . . . 0.0 109.181 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.04 174.21 42.93 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 123.935 0.779 . . . . 0.0 112.555 -175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t 69.45 6.55 5.75 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.461 2.304 . . . . 0.0 114.908 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.81 163.29 1.46 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.431 1.492 . . . . 0.0 114.023 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.57 57.76 0.32 Allowed Glycine 0 CA--C 1.522 0.497 0 C-N-CA 126.169 1.843 . . . . 0.0 111.159 165.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.9 mp0 -75.8 22.33 0.14 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.87 2.468 . . . . 0.0 115.766 -153.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 9' ' ' VAL . 3.1 t -65.16 -51.43 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 O-C-N 120.156 -1.59 . . . . 0.0 110.88 -172.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -86.52 -7.97 57.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.804 0.442 . . . . 0.0 111.118 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -64.07 162.58 29.89 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 125.08 1.352 . . . . 0.0 109.912 175.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -69.01 164.52 33.47 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 109.151 -1.134 . . . . 0.0 109.151 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.6 tt -66.63 -34.21 77.37 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.301 0.64 . . . . 0.0 110.058 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -72.19 -2.82 20.19 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -115.65 2.15 13.67 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.357 1.463 . . . . 0.0 109.766 -177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -69.96 165.32 21.99 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.592 1.187 . . . . 0.0 111.096 -176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -48.99 5.04 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.761 1.624 . . . . 0.0 108.262 -169.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.3 p-90 -70.01 -9.76 56.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.357 1.463 . . . . 0.0 112.685 173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -81.61 80.57 7.93 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.518 1.054 . . . . 0.0 111.417 -177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -72.36 -30.64 64.9 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.981 -1.074 . . . . 0.0 112.062 -174.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 112.87 -145.92 18.28 Favored Glycine 0 C--N 1.339 0.739 0 C-N-CA 126.472 1.987 . . . . 0.0 109.328 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -77.97 39.5 0.3 Allowed 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 127.152 2.181 . . . . 0.0 114.769 -169.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -71.15 145.92 91.8 Favored Pre-proline 0 CA--C 1.556 1.188 0 C-N-CA 125.307 1.443 . . . . 0.0 111.7 -174.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.28 160.29 45.32 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 125.023 3.815 . . . . 0.0 112.019 172.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -61.66 -32.43 72.61 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.896 -1.753 . . . . 0.0 111.649 176.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.69 73.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.306 0.643 . . . . 0.0 111.695 -173.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -73.24 -34.84 66.1 Favored 'General case' 0 C--O 1.219 -0.531 0 C-N-CA 123.411 0.684 . . . . 0.0 111.424 -177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 95.5 t -38.73 -60.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 126.275 1.83 . . . . 0.0 111.531 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -65.44 -13.72 59.37 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -73.29 -38.07 66.02 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 169.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -83.14 -41.65 18.26 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.412 1.485 . . . . 0.0 109.603 -170.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.0 mt -86.74 131.44 34.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 55.9 t -130.45 -35.86 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.045 0.538 . . . . 0.0 111.019 -173.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 82.1 m-70 -105.4 154.64 20.04 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.0 p -64.23 112.98 3.28 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 125.24 -18.09 6.97 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-O 116.425 -2.319 . . . . 0.0 115.309 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -50.7 110.39 0.41 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.266 2.226 . . . . 0.0 108.741 165.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -116.04 156.95 25.43 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.036 -1.04 . . . . 0.0 109.389 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.7 pp -137.58 161.31 36.78 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 167.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.7 t -114.06 134.43 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 17.2 ptt180 -131.57 171.64 13.19 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.21 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -113.85 163.4 15.12 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.621 0.768 . . . . 0.0 111.432 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 87.2 p -66.26 179.68 0.93 Allowed 'General case' 0 C--O 1.233 0.225 0 C-N-CA 127.155 2.182 . . . . 0.0 113.694 -176.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -69.42 -6.95 33.46 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.403 0.681 . . . . 0.0 112.585 169.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.1 65.28 0.21 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -171.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtm -132.58 -0.41 3.55 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 128.108 2.563 . . . . 0.0 112.105 178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 57.87 40.99 25.41 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.801 1.64 . . . . 0.0 110.571 -169.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -131.98 143.92 50.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.278 0.631 . . . . 0.0 110.629 -177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -100.7 161.54 13.53 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.089 0.956 . . . . 0.0 111.777 176.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.772 HG22 HD13 ' A' ' 63' ' ' ILE . 94.8 t -133.59 138.25 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 126.107 1.763 . . . . 0.0 107.298 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.0 tp -93.97 133.25 37.61 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.973 1.709 . . . . 0.0 107.898 170.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.7 m -130.97 122.61 27.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.18 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.487 HG11 ' CG1' ' A' ' 101' ' ' VAL . 8.2 p -134.43 147.02 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 124.334 1.053 . . . . 0.0 109.593 177.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 12.6 tp -81.87 119.85 24.44 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 126.667 1.987 . . . . 0.0 106.59 170.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 102' ' ' VAL . 3.2 t-105 -131.02 110.87 11.54 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.44 44.51 18.0 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.883 1.673 . . . . 0.0 111.599 -174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.3 69.74 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 121.387 -0.821 . . . . 0.0 113.304 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD23 ' C ' ' A' ' 58' ' ' LEU . 5.2 tt -113.33 108.27 52.67 Favored Pre-proline 0 N--CA 1.451 -0.384 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -67.22 92.94 0.34 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.979 2.453 . . . . 0.0 107.993 173.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -63.8 165.21 8.84 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -144.81 126.15 14.83 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 168.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -122.3 132.99 54.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.772 HD13 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -62.15 140.46 19.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 8.0 mm -63.23 143.62 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-O 122.917 1.341 . . . . 0.0 108.488 173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.544 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -56.73 164.46 1.49 Allowed 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 128.31 2.644 . . . . 0.0 110.774 -179.559 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 8.1 t 178.2 135.83 0.08 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.708 2.003 . . . . 0.0 105.774 168.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.5 OUTLIER -139.62 -37.5 0.49 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -160.98 -55.99 0.05 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 119.151 0.887 . . . . 0.0 109.677 173.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -152.83 28.85 0.53 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.91 1.284 . . . . 0.0 109.396 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 mt -142.96 -176.05 4.75 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 125.761 1.625 . . . . 0.0 108.385 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -137.71 130.43 29.89 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 168.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.562 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.24 140.73 23.34 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.149 1.34 . . . . 0.0 110.755 -179.182 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.0 tp -117.41 -68.01 0.95 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-N 120.093 1.315 . . . . 0.0 110.014 -174.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -106.44 -23.7 12.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.274 1.03 . . . . 0.0 110.757 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.96 -161.98 11.56 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 126.397 1.951 . . . . 0.0 110.408 -168.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -67.5 170.1 8.1 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 117.956 0.878 . . . . 0.0 110.972 174.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.87 167.19 25.33 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-O 121.161 0.312 . . . . 0.0 113.695 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -137.08 160.5 65.76 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.011 1.324 . . . . 0.0 109.734 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.93 1.47 9.29 Favored 'Trans proline' 0 CA--C 1.544 0.984 1 C-N-CA 126.066 4.511 . . . . 0.0 113.536 -175.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -143.77 149.96 37.87 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.984 1.714 . . . . 0.0 106.488 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 9.8 mt -64.84 -48.44 72.43 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-O 117.132 -1.414 . . . . 0.0 108.334 168.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.0 Cg_endo -63.81 -26.39 67.73 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 CA-C-N 121.775 1.67 . . . . 0.0 112.888 -174.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.91 -45.8 87.66 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.618 0.767 . . . . 0.0 111.389 171.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.55 -35.64 77.7 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.4 mm -51.07 -46.25 30.96 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.584 0 CA-C-O 116.435 -1.745 . . . . 0.0 108.799 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.37 -44.49 91.23 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 122.131 2.241 . . . . 0.0 111.748 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -67.7 -6.79 22.45 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 119.009 -0.52 . . . . 0.0 112.014 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.45 -35.54 8.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.893 1.224 . . . . 0.0 113.054 163.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.23 -32.29 33.46 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 124.431 1.092 . . . . 0.0 110.813 -169.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.42 2.73 55.75 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 123.229 0.611 . . . . 0.0 110.441 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.1 p -120.76 -26.75 5.19 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.444 1.098 . . . . 0.0 110.167 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 64.14 31.08 13.55 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.893 1.277 . . . . 0.0 109.499 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -66.82 148.15 98.87 Favored Pre-proline 0 C--O 1.236 0.36 0 C-N-CA 123.712 0.805 . . . . 0.0 110.115 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.18 137.48 28.83 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.535 2.157 . . . . 0.0 110.193 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 13.1 mt -72.36 -41.28 66.6 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.22 1.408 . . . . 0.0 111.215 -178.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.9 t -153.56 142.13 20.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -62.39 -17.88 60.24 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.327 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.78 -19.87 65.15 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 175.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 24.9 m -147.81 -11.13 0.39 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.19 9.26 28.46 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.49 1.519 . . . . 0.0 115.655 176.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 ' CG1' HG11 ' A' ' 53' ' ' VAL . 18.2 t -46.01 148.77 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.394 0 C-N-CA 127.157 2.183 . . . . 0.0 111.428 176.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.5 m -130.32 174.08 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 120.021 1.282 . . . . 0.0 109.215 172.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.1 mt -92.01 139.59 30.49 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 120.713 -1.242 . . . . 0.0 108.319 164.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -146.41 -31.72 0.35 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.585 1.084 . . . . 0.0 113.294 -174.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -149.4 151.8 34.66 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.41 144.54 44.87 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 13.2 t -84.98 120.78 74.0 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 170.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.42 113.18 1.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.481 2.787 . . . . 0.0 112.871 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 13.4 t -106.25 -10.31 16.47 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.568 1.147 . . . . 0.0 112.374 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.08 165.66 40.82 Favored Glycine 0 CA--C 1.533 1.199 0 O-C-N 120.985 -1.072 . . . . 0.0 112.622 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.09 18.68 1.14 Allowed 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.792 2.328 . . . . 0.0 115.033 -161.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.9 m -132.51 152.03 51.7 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 119.766 1.166 . . . . 0.0 108.464 171.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.4 p -159.78 121.51 3.27 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 -177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.48 0 CA-C-O 119.239 -0.756 . . . . 0.0 111.277 177.539 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.768 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.8 m -64.27 -9.19 15.87 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 -150.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.2 m -132.56 1.44 3.71 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.484 1.038 . . . . 0.0 112.407 173.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.98 114.62 4.55 Favored Glycine 0 C--N 1.338 0.668 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 57.8 p -104.42 0.07 28.57 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.879 0.872 . . . . 0.0 112.585 -178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.0 t -151.15 -169.24 3.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.901 1.28 . . . . 0.0 108.429 170.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.85 49.85 3.03 Favored Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -123.79 15.42 9.39 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.468 1.107 . . . . 0.0 112.89 -171.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.477 ' O ' HD12 ' A' ' 83' ' ' LEU . 6.3 t -56.67 -51.36 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 125.942 1.697 . . . . 0.0 109.706 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -92.75 -9.28 41.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.526 0.73 . . . . 0.0 111.77 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.0 mttt -59.73 158.54 22.81 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 164.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -67.97 165.77 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 121.565 1.51 . . . . 0.0 110.52 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.532 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.3 tt -59.5 -35.73 74.7 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.918 0.887 . . . . 0.0 110.583 171.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 34.2 p80 -73.0 -0.36 13.59 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -115.02 4.21 14.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.321 1.448 . . . . 0.0 111.563 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -71.11 173.86 7.05 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.072 0.949 . . . . 0.0 112.936 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -109.18 -43.41 4.16 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-O 116.818 -1.563 . . . . 0.0 109.717 -176.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -78.08 -4.21 46.16 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.598 1.959 . . . . 0.0 114.467 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -82.16 100.56 9.9 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -81.79 -9.74 59.54 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.85 -133.17 11.59 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 105.972 -2.851 . . . . 0.0 105.972 -167.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -117.94 77.2 1.13 Allowed 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 125.315 1.446 . . . . 0.0 113.328 -161.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -99.56 152.28 37.75 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.501 1.521 . . . . 0.0 109.654 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.78 162.4 41.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.673 2.915 . . . . 0.0 112.19 171.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.9 ptt-85 -63.48 -32.26 73.66 Favored 'General case' 0 N--CA 1.466 0.338 0 O-C-N 120.004 -1.685 . . . . 0.0 112.582 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.07 -37.54 86.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.55 1.068 . . . . 0.0 110.726 -169.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.9 -30.16 70.01 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.691 1.196 . . . . 0.0 110.881 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.13 -61.15 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.46 0 C-N-CA 123.91 0.884 . . . . 0.0 110.145 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.594 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.57 -13.18 62.19 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.22 0.918 . . . . 0.0 113.095 -170.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -74.35 -38.13 63.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 123.834 0.854 . . . . 0.0 109.386 170.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HB3' HG11 ' A' ' 107' ' ' VAL . 80.7 mt -71.35 -47.68 54.92 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.035 1.334 . . . . 0.0 110.019 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.648 HD21 HD23 ' A' ' 39' ' ' LEU . 7.9 mt -78.44 155.3 29.99 Favored 'General case' 0 C--O 1.233 0.214 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -172.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.0 t -145.74 -41.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.981 0.912 . . . . 0.0 109.193 -165.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -127.86 156.97 41.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.0 0.92 . . . . 0.0 109.401 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 p -61.18 136.65 58.13 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.6 -13.97 64.75 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-O 115.956 -2.58 . . . . 0.0 113.362 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.462 ' HB3' HD22 ' A' ' 32' ' ' LEU . 3.1 m-20 -57.9 129.6 42.68 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 119.892 1.846 . . . . 0.0 107.473 172.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.8 p90 -139.4 156.91 46.68 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 125.048 1.339 . . . . 0.0 111.084 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD23 HD21 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -140.87 168.08 20.65 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 125.847 1.659 . . . . 0.0 108.519 162.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 98.4 t -108.09 126.77 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 105.35 -2.092 . . . . 0.0 105.35 162.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -113.05 159.55 19.06 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -96.07 164.17 12.81 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 124.438 1.095 . . . . 0.0 109.343 168.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 t -62.4 -167.78 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.316 3.047 . . . . 0.0 112.767 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -74.35 8.51 2.17 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.243 2.217 . . . . 0.0 114.032 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 124.51 37.43 0.55 Allowed Glycine 0 CA--C 1.528 0.878 0 C-N-CA 126.199 1.857 . . . . 0.0 111.228 -175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.1 mmtt -136.92 165.43 25.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.836 1.654 . . . . 0.0 108.404 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -77.78 34.59 0.19 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.355 1.062 . . . . 0.0 113.234 -176.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -112.74 134.94 54.01 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.514 1.526 . . . . 0.0 106.959 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -106.83 158.89 16.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.717 0.77 . . . . 0.0 109.731 170.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG22 HD13 ' A' ' 63' ' ' ILE . 70.3 t -131.4 128.78 61.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 126.673 1.989 . . . . 0.0 106.084 179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.2 tp -77.1 128.65 34.83 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 166.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.3 m -125.9 106.52 9.71 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 p -128.9 143.15 42.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.161 1.785 . . . . 0.0 108.91 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.475 HD23 ' HB2' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.72 120.74 29.35 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 177.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.599 ' CH2' HG22 ' A' ' 102' ' ' VAL . 4.7 t-105 -127.76 122.76 33.64 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 169.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.3 t0 42.95 60.31 2.54 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.581 1.953 . . . . 0.0 112.913 -178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 72.25 6.45 65.12 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 121.391 -0.818 . . . . 0.0 113.344 173.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.9 tt -125.81 105.55 26.41 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 124.709 1.203 . . . . 0.0 109.519 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.594 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 59.8 Cg_endo -63.04 98.17 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.725 3.617 . . . . 0.0 110.215 169.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.9 mmt180 -76.22 157.61 32.47 Favored 'General case' 0 N--CA 1.461 0.079 0 C-N-CA 124.328 1.051 . . . . 0.0 109.86 173.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 2.0 p80 -136.4 106.11 6.19 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -111.73 123.2 49.75 Favored 'General case' 0 C--O 1.224 -0.237 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.584 HD13 HG22 ' A' ' 50' ' ' VAL . 2.5 mm -55.32 135.0 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-N 119.616 1.098 . . . . 0.0 108.328 174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.9 mm -60.43 139.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.508 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -55.68 169.11 0.35 Allowed 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 127.535 2.334 . . . . 0.0 110.689 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.9 p 178.28 133.67 0.08 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 -170.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.43 -66.84 0.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 118.884 -0.579 . . . . 0.0 110.92 162.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -136.84 -57.44 0.73 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 125.412 1.485 . . . . 0.0 110.222 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -146.67 4.13 0.87 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.76 2.024 . . . . 0.0 111.399 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.88 175.94 9.14 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.425 1.49 . . . . 0.0 107.755 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -136.55 122.69 20.36 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 -178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 124.98 27.9 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 120.421 1.464 . . . . 0.0 109.582 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.495 ' CD2' HD22 ' A' ' 95' ' ' LEU . 15.2 tp -107.92 -25.02 11.4 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 118.597 0.635 . . . . 0.0 111.384 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -139.85 -67.17 0.44 Allowed 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 119.065 -0.493 . . . . 0.0 111.411 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.53 -82.99 1.71 Allowed Glycine 0 C--N 1.333 0.396 0 N-CA-C 110.714 -0.955 . . . . 0.0 110.714 -165.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -114.58 -179.9 3.76 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.632 1.573 . . . . 0.0 110.911 175.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -113.82 161.9 12.56 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 123.482 0.563 . . . . 0.0 112.637 176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -124.01 155.42 67.41 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 125.193 1.397 . . . . 0.0 108.742 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.65 -9.82 24.4 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 124.471 3.447 . . . . 0.0 113.564 -175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.667 ' HB2' HD13 ' A' ' 83' ' ' LEU . 6.3 m -137.92 150.04 46.73 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.532 ' HB ' HD12 ' A' ' 13' ' ' LEU . 81.8 mt -62.86 -49.89 79.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 18.4 Cg_endo -64.07 -27.19 65.53 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.362 1.375 . . . . 0.0 112.952 -171.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.667 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.0 mp -67.11 -41.49 86.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.347 1.059 . . . . 0.0 110.204 177.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.19 -31.26 62.59 Favored 'General case' 0 C--N 1.333 -0.11 0 O-C-N 122.29 -0.256 . . . . 0.0 110.922 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.9 mm -51.08 -47.95 30.85 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.274 176.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -66.77 -38.06 85.82 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.491 1.041 . . . . 0.0 111.006 -170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -71.91 -14.65 61.99 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-O 118.289 -0.862 . . . . 0.0 110.66 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -41.3 9.9 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 121.599 2.0 . . . . 0.0 110.033 170.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.73 -44.72 80.79 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 124.102 0.961 . . . . 0.0 109.473 -173.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.5 t -80.6 -15.45 56.58 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 123.562 0.745 . . . . 0.0 110.42 -172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.1 p -109.07 -20.68 12.93 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.623 1.169 . . . . 0.0 110.661 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 67.34 28.37 7.9 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.252 1.421 . . . . 0.0 110.619 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -68.93 142.22 93.14 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.709 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 74.4 Cg_endo -76.65 136.72 17.44 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 124.396 3.397 . . . . 0.0 112.324 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.495 HD22 ' CD2' ' A' ' 73' ' ' LEU . 19.9 mt -68.93 -31.39 70.25 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.305 -0.872 . . . . 0.0 112.199 -175.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -161.85 149.88 14.91 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -56.63 -12.51 1.85 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 126.395 1.878 . . . . 0.0 112.682 171.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -83.25 -20.65 34.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 117.238 -1.363 . . . . 0.0 113.711 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.0 p -142.26 -27.07 0.63 Allowed 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 67.37 21.39 72.28 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.575 1.08 . . . . 0.0 113.741 176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.4 t -53.85 143.4 5.93 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 CA-C-O 117.667 -1.158 . . . . 0.0 109.253 170.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.599 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.4 m -123.97 162.44 25.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 119.453 1.024 . . . . 0.0 108.358 166.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 26.8 mt -88.76 139.19 30.71 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 172.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.14 -51.46 0.23 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 117.933 0.333 . . . . 0.0 111.481 -173.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -127.9 139.23 52.73 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 122.065 -0.397 . . . . 0.0 110.226 -174.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -104.71 135.38 46.21 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -177.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 31' ' ' LEU . 48.0 t -86.6 106.85 11.54 Favored Pre-proline 0 N--CA 1.466 0.348 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 174.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -68.14 134.91 32.97 Favored 'Trans proline' 0 N--CA 1.446 -1.302 0 CA-C-N 120.357 1.163 . . . . 0.0 110.044 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -101.7 -41.63 6.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 159.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.35 174.71 19.53 Favored Glycine 0 CA--C 1.532 1.139 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.73 91.12 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 124.284 3.323 . . . . 0.0 110.089 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 25.9 t -149.13 163.41 37.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.532 1.533 . . . . 0.0 108.719 -167.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 22.2 p -151.97 149.16 28.6 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 118.712 0.687 . . . . 0.0 111.486 -176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.894 0 N-CA-C 108.52 -1.832 . . . . 0.0 108.52 -178.326 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.808 0 N-CA-C 110.654 -0.978 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -70.89 -26.96 63.46 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.625 1.17 . . . . 0.0 110.875 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.33 160.64 21.3 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.253 1.021 . . . . 0.0 108.886 175.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -152.63 159.07 28.23 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 170.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.6 m -128.57 -40.28 1.59 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 124.877 1.271 . . . . 0.0 108.75 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.4 m 46.1 68.86 0.53 Allowed 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.788 2.435 . . . . 0.0 111.668 165.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.6 -94.43 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 61.04 17.98 8.52 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.684 1.193 . . . . 0.0 112.408 173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 83' ' ' LEU . 5.5 t -60.78 -54.3 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 125.967 1.707 . . . . 0.0 108.969 -165.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -86.28 -3.22 58.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.0 0.52 . . . . 0.0 111.738 -168.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.2 mttp -65.73 159.64 67.33 Favored Pre-proline 0 C--O 1.236 0.343 0 O-C-N 122.006 -0.434 . . . . 0.0 110.479 168.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -63.27 162.53 26.48 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 121.274 1.316 . . . . 0.0 111.18 170.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD23 ' CD2' ' A' ' 19' ' ' TYR . 8.7 tt -66.03 -34.47 78.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.394 0.678 . . . . 0.0 110.395 174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -75.95 2.91 11.32 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.556 0.947 . . . . 0.0 113.556 -167.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -120.05 2.91 10.99 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.719 1.207 . . . . 0.0 109.19 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 60.3 mm-40 -70.77 167.47 18.74 Favored 'General case' 0 C--N 1.342 0.251 0 O-C-N 120.972 -1.08 . . . . 0.0 111.58 -172.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.73 -52.05 5.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 125.167 1.387 . . . . 0.0 108.989 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 12.0 p-90 -70.15 -10.51 59.05 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.974 1.31 . . . . 0.0 112.153 175.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.403 ' CD2' HD23 ' A' ' 13' ' ' LEU . 11.8 t80 -83.46 93.82 7.88 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.691 1.132 . . . . 0.0 110.192 175.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -74.45 -52.19 12.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.936 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.95 -150.87 20.26 Favored Glycine 0 C--N 1.341 0.856 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.98 103.82 1.93 Allowed 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 167.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.94 147.11 64.13 Favored Pre-proline 0 CA--C 1.54 0.574 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 27' ' ' GLU . 84.7 Cg_endo -74.2 162.55 38.44 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.547 2.832 . . . . 0.0 112.732 176.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -63.28 -28.52 70.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.469 -1.394 . . . . 0.0 111.933 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.82 -32.24 72.65 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 123.316 0.647 . . . . 0.0 111.051 -175.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HG2' ' HG2' ' A' ' 24' ' ' PRO . 8.4 mm-40 -77.88 -27.44 49.68 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.369 0.531 . . . . 0.0 111.071 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.1 t -44.7 -59.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.444 1.498 . . . . 0.0 111.603 -175.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.662 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.42 -11.91 58.95 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.37 -33.01 49.22 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.76 0.824 . . . . 0.0 110.647 169.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD12 HD22 ' A' ' 39' ' ' LEU . 91.2 mt -75.64 -43.39 47.97 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.15 0.98 . . . . 0.0 109.961 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 39' ' ' LEU . 9.8 mt -90.13 134.14 34.45 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -175.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.1 t -123.75 -30.7 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 118.997 0.817 . . . . 0.0 110.697 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -117.69 149.83 40.07 Favored 'General case' 0 N--CA 1.45 -0.46 0 O-C-N 121.42 -0.8 . . . . 0.0 109.232 -169.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.18 103.13 0.58 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 129.16 -19.2 5.46 Favored Glycine 0 N--CA 1.447 -0.596 0 CA-C-O 116.994 -2.003 . . . . 0.0 114.48 -172.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -61.79 128.09 34.54 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 176.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -134.82 153.92 51.83 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.004 0.921 . . . . 0.0 111.471 175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -136.83 165.94 24.76 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.566 1.946 . . . . 0.0 107.71 167.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.42 126.96 72.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 169.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -121.8 167.15 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.169 1.388 . . . . 0.0 108.647 176.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -98.16 164.54 12.28 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.188 0.595 . . . . 0.0 110.329 168.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.8 t -76.78 176.82 8.13 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.721 2.408 . . . . 0.0 110.684 173.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -60.35 -61.78 2.34 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.133 1.773 . . . . 0.0 111.842 -165.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -138.96 15.16 3.3 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 126.058 1.79 . . . . 0.0 111.081 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.95 140.26 37.44 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.879 1.671 . . . . 0.0 107.13 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -76.52 67.1 2.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 165.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -137.86 135.92 36.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -95.07 157.9 15.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 122.14 0.972 . . . . 0.0 110.724 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 63' ' ' ILE . 48.3 t -128.44 129.17 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.917 2.087 . . . . 0.0 105.631 175.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 17.3 tp -77.87 134.67 37.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 162.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -126.22 109.05 11.88 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.5 p -132.29 133.99 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.419 1.087 . . . . 0.0 109.517 -174.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 21.7 tp -86.92 126.08 34.46 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -174.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.534 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 2.3 t-105 -136.78 116.21 12.75 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -177.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.0 t70 43.37 55.4 4.8 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.571 1.548 . . . . 0.0 111.943 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 87.84 3.43 80.21 Favored Glycine 0 C--N 1.34 0.772 0 CA-C-N 115.105 -0.952 . . . . 0.0 114.628 172.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -133.29 111.18 12.83 Favored Pre-proline 0 N--CA 1.464 0.261 0 CA-C-N 119.494 1.647 . . . . 0.0 109.834 -170.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.662 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 99.0 Cg_endo -70.51 94.05 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.827 3.018 . . . . 0.0 108.925 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -61.56 165.66 4.76 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.367 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -144.04 88.88 1.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 101' ' ' VAL . 59.0 m-85 -92.75 131.72 37.57 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.653 HD13 HG22 ' A' ' 50' ' ' VAL . 5.6 mm -60.5 139.46 19.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.2 mm -60.13 145.41 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.45 169.38 0.91 Allowed 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.989 1.316 . . . . 0.0 110.796 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.67 140.66 0.12 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 165.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.58 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.6 OUTLIER -136.22 -38.89 0.68 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.183 1.393 . . . . 0.0 111.813 -179.081 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.9 -70.74 0.17 Allowed 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 166.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -136.53 25.86 3.14 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.918 2.087 . . . . 0.0 110.416 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 67' ' ' LEU . 2.9 mt -133.58 -172.49 2.98 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.591 1.556 . . . . 0.0 110.168 179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -140.7 108.37 5.63 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 117.62 -1.181 . . . . 0.0 109.892 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.58 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -128.93 144.4 51.17 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.201 1.819 . . . . 0.0 112.104 -174.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.1 tp -137.76 -29.03 0.87 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.68 1.582 . . . . 0.0 115.026 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -142.44 -39.28 0.35 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.201 1.0 . . . . 0.0 109.4 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.58 -163.76 11.84 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 128.152 2.787 . . . . 0.0 108.65 176.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -57.68 166.58 1.32 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.264 1.026 . . . . 0.0 112.879 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -94.87 166.81 26.4 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 123.767 0.699 . . . . 0.0 111.959 178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -136.41 160.3 67.33 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.036 1.334 . . . . 0.0 109.023 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.57 -3.07 13.38 Favored 'Trans proline' 0 CA--C 1.54 0.793 1 C-N-CA 125.671 4.248 . . . . 0.0 114.991 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.641 ' HB2' HD13 ' A' ' 83' ' ' LEU . 69.7 m -141.37 153.13 44.91 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 173.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.448 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 26.9 mt -66.16 -51.14 46.88 Favored Pre-proline 0 N--CA 1.448 -0.562 0 CA-C-O 117.044 -1.455 . . . . 0.0 107.35 171.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 20.0 Cg_endo -61.64 -28.27 82.44 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 121.925 1.75 . . . . 0.0 111.869 -175.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.641 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.4 mp -66.3 -42.38 88.41 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -33.11 58.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 123.44 0.696 . . . . 0.0 109.807 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.8 mm -50.4 -45.48 25.38 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-O 117.727 -1.13 . . . . 0.0 109.333 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.64 -34.66 78.73 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.723 1.147 . . . . 0.0 110.925 -174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -71.88 -17.05 62.14 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.554 0.741 . . . . 0.0 112.738 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.12 -42.43 11.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 120.368 -1.457 . . . . 0.0 109.881 170.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.6 -41.84 75.2 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.456 1.103 . . . . 0.0 110.333 -173.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.8 t -79.28 -21.98 45.32 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 118.808 -0.615 . . . . 0.0 110.378 -173.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.4 p -111.51 -16.5 13.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 118.818 0.735 . . . . 0.0 110.493 -172.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 69.15 32.2 3.76 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.522 1.129 . . . . 0.0 110.676 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -66.08 142.29 97.87 Favored Pre-proline 0 CA--C 1.539 0.553 0 O-C-N 121.912 -0.492 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.72 146.96 27.24 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 124.695 3.596 . . . . 0.0 112.992 178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.71 -25.87 28.07 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -165.98 149.37 7.62 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 173.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 38.5 mmtt -66.5 16.28 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.91 1.684 . . . . 0.0 113.069 171.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -111.8 -7.0 14.23 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 117.128 -1.415 . . . . 0.0 114.294 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.533 ' HB3' HG23 ' A' ' 101' ' ' VAL . 1.8 t -156.16 -0.55 0.14 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 169.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.6 27.79 35.6 Favored Glycine 0 CA--C 1.532 1.116 0 O-C-N 120.611 -1.305 . . . . 0.0 114.752 -179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.534 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 39.6 t -59.57 135.81 23.79 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 126.222 1.809 . . . . 0.0 109.8 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.406 HG22 ' CH2' ' A' ' 55' ' ' TRP . 1.5 m -127.18 156.16 38.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 119.385 0.993 . . . . 0.0 108.999 174.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 67.1 mt -79.53 135.61 36.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 173.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -143.26 -39.87 0.32 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 117.977 0.353 . . . . 0.0 111.497 -173.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -138.08 144.67 41.04 Favored 'General case' 0 C--O 1.222 -0.376 0 C-N-CA 123.794 0.838 . . . . 0.0 108.937 175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.37 124.49 52.59 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.457 HG21 HD23 ' A' ' 32' ' ' LEU . 17.9 t -67.63 129.88 93.31 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 172.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -79.53 150.59 22.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.677 2.252 . . . . 0.0 111.909 166.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.9 t -131.91 -3.22 3.62 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.481 1.112 . . . . 0.0 112.059 174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.66 166.12 32.14 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 -155.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.17 -21.24 12.17 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.45 2.1 . . . . 0.0 113.647 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.9 m -85.68 173.01 10.41 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 120.509 1.504 . . . . 0.0 111.258 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.4 p -142.18 163.13 33.69 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.653 0.781 . . . . 0.0 110.164 174.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.155 0 N-CA-C 107.286 -2.325 . . . . 0.0 107.286 174.676 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.086 0 CA-C-O 118.906 -0.941 . . . . 0.0 115.304 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -93.7 -14.8 25.92 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.466 1.633 . . . . 0.0 112.657 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.6 m -134.19 129.32 35.61 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 125.506 1.523 . . . . 0.0 106.929 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 79.14 159.21 14.89 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 124.245 0.926 . . . . 0.0 110.855 -163.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.3 t -143.46 -43.09 0.28 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.921 1.288 . . . . 0.0 109.899 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.0 p -145.48 173.87 11.65 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.313 1.045 . . . . 0.0 110.388 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.65 -136.45 12.16 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.754 -2.138 . . . . 0.0 107.754 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 57.11 26.68 12.37 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.047 1.339 . . . . 0.0 110.61 -178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -59.52 -55.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.939 2.096 . . . . 0.0 109.611 -170.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -79.68 -9.75 59.69 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 123.908 0.883 . . . . 0.0 111.818 -168.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -55.02 160.83 2.77 Favored Pre-proline 0 C--O 1.237 0.432 0 CA-C-N 118.015 0.37 . . . . 0.0 110.331 168.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -61.82 166.05 12.84 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.017 1.145 . . . . 0.0 109.359 168.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.46 -29.53 70.8 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 122.872 0.469 . . . . 0.0 110.176 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -82.34 7.19 14.66 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -173.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -114.82 4.84 15.02 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.105 0.962 . . . . 0.0 110.787 171.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -81.51 178.29 8.44 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.151 -0.968 . . . . 0.0 112.93 -166.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.07 -62.4 1.32 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 126.422 1.889 . . . . 0.0 111.03 -169.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 35.7 p-90 -62.2 -10.18 9.88 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 126.152 1.781 . . . . 0.0 113.385 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -82.32 82.84 7.65 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.529 1.532 . . . . 0.0 109.229 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -76.29 -12.45 60.08 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 121.249 -0.907 . . . . 0.0 112.538 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 113.14 -123.05 6.04 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 169.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -104.34 109.71 21.66 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 128.315 2.646 . . . . 0.0 107.554 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.02 145.03 52.8 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.3 162.59 38.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 123.049 2.5 . . . . 0.0 112.264 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -61.13 -25.57 67.08 Favored 'General case' 0 N--CA 1.464 0.268 0 O-C-N 120.909 -1.119 . . . . 0.0 113.545 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.28 68.06 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.792 0.837 . . . . 0.0 111.222 -176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -68.31 -40.67 81.63 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 123.805 0.842 . . . . 0.0 110.435 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -35.57 -60.68 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 126.434 1.894 . . . . 0.0 113.252 -174.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -14.73 53.17 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -171.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.63 -14.37 54.85 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.465 1.106 . . . . 0.0 111.604 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.36 -48.16 4.67 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.634 1.574 . . . . 0.0 108.944 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.3 mt -74.45 147.68 41.75 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 t -141.36 -24.37 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-N 120.329 1.422 . . . . 0.0 112.729 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -131.06 154.57 48.1 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.539 1.536 . . . . 0.0 108.285 -172.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.3 p -66.78 99.94 0.66 Allowed 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 141.08 -23.58 2.58 Favored Glycine 0 CA--C 1.507 -0.464 0 CA-C-O 118.229 -1.317 . . . . 0.0 114.835 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.39 131.38 50.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -137.21 153.7 50.35 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.826 1.65 . . . . 0.0 109.739 171.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -136.49 158.99 43.13 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 124.393 1.077 . . . . 0.0 108.574 166.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.8 t -108.18 122.94 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 26.2 ptt85 -124.41 161.77 25.29 Favored 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 125.024 1.33 . . . . 0.0 108.123 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -82.81 166.32 19.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.525 0.678 . . . . 0.0 109.463 169.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.4 p -64.5 -148.11 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 126.224 1.81 . . . . 0.0 111.43 167.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -94.83 -0.27 54.25 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.065 -1.022 . . . . 0.0 111.801 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.03 8.88 0.85 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.813 1.197 . . . . 0.0 114.46 -174.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.62 -173.41 0.32 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.967 1.384 . . . . 0.0 107.316 159.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -112.82 62.63 0.63 Allowed 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.163 -1.792 . . . . 0.0 106.163 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -135.48 133.36 38.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 177.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -93.75 162.48 13.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.603 1.192 . . . . 0.0 110.332 175.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -131.88 141.94 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 C-N-CA 127.676 2.39 . . . . 0.0 106.219 -175.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.8 tp -103.85 111.37 23.87 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 125.616 1.566 . . . . 0.0 107.089 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 m -115.46 110.42 19.27 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.59 140.44 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 125.685 1.594 . . . . 0.0 109.285 -167.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 14.1 tp -93.0 117.38 30.0 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -167.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -134.85 114.74 12.89 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.588 0.708 . . . . 0.0 109.901 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.7 t70 52.95 42.48 32.17 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.49 2.316 . . . . 0.0 113.411 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.77 36.31 48.24 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-O 118.648 -1.085 . . . . 0.0 112.142 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.15 111.65 4.07 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 124.44 1.096 . . . . 0.0 108.322 169.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -65.67 94.69 0.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.317 2.678 . . . . 0.0 109.411 168.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -60.26 168.52 1.98 Allowed 'General case' 0 C--O 1.236 0.392 0 C-N-CA 125.192 1.397 . . . . 0.0 109.362 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -143.46 103.34 4.09 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -112.66 132.56 55.11 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.104 -2.554 . . . . 0.0 104.104 170.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.534 HD13 HG22 ' A' ' 50' ' ' VAL . 3.6 mm -67.1 143.79 15.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 175.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 18.0 mm -59.13 137.78 21.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.78 158.14 0.7 Allowed 'General case' 0 C--O 1.224 -0.269 0 C-N-CA 125.592 1.557 . . . . 0.0 109.849 176.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -173.16 126.59 0.44 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.71 -145.48 0.29 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.66 1.584 . . . . 0.0 107.824 168.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.22 -53.55 52.0 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.855 1.262 . . . . 0.0 111.221 -167.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -147.65 11.29 0.98 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.495 1.118 . . . . 0.0 111.395 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.48 176.64 7.32 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.751 1.22 . . . . 0.0 108.85 -171.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -133.0 128.3 36.04 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 127.739 2.416 . . . . 0.0 104.797 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.76 137.7 21.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.952 1.705 . . . . 0.0 110.383 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.0 tp -120.84 -34.74 3.49 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 120.517 1.508 . . . . 0.0 113.445 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 -124.08 -47.65 1.9 Allowed 'General case' 0 C--O 1.235 0.32 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.53 -125.38 2.95 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 126.203 1.858 . . . . 0.0 110.066 -171.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -66.96 167.37 11.8 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 125.045 1.338 . . . . 0.0 112.354 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -118.79 158.37 14.85 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 125.784 1.659 . . . . 0.0 112.0 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -128.3 158.32 71.74 Favored Pre-proline 0 CA--C 1.521 -0.162 0 C-N-CA 123.868 0.867 . . . . 0.0 110.208 -177.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -78.31 1.13 9.28 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.689 3.593 . . . . 0.0 113.061 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.3 m -145.4 152.55 40.02 Favored 'General case' 0 N--CA 1.452 -0.332 0 O-C-N 119.925 -1.734 . . . . 0.0 108.765 174.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 72.3 mt -61.67 -50.08 83.68 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 170.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 21.4 Cg_endo -63.47 -32.01 71.3 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.179 1.253 . . . . 0.0 112.184 -175.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.604 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -67.32 -24.62 65.76 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.604 0.762 . . . . 0.0 111.538 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 13.9 tp -93.8 -28.7 15.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 124.115 0.966 . . . . 0.0 112.369 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.9 mm -53.86 -48.0 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 117.509 -1.234 . . . . 0.0 108.799 173.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -67.98 -38.31 82.57 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.061 -172.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.6 m170 -73.21 -8.93 57.94 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.018 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.03 -33.33 10.53 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 120.811 1.641 . . . . 0.0 113.037 166.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.702 HD12 ' HB3' ' A' ' 103' ' ' LEU . 8.9 tp -75.62 -48.09 23.71 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -72.44 -16.79 61.82 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.912 0.885 . . . . 0.0 110.133 -174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -106.3 -24.06 12.38 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.046 0.938 . . . . 0.0 109.304 -174.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 65.91 69.76 0.44 Allowed 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -174.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -117.56 147.41 40.75 Favored Pre-proline 0 C--O 1.235 0.33 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -78.85 148.52 22.38 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 123.88 3.053 . . . . 0.0 114.069 -168.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.55 -34.88 15.35 Favored 'General case' 0 C--N 1.333 -0.11 0 C-N-CA 124.994 1.318 . . . . 0.0 113.968 -174.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.5 t -160.01 145.83 15.51 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 119.986 -1.696 . . . . 0.0 107.969 176.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -58.41 -25.71 62.43 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 171.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -68.82 -3.22 11.62 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 175.593 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.76 -12.43 0.08 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.985 1.72 . . . . 0.0 114.967 171.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 42.67 39.01 3.29 Favored Glycine 0 C--N 1.341 0.806 0 C-N-CA 125.968 1.747 . . . . 0.0 113.02 -169.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.91 134.72 21.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 169.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.17 135.58 60.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.702 ' HB3' HD12 ' A' ' 89' ' ' LEU . 5.6 mt -53.88 139.05 34.85 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 168.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 9.2 m-70 -154.24 -30.69 0.11 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 118.067 -0.968 . . . . 0.0 112.654 -175.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -150.43 149.85 30.57 Favored 'General case' 0 C--N 1.343 0.317 0 CA-C-N 120.479 1.491 . . . . 0.0 110.393 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -123.07 121.84 37.01 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.113 1.365 . . . . 0.0 112.09 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 t -70.64 122.46 86.71 Favored Pre-proline 0 C--O 1.226 -0.143 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.44 109.3 2.62 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.142 1.895 . . . . 0.0 111.439 172.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.3 t -72.62 -43.4 63.32 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.196 0.998 . . . . 0.0 108.81 163.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 112.21 160.74 15.51 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 108.419 -1.872 . . . . 0.0 108.419 -159.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.96 -21.41 27.93 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.35 2.034 . . . . 0.0 113.062 -168.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 24.6 t -109.87 134.75 51.72 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 11.7 m -171.57 -173.94 1.3 Allowed 'General case' 0 C--O 1.242 0.704 0 C-N-CA 129.443 3.097 . . . . 0.0 106.899 -176.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.734 0 CA-C-O 118.588 -1.118 . . . . 0.0 111.01 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.943 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 m -94.96 -59.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.751 0.82 . . . . 0.0 109.95 -167.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -160.0 177.11 11.08 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.313 1.845 . . . . 0.0 107.812 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.5 156.2 24.53 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 124.277 0.941 . . . . 0.0 111.921 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 p -87.86 66.02 8.57 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.637 1.175 . . . . 0.0 112.134 -171.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.9 m -79.05 59.54 2.72 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.035 1.734 . . . . 0.0 110.434 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.69 -34.36 19.32 Favored Glycine 0 CA--C 1.525 0.674 0 C-N-CA 124.518 1.056 . . . . 0.0 111.262 174.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 54.06 26.98 6.98 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.857 1.663 . . . . 0.0 113.163 168.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG12 HD23 ' A' ' 83' ' ' LEU . 4.1 t -56.55 -49.96 75.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 126.659 1.984 . . . . 0.0 111.204 -166.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 88.4 mm-40 -87.25 -7.71 57.58 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.565 1.146 . . . . 0.0 111.401 -170.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -67.85 161.56 65.88 Favored Pre-proline 0 C--O 1.239 0.52 0 C-N-CA 123.376 0.67 . . . . 0.0 109.643 174.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -62.46 163.23 21.46 Favored 'Trans proline' 0 N--CA 1.447 -1.251 0 C-N-CA 120.466 0.778 . . . . 0.0 110.083 166.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.9 tt -64.74 -33.86 76.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.081 171.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -66.81 -9.68 39.81 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -114.42 -2.68 13.17 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 125.103 1.361 . . . . 0.0 110.943 -171.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mm-40 -63.47 173.54 1.58 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 122.579 1.181 . . . . 0.0 111.964 -175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.92 -54.6 2.95 Favored 'General case' 0 CA--C 1.513 -0.465 0 C-N-CA 125.409 1.484 . . . . 0.0 109.162 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 10.0 p-90 -70.58 -7.51 44.54 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 124.691 1.197 . . . . 0.0 112.655 178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -77.22 102.1 6.5 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.568 1.076 . . . . 0.0 108.851 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.416 ' CE1' HD13 ' A' ' 31' ' ' LEU . 14.0 m-70 -92.45 5.22 51.52 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.247 1.019 . . . . 0.0 112.589 174.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.64 -105.67 2.86 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 172.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.457 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -131.36 114.57 15.15 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.884 3.274 . . . . 0.0 107.678 -178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.78 153.55 72.17 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 125.786 1.634 . . . . 0.0 106.708 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.7 156.27 57.54 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.781 2.32 . . . . 0.0 112.317 170.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -63.39 -32.24 73.62 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 119.933 -1.73 . . . . 0.0 112.289 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.0 -28.86 69.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 118.125 0.42 . . . . 0.0 111.524 -171.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.18 -30.39 67.51 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.944 1.298 . . . . 0.0 112.251 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.455 HG11 ' HB3' ' A' ' 52' ' ' SER . 55.2 t -48.05 -56.38 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 124.02 0.928 . . . . 0.0 110.637 -174.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -62.47 -13.38 29.62 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.4 -24.85 20.66 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.304 1.842 . . . . 0.0 110.96 177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 20' ' ' HIS . 92.6 mt -78.11 -53.63 7.17 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.623 1.569 . . . . 0.0 109.106 174.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.801 HD21 HD23 ' A' ' 39' ' ' LEU . 1.8 mt -70.0 163.17 26.68 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 t -144.16 -45.5 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -123.9 160.36 27.66 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.316 1.046 . . . . 0.0 109.803 -173.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 p -72.58 94.99 1.77 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.167 1.387 . . . . 0.0 108.561 -172.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.98 -29.96 1.81 Allowed Glycine 0 N--CA 1.448 -0.521 0 CA-C-O 116.603 -2.221 . . . . 0.0 115.043 -170.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.498 ' O ' HD22 ' A' ' 32' ' ' LEU . 6.4 m-20 -56.99 107.7 0.43 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 127.89 2.476 . . . . 0.0 109.935 171.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -118.67 151.74 37.4 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.98 1.312 . . . . 0.0 111.245 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.801 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -135.75 171.58 14.25 Favored 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 125.889 1.676 . . . . 0.0 108.014 167.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.49 131.65 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 170.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -129.77 169.12 15.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 13.9 tt0 -96.57 152.3 18.76 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -63.67 166.3 7.15 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 164.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.09 88.77 5.96 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 120.271 -1.518 . . . . 0.0 108.652 -171.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.63 60.37 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 118.343 0.52 . . . . 0.0 113.235 175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -121.15 141.96 50.33 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 176.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -74.59 30.49 0.09 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.563 1.545 . . . . 0.0 112.006 -174.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -126.82 126.91 44.15 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.888 2.075 . . . . 0.0 106.772 -167.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -83.94 164.09 19.59 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 123.089 1.423 . . . . 0.0 111.295 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.624 HG22 HD13 ' A' ' 63' ' ' ILE . 6.7 t -136.45 124.86 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.0 tp -76.09 135.8 39.87 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 167.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.455 ' HB3' HG11 ' A' ' 28' ' ' VAL . 7.4 m -133.64 107.89 8.23 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 10.7 p -131.92 153.96 39.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 C-N-CA 125.947 1.699 . . . . 0.0 107.623 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.59 128.36 38.42 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.916 2.487 . . . . 0.0 106.111 177.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.2 t-105 -135.93 125.77 25.71 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t0 44.48 46.69 8.13 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.691 1.596 . . . . 0.0 113.172 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 83.38 4.37 89.46 Favored Glycine 0 CA--C 1.526 0.734 0 O-C-N 121.363 -0.835 . . . . 0.0 113.279 170.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.1 tt -122.96 106.84 33.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 118.894 1.347 . . . . 0.0 108.879 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.402 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 56.1 Cg_endo -62.29 94.62 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 124.603 3.535 . . . . 0.0 110.811 171.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -64.44 176.14 1.17 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.773 0.797 . . . . 0.0 110.601 173.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.1 p80 -151.85 46.63 0.78 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-O 122.558 1.171 . . . . 0.0 112.647 -173.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 30.9 m-85 -59.8 117.15 4.65 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 108.803 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.624 HD13 HG22 ' A' ' 50' ' ' VAL . 6.8 mm -56.02 140.67 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.0 mm -67.46 147.19 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.599 1.19 . . . . 0.0 108.302 176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.78 167.11 6.29 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.341 1.857 . . . . 0.0 111.218 -172.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.5 t 178.98 127.58 0.06 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.69 1.196 . . . . 0.0 108.248 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.596 HD22 ' HG3' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.5 -88.9 0.46 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.515 1.526 . . . . 0.0 108.507 178.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.95 -63.65 1.42 Allowed 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -141.62 16.15 2.17 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.881 1.272 . . . . 0.0 112.038 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 mt -134.11 -176.1 4.08 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 126.331 1.852 . . . . 0.0 109.073 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -136.28 125.49 24.66 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.068 2.547 . . . . 0.0 105.365 177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HG3' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -145.49 144.15 30.4 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 121.2 1.818 . . . . 0.0 110.574 -177.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 tp -135.52 -25.88 1.28 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -173.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -130.24 -55.24 1.11 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 173.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.09 -128.07 5.03 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 125.969 1.747 . . . . 0.0 109.39 -174.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -69.75 171.81 8.56 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.784 0.802 . . . . 0.0 112.609 -178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.54 164.05 13.04 Favored Glycine 0 C--N 1.336 0.538 0 C-N-CA 124.138 0.875 . . . . 0.0 112.183 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -126.96 158.69 67.91 Favored Pre-proline 0 C--O 1.23 0.078 0 C-N-CA 123.953 0.901 . . . . 0.0 109.633 177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -78.74 -13.09 14.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.949 3.1 . . . . 0.0 113.117 -177.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.4 m -133.34 150.03 51.86 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 54.3 mt -63.5 -49.05 79.95 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 170.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 30.3 Cg_endo -65.23 -24.43 58.51 Favored 'Trans proline' 0 C--N 1.351 0.692 0 CA-C-N 121.04 1.407 . . . . 0.0 112.567 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.445 HD23 HG12 ' A' ' 9' ' ' VAL . 7.2 mt -67.04 -40.73 87.24 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.452 0.701 . . . . 0.0 111.573 172.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -32.95 64.65 Favored 'General case' 0 N--CA 1.46 0.064 0 O-C-N 121.99 -0.444 . . . . 0.0 109.874 -176.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 34.0 mm -57.83 -41.14 79.12 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 CA-C-O 117.731 -1.128 . . . . 0.0 109.841 177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.72 -37.81 85.44 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 120.127 1.331 . . . . 0.0 111.441 -178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -69.05 -13.1 62.25 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 118.641 -0.695 . . . . 0.0 110.363 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.26 -38.18 10.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 121.391 1.905 . . . . 0.0 111.839 169.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.59 -42.28 35.71 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.737 0.815 . . . . 0.0 109.655 -170.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 t -87.05 -7.25 58.28 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 122.15 -0.344 . . . . 0.0 111.631 -174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.8 p -102.95 -31.59 10.16 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 124.813 1.245 . . . . 0.0 109.99 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.466 ' HA ' HE21 ' A' ' 92' ' ' GLN . 0.8 OUTLIER 63.26 73.37 0.45 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.609 1.964 . . . . 0.0 109.671 -166.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -118.82 157.26 50.63 Favored Pre-proline 0 C--O 1.233 0.192 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -80.04 147.79 19.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.764 3.643 . . . . 0.0 114.306 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.2 mt -80.3 -37.58 32.4 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 114.745 -1.116 . . . . 0.0 113.185 175.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.6 t -159.97 144.57 14.8 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -52.74 -24.92 9.71 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.73 0.812 . . . . 0.0 111.35 165.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -72.51 -13.87 61.52 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.2 t -159.66 -7.15 0.06 Allowed 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 121.114 1.779 . . . . 0.0 113.988 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 66.53 0.73 8.7 Favored Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.148 1.619 . . . . 0.0 117.148 173.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.4 ' H ' HG23 ' A' ' 101' ' ' VAL . 60.7 t -35.5 119.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 129.101 2.961 . . . . 0.0 113.611 -176.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 22.3 t -111.87 130.2 65.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.385 0.993 . . . . 0.0 110.276 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.46 139.72 57.59 Favored 'General case' 0 C--N 1.34 0.186 0 C-N-CA 124.196 0.998 . . . . 0.0 108.738 173.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -147.03 -35.36 0.25 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 118.291 0.496 . . . . 0.0 111.649 -175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -143.63 144.5 31.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.278 0.631 . . . . 0.0 109.652 -175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -111.14 147.36 35.07 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.4 112.47 55.52 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 173.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.06 109.39 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.25 2.633 . . . . 0.0 112.62 -177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.2 t -93.44 -20.92 19.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.237 1.415 . . . . 0.0 111.283 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 82.38 160.0 26.76 Favored Glycine 0 CA--C 1.534 1.231 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -163.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.74 86.24 1.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.554 2.836 . . . . 0.0 111.074 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.7 p -120.7 -174.66 2.86 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.005 1.722 . . . . 0.0 109.06 167.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 67.9 m -143.75 46.73 1.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 120.66 -1.275 . . . . 0.0 108.202 176.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 N-CA-C 107.451 -2.26 . . . . 0.0 107.451 -167.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.822 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -134.6 110.12 9.1 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 -167.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t -166.03 -170.41 1.72 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.56 0.744 . . . . 0.0 110.852 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.09 -164.8 22.32 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 124.92 1.248 . . . . 0.0 112.234 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.1 t -132.15 29.34 4.36 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.191 1.796 . . . . 0.0 111.036 -167.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 34.9 t 57.31 42.56 24.89 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 120.886 -1.134 . . . . 0.0 110.209 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.45 75.68 0.21 Allowed Glycine 0 C--N 1.334 0.461 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -172.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -131.82 22.65 4.61 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.718 1.207 . . . . 0.0 110.34 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 83' ' ' LEU . 18.1 t -55.83 -48.0 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 126.804 2.041 . . . . 0.0 108.995 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -76.66 -18.04 58.8 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 119.364 -0.35 . . . . 0.0 111.887 -169.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -67.41 162.97 51.38 Favored Pre-proline 0 C--O 1.233 0.215 0 C-N-CA 123.844 0.858 . . . . 0.0 109.677 -178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -63.58 164.87 19.56 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.982 1.121 . . . . 0.0 109.426 173.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.474 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.4 tt -59.83 -33.25 71.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.987 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -74.09 -4.03 33.09 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -174.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -107.83 0.5 22.19 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.26 1.024 . . . . 0.0 111.492 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -74.0 172.36 11.79 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 122.482 1.134 . . . . 0.0 111.183 -170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.429 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.3 OUTLIER -96.28 -60.39 1.63 Allowed 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 125.315 1.446 . . . . 0.0 108.421 -179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.429 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 17.3 p-90 -62.89 -13.08 29.81 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.331 1.453 . . . . 0.0 112.484 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.33 107.78 8.82 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 173.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -98.7 11.58 38.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.519 1.127 . . . . 0.0 112.659 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 80.18 -100.6 1.9 Allowed Glycine 0 C--O 1.223 -0.54 0 O-C-N 119.92 -1.738 . . . . 0.0 109.287 168.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -135.58 123.21 22.23 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 130.791 3.637 . . . . 0.0 107.262 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.57 147.01 23.76 Favored Pre-proline 0 CA--C 1.544 0.727 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 -176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -68.09 170.08 15.22 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.037 2.491 . . . . 0.0 112.58 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -80.01 -19.76 46.98 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 120.004 -1.685 . . . . 0.0 113.433 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.48 -36.74 57.68 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 118.308 -1.357 . . . . 0.0 110.177 -179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -55.69 -31.02 62.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.363 1.065 . . . . 0.0 111.305 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.7 t -49.82 -59.56 1.01 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 110.75 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -66.5 -12.98 60.18 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 119.055 0.843 . . . . 0.0 112.651 -174.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -75.47 -34.54 60.91 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 118.715 0.689 . . . . 0.0 110.585 168.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.4 mt -76.76 -46.28 25.78 Favored 'General case' 0 C--O 1.231 0.103 0 C-N-CA 124.392 1.077 . . . . 0.0 109.973 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.85 HD21 HD23 ' A' ' 39' ' ' LEU . 6.1 mt -82.76 156.39 23.74 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.77 -40.05 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.616 0 O-C-N 120.835 -1.166 . . . . 0.0 109.322 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -127.2 171.65 11.25 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 125.564 1.545 . . . . 0.0 109.346 -175.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.9 p -59.08 145.75 41.05 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.476 0.655 . . . . 0.0 110.662 175.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.7 -15.81 49.69 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-O 116.915 -2.047 . . . . 0.0 113.392 171.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -58.1 121.11 9.86 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -133.11 152.68 51.94 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 124.359 1.064 . . . . 0.0 110.508 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.85 HD23 HD21 ' A' ' 32' ' ' LEU . 0.7 OUTLIER -137.93 167.47 21.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 C-N-CA 125.841 1.656 . . . . 0.0 107.899 166.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.66 130.6 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 171.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -130.35 163.69 26.31 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 125.438 1.495 . . . . 0.0 108.033 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.03 163.19 18.09 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 172.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.7 t -74.36 -152.97 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.999 0.919 . . . . 0.0 109.862 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -99.23 74.27 1.94 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -177.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.13 37.14 93.77 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 124.689 1.138 . . . . 0.0 111.133 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -111.42 153.13 26.54 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -84.84 60.4 6.16 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 176.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -153.77 138.19 16.74 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -104.33 164.01 12.03 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.954 0.902 . . . . 0.0 109.914 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.623 HG22 HD13 ' A' ' 63' ' ' ILE . 74.9 t -131.03 127.64 61.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.471 2.309 . . . . 0.0 106.271 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 tp -82.72 122.56 28.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 168.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.5 m -121.76 107.83 12.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 -178.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.22 138.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 125.99 1.716 . . . . 0.0 108.195 -172.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.18 121.8 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.63 ' CH2' HG22 ' A' ' 102' ' ' VAL . 2.0 t-105 -124.35 122.61 38.18 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 168.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 34.21 66.61 0.26 Allowed 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 129.005 2.922 . . . . 0.0 113.438 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.84 9.81 71.17 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 125.98 1.752 . . . . 0.0 113.168 172.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -127.14 106.34 21.9 Favored Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 124.459 1.104 . . . . 0.0 109.715 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 52.2 Cg_endo -60.98 91.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 124.189 3.259 . . . . 0.0 111.414 169.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.544 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 3.3 mmp_? -64.21 158.3 23.5 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.137 -0.977 . . . . 0.0 109.205 167.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -141.99 115.48 9.01 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 172.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -115.34 127.95 55.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 177.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.623 HD13 HG22 ' A' ' 50' ' ' VAL . 2.9 mm -57.54 134.79 21.99 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 173.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 15.1 mm -54.69 149.42 2.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-O 123.072 1.415 . . . . 0.0 107.964 175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -60.18 163.93 4.54 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 113.348 -1.751 . . . . 0.0 110.466 -177.58 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 t -177.06 138.93 0.26 Allowed 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 172.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 -84.54 0.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 166.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -112.83 -62.89 1.52 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -134.02 5.54 3.59 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.754 2.022 . . . . 0.0 110.957 176.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.0 mt -123.28 168.67 12.17 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.911 1.284 . . . . 0.0 109.425 -171.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -130.91 119.19 21.79 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 -174.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.23 145.96 36.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.766 1.166 . . . . 0.0 110.917 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.1 tp -124.71 -64.19 1.12 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 120.232 1.378 . . . . 0.0 111.152 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -97.7 -30.82 12.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.682 0.793 . . . . 0.0 110.808 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.14 -140.23 4.36 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 -165.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -74.26 172.0 12.61 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.077 0.951 . . . . 0.0 111.665 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 170.21 21.58 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 124.572 1.082 . . . . 0.0 112.748 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -135.89 159.0 72.83 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 124.73 1.212 . . . . 0.0 108.869 171.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.09 -10.36 27.29 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 124.515 3.477 . . . . 0.0 114.079 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' HD13 ' A' ' 83' ' ' LEU . 15.0 m -138.61 152.48 48.16 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.109 1.364 . . . . 0.0 108.26 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.474 ' HB ' HD12 ' A' ' 13' ' ' LEU . 71.4 mt -67.18 -47.62 50.18 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.714 175.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 31.0 Cg_endo -66.19 -30.03 46.66 Favored 'Trans proline' 0 C--N 1.353 0.792 0 CA-C-N 121.382 1.529 . . . . 0.0 112.549 -174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.549 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.2 mp -64.95 -35.4 81.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.252 1.021 . . . . 0.0 109.703 176.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.33 -38.03 51.25 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.015 0.926 . . . . 0.0 110.598 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.3 mm -51.12 -41.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 123.547 0.739 . . . . 0.0 110.373 -177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.31 -42.54 95.78 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.537 0.608 . . . . 0.0 110.412 -174.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -72.96 -11.09 60.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 117.579 -1.2 . . . . 0.0 112.169 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.53 -12.39 15.62 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 128.986 2.914 . . . . 0.0 113.782 176.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 -53.59 4.63 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 168.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.1 m -92.35 0.95 57.49 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 120.524 -0.471 . . . . 0.0 111.916 -154.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 p -117.12 -20.38 9.31 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.176 2.19 . . . . 0.0 110.375 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 71.89 39.66 0.81 Allowed 'General case' 0 C--N 1.352 0.697 0 C-N-CA 127.348 2.259 . . . . 0.0 110.707 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -71.91 142.94 86.04 Favored Pre-proline 0 CA--C 1.539 0.534 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 69.1 Cg_endo -70.97 152.25 62.9 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.331 2.687 . . . . 0.0 112.074 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 42.3 mt -95.22 -20.7 19.0 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.67 146.65 26.61 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 165.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -61.48 -14.61 30.31 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.83 -71.59 0.49 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 171.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.6 m -79.12 -20.17 49.32 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 124.069 0.856 . . . . 0.0 112.883 -156.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 60.7 15.6 41.71 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.181 -1.344 . . . . 0.0 115.015 178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.497 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 22.4 t -49.91 146.38 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 CA-C-N 119.1 1.45 . . . . 0.0 108.996 173.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.63 HG22 ' CH2' ' A' ' 55' ' ' TRP . 3.1 m -126.41 162.79 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-N 119.915 1.234 . . . . 0.0 107.783 170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 mt -84.13 141.29 31.19 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.9 -46.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.418 0.553 . . . . 0.0 111.532 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -132.4 142.8 49.44 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 123.313 0.645 . . . . 0.0 110.296 -176.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -110.78 133.48 53.31 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.734 0.814 . . . . 0.0 109.216 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.0 t -81.8 132.88 53.18 Favored Pre-proline 0 CA--C 1.536 0.438 0 C-N-CA 124.901 1.281 . . . . 0.0 107.734 172.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.95 115.19 3.25 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.775 2.984 . . . . 0.0 112.924 172.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.8 t -83.76 -35.48 24.34 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 121.793 -0.567 . . . . 0.0 110.769 166.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 106.67 164.2 22.48 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.948 1.261 . . . . 0.0 110.639 -168.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -77.56 -38.95 0.6 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.406 2.07 . . . . 0.0 112.59 -170.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.0 t -86.26 148.49 25.61 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 172.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.2 p -144.95 168.83 19.31 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -163.707 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.739 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 m -140.73 121.42 14.31 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 118.467 1.134 . . . . 0.0 109.444 -171.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 t -90.48 -75.95 0.45 Allowed 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.79 162.25 26.87 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 125.07 1.319 . . . . 0.0 111.255 -175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.25 133.36 8.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.468 1.107 . . . . 0.0 108.403 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.5 m -147.64 138.08 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.941 1.297 . . . . 0.0 107.621 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.18 76.99 0.93 Allowed Glycine 0 C--N 1.333 0.408 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -130.38 30.11 4.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.688 1.595 . . . . 0.0 110.202 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.8 t -68.49 -56.87 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 O-C-N 120.235 -1.541 . . . . 0.0 109.413 -175.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.89 -17.38 63.35 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.477 0.711 . . . . 0.0 112.051 -172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -58.64 163.11 5.52 Favored Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 125.384 1.474 . . . . 0.0 110.373 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -71.68 164.98 33.95 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 120.822 1.015 . . . . 0.0 109.75 171.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.0 tt -59.75 -39.23 84.09 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.883 0.873 . . . . 0.0 109.45 167.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -74.77 10.8 1.25 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -171.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -130.03 5.81 4.97 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.699 1.2 . . . . 0.0 111.762 172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -72.36 164.17 26.77 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.654 1.116 . . . . 0.0 111.714 -174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.39 -58.4 2.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 127.196 2.198 . . . . 0.0 107.489 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 25.4 p-90 -67.58 -8.9 38.05 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.864 1.266 . . . . 0.0 112.733 175.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -80.02 109.09 14.14 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 119.567 1.076 . . . . 0.0 108.397 168.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -96.58 -42.53 8.01 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 125.844 1.658 . . . . 0.0 110.668 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' ARG . . . 126.01 -143.59 14.52 Favored Glycine 0 C--N 1.338 0.694 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.92 35.56 0.53 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -165.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.38 146.56 97.94 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.092 1.357 . . . . 0.0 111.471 -164.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.18 163.42 30.47 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.085 3.19 . . . . 0.0 113.135 175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.9 ptt180 -62.35 -27.01 68.77 Favored 'General case' 0 N--CA 1.465 0.315 0 O-C-N 120.605 -1.309 . . . . 0.0 114.215 -179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.22 -40.92 70.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -67.09 -33.12 74.8 Favored 'General case' 0 C--O 1.212 -0.879 0 C-N-CA 123.372 0.669 . . . . 0.0 109.988 -175.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 52' ' ' SER . 88.0 t -42.12 -62.8 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 O-C-N 120.951 -1.093 . . . . 0.0 109.973 170.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.47 -13.9 61.96 Favored 'General case' 0 C--N 1.33 -0.243 0 O-C-N 121.394 -0.817 . . . . 0.0 112.714 -170.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 tp10 -72.21 -32.67 66.98 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.051 0.94 . . . . 0.0 110.768 168.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.6 mt -90.64 -46.73 8.1 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.623 1.169 . . . . 0.0 111.543 -174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.421 HD21 HD23 ' A' ' 39' ' ' LEU . 10.0 mt -78.55 134.23 37.27 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.74 -22.51 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 120.477 1.49 . . . . 0.0 113.189 -176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -127.36 167.67 15.86 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 119.1 0.863 . . . . 0.0 109.116 172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 p -54.39 125.5 19.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.398 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.84 -9.28 63.89 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-O 116.25 -2.417 . . . . 0.0 114.895 171.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -57.05 122.3 12.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.54 1.67 . . . . 0.0 106.654 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.75 159.21 36.4 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 120.171 1.35 . . . . 0.0 112.335 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.421 HD23 HD21 ' A' ' 32' ' ' LEU . 1.7 pp -148.39 157.51 43.53 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.909 2.084 . . . . 0.0 109.212 173.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.2 t -116.08 98.94 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 127.806 2.443 . . . . 0.0 108.151 -179.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' GLY . 25.9 ptt85 -99.53 152.09 20.42 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-O 118.835 -0.602 . . . . 0.0 110.754 -175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -85.69 152.64 22.92 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 119.523 1.056 . . . . 0.0 108.393 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 t -70.76 170.32 12.7 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.497 1.519 . . . . 0.0 113.408 -173.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.58 84.04 0.04 OUTLIER 'General case' 0 C--O 1.242 0.669 0 C-N-CA 125.883 1.673 . . . . 0.0 111.059 171.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.03 27.11 74.2 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 117.825 -1.542 . . . . 0.0 111.932 175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 22.5 mmtm -128.42 141.49 51.39 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.642 1.721 . . . . 0.0 107.565 172.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -73.12 61.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.788 1.635 . . . . 0.0 108.874 170.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -133.83 151.97 51.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.944 2.097 . . . . 0.0 107.323 175.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -109.61 159.96 16.67 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.252 1.025 . . . . 0.0 111.212 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.727 HG22 HD13 ' A' ' 63' ' ' ILE . 61.1 t -134.17 124.8 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 128.692 2.797 . . . . 0.0 106.031 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.451 HD23 HD13 ' A' ' 95' ' ' LEU . 13.4 tp -76.91 138.42 39.71 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 165.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 28' ' ' VAL . 51.0 m -137.25 134.72 36.5 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 120.383 -1.448 . . . . 0.0 109.91 164.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.81 143.13 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 125.166 1.386 . . . . 0.0 109.586 -174.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 13.8 tp -87.2 107.6 18.55 Favored 'General case' 0 CA--C 1.517 -0.31 0 N-CA-C 105.129 -2.174 . . . . 0.0 105.129 -176.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.528 ' CD2' HG23 ' A' ' 101' ' ' VAL . 3.4 t-105 -122.75 125.63 45.89 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.0 t70 51.03 44.15 28.71 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.519 1.128 . . . . 0.0 111.731 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.94 29.11 67.51 Favored Glycine 0 CA--C 1.525 0.692 0 O-C-N 121.109 -0.994 . . . . 0.0 112.621 175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.93 110.0 3.78 Favored Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -176.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.65 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.2 Cg_endo -65.02 95.77 0.25 Allowed 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.7 2.933 . . . . 0.0 107.238 171.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 62' ' ' PHE . 10.3 mmt180 -64.43 148.78 49.78 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.3 m-70 -130.54 109.03 10.37 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 174.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 60' ' ' ARG . 24.4 m-85 -117.56 139.32 51.11 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.727 HD13 HG22 ' A' ' 50' ' ' VAL . 5.3 mm -66.37 143.59 15.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 173.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 22.7 mm -63.97 151.09 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 124.255 1.979 . . . . 0.0 109.61 172.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.6 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -64.47 164.8 10.91 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.049 -178.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t 179.57 134.25 0.1 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.681 -2.34 . . . . 0.0 104.681 175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -128.44 -81.08 0.58 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 172.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 6.7 t70 -123.19 -62.75 1.31 Allowed 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.767 0.318 . . . . 0.0 111.225 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -145.06 20.93 1.6 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.509 1.524 . . . . 0.0 110.555 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.2 mt -131.9 179.65 5.95 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.399 1.88 . . . . 0.0 109.174 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.39 129.59 33.56 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 127.43 2.292 . . . . 0.0 106.063 176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -142.64 138.51 30.74 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.942 1.701 . . . . 0.0 110.764 -177.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.8 tp -136.52 -25.26 1.16 Allowed 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.33 -64.98 1.19 Allowed 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 170.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.87 -97.9 0.95 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -169.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.57 172.25 13.99 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.851 1.261 . . . . 0.0 111.757 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -109.51 167.09 12.72 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 123.997 0.808 . . . . 0.0 112.432 -177.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -132.32 159.03 73.98 Favored Pre-proline 0 N--CA 1.462 0.167 0 C-N-CA 124.422 1.089 . . . . 0.0 109.636 172.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.71 -8.25 14.64 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.846 3.697 . . . . 0.0 114.701 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB3' ' HD2' ' A' ' 82' ' ' PRO . 16.5 m -136.34 152.13 50.33 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.423 -1.695 . . . . 0.0 106.423 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 94.2 mt -61.7 -49.98 83.97 Favored Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 168.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 80' ' ' SER . 24.0 Cg_endo -64.4 -30.49 62.7 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.585 1.523 . . . . 0.0 113.128 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 80' ' ' SER . 6.3 mp -67.18 -34.24 77.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.424 0.556 . . . . 0.0 110.29 177.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.35 -34.13 58.94 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 119.396 -0.335 . . . . 0.0 110.691 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.4 mm -50.87 -48.69 28.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.277 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.238 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -63.96 -40.12 95.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.674 1.125 . . . . 0.0 109.958 -174.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.4 -5.74 44.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.297 1.039 . . . . 0.0 112.819 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.08 -35.34 8.56 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-N 120.88 1.673 . . . . 0.0 112.049 163.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -43.97 83.42 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -175.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.9 t -81.54 -17.61 47.85 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.907 -171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.3 p -110.4 -18.83 13.15 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 124.649 1.18 . . . . 0.0 110.362 -167.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 60.13 54.17 4.21 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 125.486 1.514 . . . . 0.0 109.373 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -92.75 145.52 30.46 Favored Pre-proline 0 C--N 1.333 -0.123 0 C-N-CA 123.257 0.623 . . . . 0.0 111.651 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.65 141.6 27.97 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.337 2.691 . . . . 0.0 112.937 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' HB2' HG13 ' A' ' 101' ' ' VAL . 18.4 mt -78.07 -19.17 54.75 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.1 t -167.14 157.67 11.49 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 164.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -52.42 -32.05 37.23 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 123.425 0.69 . . . . 0.0 111.508 170.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 3.6 mmpt? -64.85 -33.08 75.15 Favored 'General case' 0 CA--C 1.527 0.071 0 CA-C-O 118.505 -0.76 . . . . 0.0 112.776 -175.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.1 p -136.03 -10.29 2.02 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 114.122 1.156 . . . . 0.0 114.122 -163.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 65.73 14.62 60.88 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-N 119.651 1.114 . . . . 0.0 114.617 167.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.602 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -79.62 138.32 20.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 CA-C-N 118.744 1.272 . . . . 0.0 113.121 -164.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.9 m -118.6 142.92 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.888 1.222 . . . . 0.0 110.173 -175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.0 mt -67.31 141.72 57.08 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.4 -38.28 0.18 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 6.3 tpt180 -139.71 148.32 42.16 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 118.806 0.73 . . . . 0.0 109.261 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.11 136.06 54.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.54 125.65 73.28 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -81.44 108.95 2.02 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.134 2.556 . . . . 0.0 113.502 175.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.6 t -89.6 2.15 55.06 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.969 1.307 . . . . 0.0 112.399 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.9 -172.64 54.42 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.792 -1.192 . . . . 0.0 111.15 -171.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -85.56 -5.54 9.09 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 124.548 3.498 . . . . 0.0 115.159 -169.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.2 t -155.55 169.44 24.28 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 124.006 0.922 . . . . 0.0 109.09 -168.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.1 m -113.11 161.91 16.56 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.46 1.504 . . . . 0.0 108.712 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.838 0 N-CA-C 105.735 -2.946 . . . . 0.0 105.735 -177.1 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.485 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.1 m -140.96 -3.79 1.22 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.79 1.236 . . . . 0.0 112.308 -164.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.8 m -75.39 -169.24 0.95 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.104 0.962 . . . . 0.0 110.566 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.76 -69.33 0.22 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.868 -2.493 . . . . 0.0 106.868 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 m 39.61 65.76 0.66 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.184 1.794 . . . . 0.0 111.686 166.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 m -66.2 157.81 30.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.956 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 38.79 67.84 0.52 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 127.129 2.299 . . . . 0.0 113.521 172.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -83.68 20.49 1.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.156 0.982 . . . . 0.0 111.941 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.52 -55.44 10.97 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 C-N-CA 126.371 1.868 . . . . 0.0 110.68 -178.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 90.1 mm-40 -80.19 -12.05 59.68 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 123.756 0.822 . . . . 0.0 112.158 -165.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -58.39 160.26 10.04 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 123.959 0.904 . . . . 0.0 110.292 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.3 164.85 26.61 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 120.997 1.132 . . . . 0.0 109.195 176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.0 tt -57.64 -35.8 70.99 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.251 170.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -76.87 1.19 18.24 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -173.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -112.13 3.34 17.22 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.023 -1.048 . . . . 0.0 110.865 170.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -70.77 161.73 30.37 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 122.71 1.243 . . . . 0.0 110.625 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 18' ' ' TRP . 0.2 OUTLIER -98.43 -50.08 4.43 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.802 2.441 . . . . 0.0 107.635 -169.137 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.438 ' H ' ' HG ' ' A' ' 17' ' ' LEU . 11.5 p-90 -70.55 -4.32 22.43 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.112 1.365 . . . . 0.0 112.729 173.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -83.56 91.08 7.35 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 119.018 0.826 . . . . 0.0 109.379 172.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -80.9 8.84 7.4 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 121.766 -0.584 . . . . 0.0 111.774 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.15 -112.72 3.77 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 126.954 2.216 . . . . 0.0 108.226 177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.512 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -125.13 98.65 5.75 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.111 2.964 . . . . 0.0 109.303 -175.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.67 146.76 63.24 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.159 0.984 . . . . 0.0 109.136 -171.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.14 161.46 29.33 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 124.404 3.402 . . . . 0.0 114.023 176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -54.83 -35.94 64.5 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 121.056 -1.028 . . . . 0.0 112.274 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.26 -1.0 34.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.885 0.474 . . . . 0.0 112.218 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -99.0 -28.99 13.16 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 119.001 0.819 . . . . 0.0 111.012 169.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 87.9 t -44.81 -63.14 0.27 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 C-N-CA 125.639 1.576 . . . . 0.0 111.588 179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.772 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.25 -14.57 63.03 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 119.746 1.157 . . . . 0.0 113.895 -169.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.3 -32.19 64.48 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.479 1.112 . . . . 0.0 110.191 169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 mt -88.07 -44.0 11.28 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.328 1.051 . . . . 0.0 109.883 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mt -81.07 128.77 34.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.3 t -124.77 -41.14 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 C-N-CA 124.367 1.067 . . . . 0.0 109.942 -174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 -102.53 158.5 16.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.3 m -77.08 89.23 3.59 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 149.63 -21.5 1.17 Allowed Glycine 0 CA--C 1.51 -0.253 0 CA-C-O 119.372 -0.682 . . . . 0.0 112.968 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -61.87 127.49 31.66 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -131.61 160.08 36.38 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.81 1.644 . . . . 0.0 110.217 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.426 HD11 ' HD3' ' A' ' 41' ' ' ARG . 2.1 pp -144.24 154.38 43.04 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 126.481 1.912 . . . . 0.0 108.431 169.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.5 t -103.5 134.6 44.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 166.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.426 ' HD3' HD11 ' A' ' 39' ' ' LEU . 35.4 ptt85 -136.52 162.27 33.57 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.533 1.533 . . . . 0.0 107.69 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.512 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 5.5 tm-20 -88.19 161.61 17.15 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 120.968 -1.083 . . . . 0.0 109.217 169.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.1 t -62.25 -179.21 0.21 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.163 1.385 . . . . 0.0 110.392 169.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -77.48 51.76 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.869 -1.144 . . . . 0.0 110.086 169.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.1 77.62 0.58 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.5 mmtt -124.06 -6.34 7.82 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.917 1.287 . . . . 0.0 112.537 161.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 55.68 44.59 26.14 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.566 1.147 . . . . 0.0 108.901 -164.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -137.12 138.57 40.45 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 171.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -88.13 163.95 15.94 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.056 1.407 . . . . 0.0 111.452 176.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 63' ' ' ILE . 5.7 t -135.88 134.71 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.023 0 C-N-CA 127.775 2.43 . . . . 0.0 104.93 -177.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.6 tp -93.64 139.63 30.57 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 168.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -142.3 135.71 29.01 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.248 -1.533 . . . . 0.0 109.152 172.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 p -149.99 137.23 13.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.01 1.324 . . . . 0.0 109.398 -164.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 29.4 tp -91.97 106.01 18.13 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.414 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 12.2 t-105 -132.46 127.78 36.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.2 t0 49.38 40.39 18.49 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.343 1.857 . . . . 0.0 112.174 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 77.37 8.8 87.07 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-O 119.053 -0.859 . . . . 0.0 113.634 177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.525 HD22 ' HD3' ' A' ' 60' ' ' ARG . 2.3 tt -123.98 111.35 28.97 Favored Pre-proline 0 C--O 1.237 0.402 0 CA-C-N 119.299 1.55 . . . . 0.0 108.249 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.772 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 74.1 Cg_endo -66.14 90.21 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 124.424 3.416 . . . . 0.0 109.949 171.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' HD3' HD22 ' A' ' 58' ' ' LEU . 19.1 mmt-85 -60.43 158.67 11.58 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 121.586 -0.696 . . . . 0.0 109.634 178.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -134.16 107.57 7.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -109.56 132.64 53.95 Favored 'General case' 0 CA--C 1.511 -0.534 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.508 HD13 HG22 ' A' ' 50' ' ' VAL . 19.5 mm -67.31 134.42 30.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 17.1 mm -56.86 146.67 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 124.107 1.908 . . . . 0.0 108.647 175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -61.18 164.94 4.77 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 111.73 -2.486 . . . . 0.0 109.934 -176.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.7 t -174.78 109.35 0.12 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.43 -149.14 0.44 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 150.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -61.35 -55.71 28.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.528 -159.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -140.48 11.75 2.32 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.569 1.548 . . . . 0.0 111.471 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.67 173.43 11.35 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 125.652 1.581 . . . . 0.0 108.773 -175.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.07 122.56 28.58 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.72 139.73 45.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 120.194 1.361 . . . . 0.0 110.043 175.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.5 tp -118.38 -40.58 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 118.907 0.776 . . . . 0.0 109.792 -177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -121.82 -70.51 0.78 Allowed 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 124.485 1.115 . . . . 0.0 109.826 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.08 -116.87 4.26 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 125.049 1.309 . . . . 0.0 111.098 -170.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -63.45 163.62 10.59 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 122.387 1.089 . . . . 0.0 111.938 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -100.96 160.74 18.64 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 168.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -127.78 155.63 77.03 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 124.037 0.935 . . . . 0.0 108.997 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.26 -8.91 23.59 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 124.824 3.682 . . . . 0.0 113.783 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.423 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -139.91 152.23 46.24 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.493 ' HB ' HD12 ' A' ' 13' ' ' LEU . 59.0 mt -64.85 -49.16 70.29 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-O 117.622 -1.18 . . . . 0.0 108.225 169.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 29.8 Cg_endo -66.24 -27.43 48.44 Favored 'Trans proline' 0 C--N 1.353 0.794 0 CA-C-N 121.342 1.515 . . . . 0.0 112.774 -171.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 80' ' ' SER . 11.1 mp -68.51 -36.75 79.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.315 1.046 . . . . 0.0 109.921 176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -32.05 56.73 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 122.807 0.443 . . . . 0.0 111.718 -178.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.1 mm -51.23 -47.51 33.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.208 0 CA-C-O 118.192 -0.909 . . . . 0.0 108.733 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -63.35 -41.64 98.87 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 119.352 0.978 . . . . 0.0 111.207 -171.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -72.95 -10.36 59.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 117.655 -1.164 . . . . 0.0 111.75 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.43 -34.55 11.48 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 121.63 2.013 . . . . 0.0 111.38 167.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.3 tt -74.05 -39.31 63.6 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.995 1.318 . . . . 0.0 110.855 -172.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 23.0 t -81.88 -28.46 32.93 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 122.156 -0.34 . . . . 0.0 110.173 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.4 p -92.41 -33.44 14.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.861 1.264 . . . . 0.0 109.51 -170.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 72.16 61.54 0.13 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 127.048 2.139 . . . . 0.0 109.849 -169.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -91.87 142.26 26.35 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 122.758 0.423 . . . . 0.0 111.272 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.41 135.21 19.95 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 124.957 3.771 . . . . 0.0 111.523 -177.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.644 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.4 mt -78.0 -22.49 49.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.3 t -157.96 148.55 20.71 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 8.9 tptt -70.61 13.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.47 1.108 . . . . 0.0 112.545 173.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 25.1 mmtt -123.73 -14.67 7.19 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.426 1.49 . . . . 0.0 113.726 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 70.7 m -135.18 -7.6 2.3 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 119.515 1.052 . . . . 0.0 113.092 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 64.53 -0.07 4.31 Favored Glycine 0 C--N 1.34 0.801 0 C-N-CA 125.228 1.394 . . . . 0.0 115.728 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.644 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.2 OUTLIER -58.78 132.42 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 125.242 1.417 . . . . 0.0 112.638 -164.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.76 131.35 67.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.45 132.66 53.25 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -126.07 -46.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.308 0 O-C-N 123.248 0.343 . . . . 0.0 111.63 -176.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -142.83 141.55 31.64 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.954 -1.091 . . . . 0.0 110.416 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -101.46 134.46 44.52 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 176.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 t -78.95 120.68 81.72 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 165.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.48 113.18 2.83 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 122.512 2.141 . . . . 0.0 112.167 173.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 -10.67 34.03 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.231 1.812 . . . . 0.0 111.967 174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.36 174.86 18.66 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.673 1.606 . . . . 0.0 111.746 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.32 -8.33 15.1 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.6 2.867 . . . . 0.0 113.918 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.98 156.55 37.9 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 125.072 1.349 . . . . 0.0 108.088 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.0 p -150.59 169.0 22.6 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 122.675 0.39 . . . . 0.0 111.322 -167.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.984 176.039 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 m -134.04 -70.91 0.51 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.2 t -53.42 137.95 34.47 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 168.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.68 -72.3 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -171.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.0 m -146.93 161.4 40.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 118.678 1.239 . . . . 0.0 109.022 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.6 m -75.61 -3.94 37.23 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.674 0.789 . . . . 0.0 112.948 -174.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.24 103.73 2.32 Favored Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 174.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -119.21 11.71 12.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.317 1.058 . . . . 0.0 111.515 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.3 t -65.62 -49.05 80.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 O-C-N 120.137 -1.602 . . . . 0.0 109.574 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 64.8 mm-40 -86.54 -5.82 59.05 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.904 0.383 . . . . 0.0 110.862 -168.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -57.98 159.93 9.61 Favored Pre-proline 0 CA--C 1.532 0.281 0 O-C-N 121.273 -0.892 . . . . 0.0 110.115 164.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -65.06 164.69 24.14 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.059 1.173 . . . . 0.0 109.361 173.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 81' ' ' ILE . 9.4 tt -58.94 -36.37 74.66 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.579 0.751 . . . . 0.0 109.569 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -78.08 9.66 3.53 Favored 'General case' 0 CA--C 1.551 0.984 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -120.0 7.64 10.91 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.596 -1.315 . . . . 0.0 110.883 168.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -73.6 167.36 21.5 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.829 0.824 . . . . 0.0 110.904 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.49 -41.93 5.15 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.306 -172.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -67.37 -10.84 54.99 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 169.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -83.52 82.07 8.45 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.726 1.148 . . . . 0.0 110.335 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -72.8 -22.45 60.82 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.288 -0.882 . . . . 0.0 111.407 -176.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.52 -109.76 1.54 Allowed Glycine 0 C--N 1.338 0.68 0 C-N-CA 124.604 1.097 . . . . 0.0 110.38 169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -121.45 85.55 2.42 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 127.831 2.452 . . . . 0.0 108.652 175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -110.51 140.82 22.91 Favored Pre-proline 0 C--O 1.242 0.71 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.431 -176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.18 158.21 52.41 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.146 1.897 . . . . 0.0 111.675 177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -64.92 -25.66 67.98 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 120.792 -1.193 . . . . 0.0 112.268 -175.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.55 -41.55 75.77 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 119.13 -0.462 . . . . 0.0 109.913 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -65.8 -34.76 78.91 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.7 0.8 . . . . 0.0 109.81 -172.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.2 t -36.74 -60.16 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 C-N-CA 125.367 1.467 . . . . 0.0 111.285 176.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.583 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -67.64 -16.43 64.15 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -170.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -22.91 51.87 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.792 0.724 . . . . 0.0 111.25 172.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.9 mt -86.12 -47.25 9.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.863 0.865 . . . . 0.0 109.905 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 37' ' ' ASP . 7.2 mt -79.49 144.23 34.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.287 1.035 . . . . 0.0 109.218 -176.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 68.9 t -135.07 -19.29 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.265 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -133.83 154.72 50.82 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.7 p -59.36 120.39 9.22 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 123.98 -24.46 6.33 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-O 117.694 -1.614 . . . . 0.0 115.351 -179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.406 ' HB3' HD22 ' A' ' 32' ' ' LEU . 12.6 m-20 -65.02 116.57 6.57 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.337 1.455 . . . . 0.0 108.046 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -123.92 156.94 35.41 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.836 1.655 . . . . 0.0 111.319 179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.4 pp -146.9 163.08 37.27 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.232 1.813 . . . . 0.0 109.113 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.7 t -111.47 131.43 62.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 171.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 35.8 ptt85 -132.11 170.48 14.92 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.164 1.385 . . . . 0.0 107.802 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.66 159.14 15.57 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 124.379 1.072 . . . . 0.0 109.423 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 45.8 t -63.2 -97.54 0.0 OUTLIER 'General case' 0 C--O 1.236 0.382 0 C-N-CA 128.742 2.817 . . . . 0.0 112.708 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -157.42 79.75 0.89 Allowed 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 157.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.89 18.52 70.67 Favored Glycine 0 CA--C 1.529 0.934 0 O-C-N 121.531 -0.73 . . . . 0.0 111.501 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -95.43 148.83 22.05 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 158.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -78.36 47.76 0.72 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.93 0.492 . . . . 0.0 109.868 177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -130.77 144.66 51.6 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.456 1.102 . . . . 0.0 110.564 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -104.15 160.91 14.47 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 122.874 1.321 . . . . 0.0 111.934 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 63' ' ' ILE . 43.2 t -128.66 133.77 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 127.041 2.136 . . . . 0.0 106.834 177.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 15.4 tp -87.03 129.32 34.94 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.842 1.657 . . . . 0.0 107.508 163.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.9 m -117.54 141.81 47.92 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 168.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.1 p -144.7 148.08 18.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 125.094 1.358 . . . . 0.0 109.428 165.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 15.1 tp -86.73 111.42 20.69 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 104.425 -2.435 . . . . 0.0 104.425 177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.524 ' CD2' HG23 ' A' ' 101' ' ' VAL . 1.7 t-105 -123.92 134.49 53.51 Favored 'General case' 0 CA--C 1.518 -0.272 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 170.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 53.6 39.78 30.57 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.865 0.866 . . . . 0.0 110.667 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.89 18.3 64.15 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 124.923 1.249 . . . . 0.0 112.719 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.4 tt -127.92 113.09 20.38 Favored Pre-proline 0 N--CA 1.453 -0.313 0 C-N-CA 125.09 1.356 . . . . 0.0 107.954 -172.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.583 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.7 Cg_endo -68.3 93.49 0.41 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.628 2.886 . . . . 0.0 109.994 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.0 mmt180 -70.11 146.62 50.75 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -126.28 104.04 7.99 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.473 1.109 . . . . 0.0 108.858 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -104.88 124.78 50.07 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.529 HD13 ' CG2' ' A' ' 50' ' ' VAL . 2.8 mm -56.95 135.23 20.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 168.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 11.7 mm -55.99 149.25 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 122.774 1.273 . . . . 0.0 107.576 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -62.16 167.31 4.09 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 125.491 1.516 . . . . 0.0 110.153 -178.267 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.3 t -175.42 143.91 0.66 Allowed 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 104.672 -2.344 . . . . 0.0 104.672 170.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -136.58 -52.58 0.71 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.295 1.038 . . . . 0.0 111.055 170.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -140.63 -76.64 0.31 Allowed 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -143.05 41.03 1.51 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.641 1.576 . . . . 0.0 108.077 170.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.1 mt -138.73 179.19 6.63 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -142.59 118.9 10.84 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.515 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -131.63 121.68 24.73 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 120.614 1.552 . . . . 0.0 109.554 -174.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' CD2' HD22 ' A' ' 95' ' ' LEU . 14.1 tp -113.68 -42.75 3.39 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.967 0.907 . . . . 0.0 111.267 -171.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -119.62 -79.24 0.6 Allowed 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.794 0.837 . . . . 0.0 109.397 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.28 -114.66 0.76 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 125.59 1.567 . . . . 0.0 110.276 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.4 169.45 11.79 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 118.645 1.222 . . . . 0.0 112.909 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.89 164.22 28.66 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 124.442 1.02 . . . . 0.0 111.896 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -133.62 157.75 77.2 Favored Pre-proline 0 N--CA 1.464 0.24 0 C-N-CA 124.767 1.227 . . . . 0.0 109.201 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.21 -13.22 33.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 124.268 3.312 . . . . 0.0 113.829 -175.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 83' ' ' LEU . 1.3 m -136.88 151.14 48.75 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -173.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 ' HB ' HD12 ' A' ' 13' ' ' LEU . 65.6 mt -64.5 -47.94 75.78 Favored Pre-proline 0 N--CA 1.454 -0.26 0 CA-C-O 116.69 -1.624 . . . . 0.0 107.713 171.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.2 Cg_endo -62.66 -32.29 78.93 Favored 'Trans proline' 0 C--N 1.355 0.883 0 CA-C-N 121.327 1.51 . . . . 0.0 112.359 -173.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.5 mp -66.87 -36.84 83.23 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.394 0.677 . . . . 0.0 111.149 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.0 -32.35 72.67 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 121.962 -0.461 . . . . 0.0 110.91 177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.9 mm -54.96 -47.19 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-O 118.768 -0.634 . . . . 0.0 109.323 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -71.17 -31.36 67.56 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.136 -170.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -77.83 -7.69 57.0 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 117.819 -1.086 . . . . 0.0 111.299 179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.53 -40.24 7.53 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 120.604 1.547 . . . . 0.0 113.188 164.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.0 -47.76 73.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 C-N-CA 124.716 1.206 . . . . 0.0 109.163 -174.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 m -92.56 6.29 47.78 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.219 -171.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.6 p -113.72 -24.35 9.22 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.998 1.319 . . . . 0.0 110.377 171.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 62.07 59.39 1.67 Allowed 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.81 1.244 . . . . 0.0 108.457 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.97 151.36 37.99 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.188 0.995 . . . . 0.0 111.363 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 65.7 Cg_endo -71.06 150.43 60.27 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 124.972 3.782 . . . . 0.0 111.539 -178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.665 ' HB2' HG13 ' A' ' 101' ' ' VAL . 17.8 mt -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.462 0.131 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 99' ' ' SER . 0.0 OUTLIER -157.32 149.15 22.36 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 104.907 -2.256 . . . . 0.0 104.907 162.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER -62.79 -9.02 7.95 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.728 0.811 . . . . 0.0 112.305 172.165 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 10.9 mmpt? -75.18 -72.79 0.28 Allowed 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 119.089 0.858 . . . . 0.0 108.69 163.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.493 ' HB2' HG12 ' A' ' 101' ' ' VAL . 30.1 m -74.6 -24.0 58.81 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -160.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.82 -11.58 5.78 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 118.849 -0.973 . . . . 0.0 114.677 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.665 HG13 ' HB2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -53.49 129.42 14.26 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 125.741 1.616 . . . . 0.0 114.841 -167.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.6 m -109.18 145.89 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 120.478 1.49 . . . . 0.0 110.389 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 41.1 mt -67.85 145.79 54.29 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.1 m-70 -143.13 -46.02 0.3 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-O 119.432 -0.318 . . . . 0.0 111.372 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -143.29 144.66 32.21 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 118.573 0.624 . . . . 0.0 109.703 -165.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.11 118.06 26.06 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -170.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.4 t -66.55 123.38 85.53 Favored Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 118.083 -0.96 . . . . 0.0 108.782 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -86.58 122.49 2.02 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.919 2.413 . . . . 0.0 112.657 178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.7 p -81.97 -8.18 59.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.799 1.64 . . . . 0.0 111.436 166.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 74.87 171.77 28.52 Favored Glycine 0 CA--C 1.535 1.331 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -152.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.56 -15.45 34.09 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 122.659 2.24 . . . . 0.0 112.069 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 p -74.98 90.7 2.45 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 125.275 1.43 . . . . 0.0 108.892 169.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.8 t -60.99 150.55 33.17 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 164.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 -176.009 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.769 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -58.42 -34.13 70.44 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.8 m -72.38 170.23 14.65 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.032 0.933 . . . . 0.0 110.817 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.55 -93.9 1.7 Allowed Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 m -138.09 150.64 47.05 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.422 1.111 . . . . 0.0 111.292 178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.5 m -72.73 156.82 38.54 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.931 1.693 . . . . 0.0 110.021 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.21 -77.87 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 163.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.5 mp0 55.15 16.62 1.66 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.546 1.138 . . . . 0.0 113.473 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.4 HG23 ' H ' ' A' ' 9' ' ' VAL . 2.6 t -63.93 -44.6 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 126.258 1.823 . . . . 0.0 110.788 -161.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 -94.19 -8.68 38.66 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.019 0.928 . . . . 0.0 110.12 -172.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -63.99 159.42 55.65 Favored Pre-proline 0 C--O 1.239 0.544 0 C-N-CA 123.583 0.753 . . . . 0.0 109.171 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -66.07 160.04 46.47 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 N-CA-C 109.551 -0.98 . . . . 0.0 109.551 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 81' ' ' ILE . 10.1 tt -59.51 -34.93 73.24 Favored 'General case' 0 C--O 1.224 -0.243 0 C-N-CA 123.675 0.79 . . . . 0.0 109.718 170.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -76.94 3.01 13.1 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -111.36 -9.63 14.26 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.825 1.193 . . . . 0.0 109.884 172.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -65.15 164.89 12.25 Favored 'General case' 0 C--N 1.341 0.236 0 O-C-N 120.992 -1.067 . . . . 0.0 110.673 -175.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 108' ' ' PRO . 0.2 OUTLIER -105.12 -42.83 5.19 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 114.999 -1.001 . . . . 0.0 110.227 -167.412 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -63.6 -13.97 47.17 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 123.442 0.697 . . . . 0.0 112.465 167.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -81.82 84.38 6.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.02 0.827 . . . . 0.0 109.167 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -75.13 3.95 7.71 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.085 0.954 . . . . 0.0 111.502 177.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 83.67 -99.77 2.22 Favored Glycine 0 N--CA 1.445 -0.744 0 O-C-N 120.163 -1.585 . . . . 0.0 109.223 173.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.479 ' HA ' ' H ' ' A' ' 42' ' ' GLU . . . -130.2 110.8 11.85 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 126.247 1.819 . . . . 0.0 108.231 -174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 146.92 42.66 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -175.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -75.92 161.43 36.08 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 124.528 3.486 . . . . 0.0 112.811 175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -63.71 -28.76 70.12 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 120.223 -1.548 . . . . 0.0 112.026 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.73 -6.16 56.68 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -177.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -84.15 -36.35 22.94 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.46 1.027 . . . . 0.0 109.999 169.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 84.6 t -42.68 -63.03 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 126.849 2.06 . . . . 0.0 112.924 -172.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -69.19 -10.08 56.01 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.771 1.169 . . . . 0.0 113.898 -170.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -79.86 -22.11 43.29 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.599 0.76 . . . . 0.0 110.363 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HB3' HG11 ' A' ' 107' ' ' VAL . 35.7 mt -93.37 -47.84 6.7 Favored 'General case' 0 CA--C 1.521 -0.159 0 C-N-CA 125.077 1.351 . . . . 0.0 109.396 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.586 HD21 HD23 ' A' ' 39' ' ' LEU . 7.6 mt -81.79 146.95 29.65 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.9 t -141.05 -37.15 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 123.177 0.591 . . . . 0.0 110.135 -168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -128.44 156.77 42.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.938 0.895 . . . . 0.0 110.008 -176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.05 119.85 5.18 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 109.319 174.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 109.42 -15.64 32.39 Favored Glycine 0 N--CA 1.442 -0.961 0 CA-C-O 115.937 -2.59 . . . . 0.0 113.752 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -63.01 129.83 42.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.425 1.612 . . . . 0.0 106.733 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -138.34 165.5 26.6 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 123.171 0.588 . . . . 0.0 110.749 174.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.586 HD23 HD21 ' A' ' 32' ' ' LEU . 2.2 pp -154.11 144.43 22.16 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 125.782 1.633 . . . . 0.0 108.311 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 37.8 t -103.17 127.29 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 175.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.62 170.48 12.62 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.199 1.8 . . . . 0.0 107.177 -176.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' H ' ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm-20 -117.58 146.77 43.39 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 125.652 1.581 . . . . 0.0 108.653 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.8 t -70.3 178.14 3.01 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.722 2.009 . . . . 0.0 111.814 -175.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -76.29 89.32 3.14 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 120.383 -1.448 . . . . 0.0 111.165 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.8 6.44 77.98 Favored Glycine 0 CA--C 1.521 0.445 0 O-C-N 121.482 -0.761 . . . . 0.0 112.74 173.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -109.48 129.07 55.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 169.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -73.58 48.81 0.28 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 127.092 2.157 . . . . 0.0 108.693 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -124.97 120.27 31.1 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 127.32 2.248 . . . . 0.0 105.413 -173.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -82.53 162.36 22.02 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 123.032 1.396 . . . . 0.0 109.438 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.685 HG22 HD13 ' A' ' 63' ' ' ILE . 55.9 t -133.41 128.68 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.6 tp -74.21 125.58 28.7 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 160.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 63.0 m -126.02 123.39 38.35 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 120.626 -1.296 . . . . 0.0 108.146 165.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.6 p -144.26 130.05 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.121 1.368 . . . . 0.0 108.265 -162.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 57' ' ' GLY . 0.8 OUTLIER -79.07 121.99 25.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -178.176 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.605 ' CH2' HG22 ' A' ' 102' ' ' VAL . 1.9 t-105 -130.27 106.04 8.31 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 168.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.5 t70 55.89 60.29 3.34 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.524 1.93 . . . . 0.0 110.313 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.632 ' H ' HD11 ' A' ' 54' ' ' LEU . . . 72.46 3.65 58.6 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 127.605 2.526 . . . . 0.0 113.338 175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.35 106.95 50.1 Favored Pre-proline 0 N--CA 1.455 -0.2 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.436 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 83.1 Cg_endo -68.98 81.93 0.61 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.776 2.984 . . . . 0.0 110.275 171.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.9 mmt85 -60.04 155.35 17.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.767 0.827 . . . . 0.0 108.904 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -131.62 101.96 5.71 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.621 0.724 . . . . 0.0 110.791 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -103.32 116.56 32.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.685 HD13 HG22 ' A' ' 50' ' ' VAL . 2.8 mm -54.99 140.48 12.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.44 143.93 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.99 1.376 . . . . 0.0 108.845 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.414 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -63.45 172.06 2.21 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 112.481 -2.145 . . . . 0.0 110.413 -172.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -174.87 142.6 0.68 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 72' ' ' ARG . 0.2 OUTLIER -131.14 -58.62 1.0 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 124.84 1.256 . . . . 0.0 110.125 172.178 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -137.7 -72.23 0.42 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -132.41 16.0 4.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.935 2.094 . . . . 0.0 112.382 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.1 mt -132.47 -175.72 3.85 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 126.138 1.775 . . . . 0.0 108.362 -168.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -137.96 123.45 19.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.574 ' CG ' HD22 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -130.2 113.4 14.4 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.877 1.217 . . . . 0.0 110.846 -178.356 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -101.86 -25.67 13.72 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -176.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -142.75 -61.04 0.43 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 124.231 0.957 . . . . 0.0 108.961 -173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.23 -123.88 5.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 124.128 0.871 . . . . 0.0 112.409 -171.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -68.16 177.1 2.38 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.64 1.176 . . . . 0.0 110.885 171.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -95.67 157.28 21.74 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 171.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -120.17 152.36 54.45 Favored Pre-proline 0 N--CA 1.462 0.16 0 CA-C-N 118.241 1.02 . . . . 0.0 109.153 166.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.32 -15.18 28.32 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 124.529 3.486 . . . . 0.0 113.354 178.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.6 m -133.48 151.18 51.74 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.103 -1.444 . . . . 0.0 107.103 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.524 ' HB ' HD12 ' A' ' 13' ' ' LEU . 91.1 mt -69.57 -47.3 25.82 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 118.061 -0.971 . . . . 0.0 108.808 174.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -69.24 -19.07 39.1 Favored 'Trans proline' 0 C--N 1.349 0.593 0 CA-C-N 121.493 1.569 . . . . 0.0 112.581 -173.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.4 mt -61.22 -50.31 73.6 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 123.616 0.766 . . . . 0.0 110.702 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 47.5 tp -71.35 -33.87 69.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 118.929 -0.558 . . . . 0.0 111.058 -177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 28.2 mm -55.74 -37.87 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 117.197 -1.382 . . . . 0.0 110.074 -178.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -71.35 -39.05 71.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 121.295 1.861 . . . . 0.0 110.787 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.45 -5.69 34.76 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.059 0.944 . . . . 0.0 112.999 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mt -107.87 -37.09 6.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.021 1.328 . . . . 0.0 112.375 167.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -80.49 -28.23 37.56 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 119.078 0.853 . . . . 0.0 109.775 -173.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.9 t -80.8 -22.15 40.31 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.8 p -104.28 -28.83 11.16 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.846 0.748 . . . . 0.0 110.478 -169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.544 HE21 ' HA ' ' A' ' 92' ' ' GLN . 0.0 OUTLIER 66.4 42.38 2.97 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.481 1.513 . . . . 0.0 109.728 -178.109 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -76.7 154.83 83.45 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 124.335 1.054 . . . . 0.0 112.346 -178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' VAL . 30.9 Cg_endo -67.25 147.88 79.33 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.856 2.37 . . . . 0.0 112.23 174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.6 mt -97.34 -20.73 17.65 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.103 1.361 . . . . 0.0 113.675 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.72 153.71 34.88 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 120.327 -1.483 . . . . 0.0 107.068 157.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -21.28 24.9 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.725 1.21 . . . . 0.0 112.468 177.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -82.32 0.1 Allowed 'General case' 0 CA--C 1.513 -0.472 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 172.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 73.7 m -73.64 -14.11 61.11 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -155.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.54 24.77 32.64 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.18 1.371 . . . . 0.0 114.733 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.444 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 60.4 t -56.61 149.75 3.53 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.169 0 CA-C-O 117.248 -1.358 . . . . 0.0 108.522 167.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.605 HG22 ' CH2' ' A' ' 55' ' ' TRP . 2.0 m -127.45 153.39 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 119.442 1.019 . . . . 0.0 108.671 164.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.732 ' HB3' HD12 ' A' ' 89' ' ' LEU . 7.6 mt -63.13 149.07 46.16 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.842 1.657 . . . . 0.0 108.18 162.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.479 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m-70 -155.95 -33.21 0.09 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.225 0.466 . . . . 0.0 111.035 169.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -142.61 145.21 33.28 Favored 'General case' 0 C--O 1.222 -0.395 0 O-C-N 121.438 -0.789 . . . . 0.0 110.124 -175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.46 122.2 45.03 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.477 HG21 HD23 ' A' ' 32' ' ' LEU . 83.4 t -66.07 119.52 62.17 Favored Pre-proline 0 N--CA 1.454 -0.24 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 171.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' A' ' 17' ' ' LEU . 85.4 Cg_endo -76.89 113.28 3.6 Favored 'Trans proline' 0 N--CA 1.434 -1.979 0 C-N-CA 120.477 0.785 . . . . 0.0 110.551 167.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 1.9 t -68.15 -52.95 28.86 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 154.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.7 173.0 13.66 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 126.314 1.912 . . . . 0.0 109.356 -155.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -83.65 -4.16 10.71 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.836 2.357 . . . . 0.0 113.708 -166.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.3 t -131.96 147.82 52.48 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.505 1.522 . . . . 0.0 109.292 -165.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 71.0 m -144.09 -178.15 5.8 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.309 1.844 . . . . 0.0 109.21 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.294 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 -168.556 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.612 0 CA-C-O 119.48 -0.622 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -68.11 -54.28 19.29 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 150.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.4 p -67.61 158.36 32.31 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 167.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -164.32 -80.07 0.04 OUTLIER Glycine 0 C--N 1.333 0.397 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 175.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 p -66.04 -174.56 0.25 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.116 1.366 . . . . 0.0 111.655 171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -142.3 9.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.231 1.012 . . . . 0.0 112.535 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -145.64 163.81 28.19 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 109.979 -1.249 . . . . 0.0 109.979 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 34.7 mp0 -145.07 21.48 1.58 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.521 1.128 . . . . 0.0 110.894 -168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' O ' HD12 ' A' ' 83' ' ' LEU . 4.5 t -64.22 -58.3 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 O-C-N 120.587 -1.321 . . . . 0.0 108.703 -170.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -77.4 -13.91 59.82 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 122.691 0.396 . . . . 0.0 111.99 -169.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.2 mttm -64.5 157.88 70.05 Favored Pre-proline 0 C--O 1.237 0.397 0 C-N-CA 124.947 1.299 . . . . 0.0 110.082 -175.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -64.0 155.25 65.58 Favored 'Trans proline' 0 N--CA 1.449 -1.124 0 N-CA-C 109.821 -0.876 . . . . 0.0 109.821 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.4 tt -58.15 -34.3 70.14 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-O 119.222 -0.418 . . . . 0.0 111.1 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -73.93 -3.19 27.47 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -117.9 -1.16 11.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.583 1.953 . . . . 0.0 109.758 -171.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 -70.35 167.75 17.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.144 1.777 . . . . 0.0 111.358 -176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -95.85 -62.12 1.34 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.605 1.962 . . . . 0.0 107.363 -172.367 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.491 ' HB3' ' HB1' ' A' ' 106' ' ' ALA . 8.3 p-90 -59.47 -14.87 14.22 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.141 0.977 . . . . 0.0 113.435 174.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 33.0 t80 -79.69 103.17 9.41 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.239 1.381 . . . . 0.0 108.238 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -90.26 -26.54 20.0 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 118.181 0.446 . . . . 0.0 112.138 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 96.51 -144.26 17.21 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 107.679 -2.168 . . . . 0.0 107.679 178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -72.51 94.78 1.72 Allowed 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 124.807 1.243 . . . . 0.0 110.515 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.408 HG13 ' HD2' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -131.18 151.13 78.35 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 126.387 1.875 . . . . 0.0 107.983 175.394 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.408 ' HD2' HG13 ' A' ' 23' ' ' ILE . 59.2 Cg_endo -64.2 -161.17 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 1.008 1 C-N-CA 125.652 4.235 . . . . 0.0 114.746 179.021 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -102.33 -11.73 18.46 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 119.888 -1.757 . . . . 0.0 113.225 161.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.44 -18.85 32.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.344 0.658 . . . . 0.0 112.507 -173.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -88.12 -24.32 23.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.719 1.607 . . . . 0.0 111.463 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 52' ' ' SER . 48.4 t -44.19 -59.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 126.131 1.772 . . . . 0.0 109.689 -176.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -64.68 -14.9 60.3 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -165.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -77.56 -38.66 48.0 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.684 0.794 . . . . 0.0 110.964 171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 89.4 mt -72.04 -39.95 68.73 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.608 1.163 . . . . 0.0 109.004 -173.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.423 HD21 HD23 ' A' ' 39' ' ' LEU . 2.9 mt -80.09 157.5 26.66 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 172.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 t -143.71 -51.42 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -167.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -121.11 167.39 12.69 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 -176.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.8 m -58.31 141.79 49.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.451 -0.899 . . . . 0.0 108.638 171.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 104' ' ' HIS . . . 100.48 -21.48 43.96 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-O 117.174 -1.903 . . . . 0.0 114.656 175.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -61.16 127.54 32.01 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 175.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.413 ' CD1' HD22 ' A' ' 103' ' ' LEU . 39.8 p90 -136.84 162.24 33.78 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.854 0.835 . . . . 0.0 111.392 168.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD23 HD21 ' A' ' 32' ' ' LEU . 1.1 pp -136.24 161.46 35.7 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.803 1.641 . . . . 0.0 108.101 166.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 87.3 t -110.19 128.17 66.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 168.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.8 ptt85 -129.71 167.33 18.2 Favored 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 125.242 1.417 . . . . 0.0 108.82 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -84.18 161.56 20.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.615 0.721 . . . . 0.0 109.705 165.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.0 t -69.0 -157.63 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 126.357 1.863 . . . . 0.0 108.777 168.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -100.24 79.05 2.11 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.04 41.3 97.92 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -106.71 -0.64 23.44 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.01 0.905 . . . . 0.0 111.365 176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 52.76 23.86 2.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.211 2.204 . . . . 0.0 112.138 -168.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -115.3 127.66 55.6 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 -174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -83.55 158.72 21.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 123.563 1.649 . . . . 0.0 110.228 -179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD13 ' A' ' 63' ' ' ILE . 11.5 t -137.82 127.33 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 -173.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 tp -80.32 143.36 33.67 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 165.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' HG11 ' A' ' 28' ' ' VAL . 72.9 m -138.37 127.63 24.41 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 120.445 -1.41 . . . . 0.0 108.015 166.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 p -149.65 134.19 9.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.377 1.071 . . . . 0.0 109.904 -159.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 32' ' ' LEU . 0.1 OUTLIER -87.87 122.7 31.82 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 -174.761 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.438 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 3.7 t-105 -130.3 124.92 33.47 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 170.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.7 t70 33.05 63.48 0.33 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.177 2.591 . . . . 0.0 112.504 -176.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.07 26.01 72.29 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.63 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.5 tt -136.41 107.7 9.36 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 124.179 0.992 . . . . 0.0 109.158 170.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 71.9 Cg_endo -63.17 92.64 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 124.191 3.261 . . . . 0.0 110.133 169.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -66.11 155.82 35.71 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.662 -1.274 . . . . 0.0 108.341 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -131.9 116.97 17.86 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 169.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -116.81 127.13 54.03 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 175.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.589 HD13 HG22 ' A' ' 50' ' ' VAL . 31.8 mm -54.42 139.55 12.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 169.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 21.0 mm -61.56 162.57 1.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 174.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.02 173.51 9.93 Favored 'General case' 0 N--CA 1.442 -0.841 0 O-C-N 121.135 -0.978 . . . . 0.0 108.926 -177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.8 t 171.78 128.28 0.02 OUTLIER 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 173.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.02 -73.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.625 1.17 . . . . 0.0 109.897 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -120.06 -65.52 1.15 Allowed 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 174.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -137.6 12.56 2.96 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.049 2.14 . . . . 0.0 111.773 -173.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 4.6 mt -139.64 170.58 15.64 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.9 1.28 . . . . 0.0 109.42 -170.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -127.35 123.67 36.81 Favored 'General case' 0 C--O 1.221 -0.411 0 C-N-CA 125.326 1.451 . . . . 0.0 107.539 -179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -146.09 138.07 25.11 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 119.39 0.996 . . . . 0.0 111.226 177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.9 tp -117.97 -75.61 0.58 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -174.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -84.12 -37.35 22.1 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.839 1.656 . . . . 0.0 111.831 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.31 -137.94 5.12 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 124.649 1.118 . . . . 0.0 110.708 -160.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -90.71 178.63 6.01 Favored 'General case' 0 C--N 1.333 -0.125 0 C-N-CA 123.207 0.603 . . . . 0.0 111.659 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.54 151.63 16.95 Favored Glycine 0 C--N 1.338 0.669 0 C-N-CA 122.99 0.329 . . . . 0.0 113.591 -169.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -128.0 157.65 73.24 Favored Pre-proline 0 N--CA 1.464 0.237 0 C-N-CA 124.159 0.983 . . . . 0.0 110.098 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.96 -9.87 21.02 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.97 3.78 . . . . 0.0 113.509 -175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.559 ' HB2' HD13 ' A' ' 83' ' ' LEU . 4.8 m -136.96 150.59 48.26 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.451 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 64.8 mt -63.9 -48.69 78.17 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 117.528 -1.225 . . . . 0.0 108.378 172.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 28.7 Cg_endo -65.92 -30.41 48.64 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.373 1.382 . . . . 0.0 112.428 -171.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 80' ' ' SER . 9.7 mp -62.66 -38.13 89.11 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -34.29 35.58 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 122.783 0.433 . . . . 0.0 110.677 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 33.2 mm -55.54 -40.21 57.86 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.757 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -63.42 -43.54 97.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 120.354 1.434 . . . . 0.0 111.173 177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -73.7 -1.86 20.83 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 121.808 -0.558 . . . . 0.0 111.003 -175.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 mt -102.52 -41.77 6.17 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 125.835 1.654 . . . . 0.0 111.829 164.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.761 HD12 ' HB3' ' A' ' 103' ' ' LEU . 7.6 tp -79.07 -24.55 43.44 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.283 -0.886 . . . . 0.0 110.763 -171.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.2 t -78.75 -32.4 46.67 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 81.3 p -101.78 -30.37 11.34 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 124.714 1.206 . . . . 0.0 110.931 -161.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 71.26 38.65 1.03 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 126.64 1.976 . . . . 0.0 109.682 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -71.77 152.04 93.32 Favored Pre-proline 0 C--O 1.235 0.299 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.952 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -74.69 136.98 21.84 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.213 2.609 . . . . 0.0 112.16 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.8 mt -74.15 -43.76 56.19 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.563 1.145 . . . . 0.0 110.986 176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.8 t -152.4 149.13 28.27 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 120.111 -1.618 . . . . 0.0 108.88 178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -63.2 -10.93 17.42 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.706 1.202 . . . . 0.0 112.922 173.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -84.62 -17.01 40.02 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 117.519 -1.229 . . . . 0.0 114.218 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 25.1 t -143.61 -18.37 0.61 Allowed 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.43 1.014 . . . . 0.0 112.075 -175.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 54.22 26.82 37.36 Favored Glycine 0 C--N 1.341 0.827 0 C-N-CA 124.96 1.267 . . . . 0.0 112.95 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.438 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 41.9 t -51.99 136.59 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-O 117.308 -1.329 . . . . 0.0 107.809 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 1.3 m -124.57 143.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 169.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.761 ' HB3' HD12 ' A' ' 89' ' ' LEU . 3.2 mt -59.16 140.46 55.87 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 164.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.453 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -156.07 -31.0 0.09 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 122.994 0.517 . . . . 0.0 110.596 -176.076 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -151.23 155.21 38.35 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 124.938 1.295 . . . . 0.0 108.805 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.491 ' HB1' ' HB3' ' A' ' 18' ' ' TRP . . . -120.12 159.54 24.64 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 176.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.9 t -100.41 123.75 45.25 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 171.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -84.7 112.01 1.51 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.076 2.517 . . . . 0.0 112.392 -174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.4 t -81.55 -9.54 59.66 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.7 1.2 . . . . 0.0 112.52 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.26 171.32 29.03 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -159.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.58 3.32 5.49 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.757 2.305 . . . . 0.0 112.667 177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.1 t -72.86 164.18 27.01 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.035 0.921 . . . . 0.0 110.195 173.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.71 153.9 46.12 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 157.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -176.065 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.905 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -78.4 149.9 33.23 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.927 0.87 . . . . 0.0 110.766 -165.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.5 p -118.34 -17.44 9.47 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 127.325 2.25 . . . . 0.0 111.495 173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 78.61 8.62 87.59 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 118.959 -0.912 . . . . 0.0 113.075 -174.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.6 m -47.75 105.19 0.07 Allowed 'General case' 0 C--O 1.238 0.482 0 C-N-CA 126.059 1.744 . . . . 0.0 111.359 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 85.2 p -152.99 -159.07 0.95 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.649 1.58 . . . . 0.0 108.39 -175.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.1 -97.79 1.43 Allowed Glycine 0 C--N 1.334 0.43 0 N-CA-C 108.074 -2.01 . . . . 0.0 108.074 -176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 44.79 34.34 1.17 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.845 2.058 . . . . 0.0 112.754 174.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -61.04 -38.97 80.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 127.019 2.127 . . . . 0.0 110.612 -166.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 mm-40 -80.75 -16.31 54.19 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.347 -174.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.48 153.19 87.44 Favored Pre-proline 0 C--N 1.344 0.342 0 CA-C-N 119.603 1.092 . . . . 0.0 108.758 174.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -67.78 152.49 77.5 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 N-CA-C 109.571 -0.973 . . . . 0.0 109.571 -176.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 81' ' ' ILE . 7.1 tt -44.67 -46.27 10.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.009 1.723 . . . . 0.0 109.837 167.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -70.84 1.83 5.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -174.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -129.47 11.43 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.31 1.844 . . . . 0.0 111.029 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 73.1 mm-40 -69.83 178.83 2.45 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 120.877 -1.14 . . . . 0.0 110.966 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.13 -42.75 3.87 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.035 0.934 . . . . 0.0 109.606 -174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 4.9 p-90 -69.26 -9.26 52.31 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 172.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -78.85 105.18 9.98 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -99.72 -2.96 33.97 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.078 0.551 . . . . 0.0 112.166 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.3 -104.11 2.75 Favored Glycine 0 C--N 1.337 0.606 0 O-C-N 120.508 -1.37 . . . . 0.0 110.717 171.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.58 32.74 3.85 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 126.682 1.993 . . . . 0.0 113.833 -165.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -63.98 150.0 92.54 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 124.997 1.319 . . . . 0.0 109.696 -170.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -75.13 165.37 31.25 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 124.719 3.613 . . . . 0.0 112.01 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -62.38 -30.5 71.24 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 120.329 -1.482 . . . . 0.0 113.438 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.42 -34.95 63.37 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.68 0.673 . . . . 0.0 110.686 -174.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -62.41 -30.58 71.32 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 99.4 t -44.65 -63.55 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 C-N-CA 124.242 1.017 . . . . 0.0 109.992 176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.701 ' HB2' ' HG3' ' A' ' 59' ' ' PRO . . . -71.43 -16.84 62.4 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.799 1.181 . . . . 0.0 112.741 -171.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -67.88 -27.42 66.64 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.891 0.876 . . . . 0.0 109.891 168.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.0 mt -95.28 -45.61 7.08 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 125.402 1.481 . . . . 0.0 111.8 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.404 HD23 HG21 ' A' ' 107' ' ' VAL . 4.8 mt -85.6 125.1 32.86 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -174.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.6 t -132.02 -17.12 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 123.164 0.585 . . . . 0.0 111.121 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -118.57 138.0 52.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 p -55.65 108.6 0.46 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.478 1.111 . . . . 0.0 109.756 176.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 118.32 -15.39 11.91 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 116.846 -2.086 . . . . 0.0 114.628 -177.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.8 116.5 3.79 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.65 1.58 . . . . 0.0 107.518 174.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -120.96 157.37 30.05 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.934 1.294 . . . . 0.0 111.352 173.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -143.58 168.03 20.83 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 126.994 2.118 . . . . 0.0 109.427 168.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 81.1 t -115.87 130.17 71.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -133.73 175.21 9.65 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.395 1.478 . . . . 0.0 109.167 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -115.14 164.05 14.75 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 119.826 1.194 . . . . 0.0 112.32 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.1 p -70.18 -174.47 0.82 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.822 2.049 . . . . 0.0 113.442 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -96.62 7.31 46.85 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.682 0.793 . . . . 0.0 112.298 172.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 154.5 5.3 0.1 OUTLIER Glycine 0 C--N 1.342 0.898 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -92.99 2.91 56.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.252 2.026 . . . . 0.0 112.6 -175.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 47.77 47.18 18.31 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 126.499 1.92 . . . . 0.0 108.854 -169.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -131.4 140.54 49.68 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.231 1.413 . . . . 0.0 108.421 -171.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -92.93 162.36 14.1 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 123.042 1.401 . . . . 0.0 110.975 175.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG22 HD13 ' A' ' 63' ' ' ILE . 3.9 t -133.93 139.92 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.1 tp -91.98 136.54 33.08 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 125.161 1.384 . . . . 0.0 107.294 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.79 112.96 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.1 p -128.05 158.6 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-O 118.487 -0.768 . . . . 0.0 109.636 175.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.5 tp -103.41 121.33 42.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.437 ' CE2' ' HA ' ' A' ' 101' ' ' VAL . 7.9 t-105 -130.71 114.76 15.78 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 -178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.1 t0 38.61 64.76 0.71 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.955 2.102 . . . . 0.0 113.509 -175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.54 26.2 73.71 Favored Glycine 0 CA--C 1.53 1.03 0 O-C-N 121.841 -0.537 . . . . 0.0 112.671 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.0 tp -138.72 102.4 7.79 Favored Pre-proline 0 C--O 1.236 0.376 0 O-C-N 121.349 -1.089 . . . . 0.0 109.367 178.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.701 ' HG3' ' HB2' ' A' ' 29' ' ' ALA . 73.9 Cg_endo -67.63 96.76 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.229 2.62 . . . . 0.0 108.943 167.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.453 ' HE ' ' HA ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -62.0 -178.45 0.16 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 122.979 1.371 . . . . 0.0 111.531 177.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -145.26 128.95 17.18 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 155.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -130.85 131.58 44.66 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 162.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.506 HD13 HG22 ' A' ' 50' ' ' VAL . 21.0 mm -58.07 141.15 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 123.975 0.91 . . . . 0.0 108.747 175.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.1 mm -60.21 143.96 13.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' H ' ' CD ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -53.99 157.55 2.45 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 126.502 1.921 . . . . 0.0 110.659 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 79.4 p -172.16 125.52 0.54 Allowed 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 123.896 0.878 . . . . 0.0 109.343 -178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' HG ' ' H ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER -125.09 -76.29 0.59 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 124.378 1.071 . . . . 0.0 109.181 169.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 67' ' ' LEU . 5.6 m-20 -126.84 -62.77 1.11 Allowed 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 123.323 0.649 . . . . 0.0 109.923 -170.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -151.46 32.74 0.57 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.828 1.251 . . . . 0.0 108.952 171.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.0 mt -139.7 174.67 10.27 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 124.949 1.3 . . . . 0.0 108.615 178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -135.57 120.88 19.08 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 104.364 -2.458 . . . . 0.0 104.364 -176.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -140.76 142.91 34.69 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 121.045 1.748 . . . . 0.0 111.838 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -138.01 -34.34 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 -171.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.16 -60.9 0.89 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 169.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.09 -166.11 37.21 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 126.201 1.858 . . . . 0.0 112.917 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -61.35 166.54 3.82 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 122.245 1.022 . . . . 0.0 111.43 173.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.09 155.95 19.16 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 126.9 2.191 . . . . 0.0 111.174 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -131.06 158.49 75.02 Favored Pre-proline 0 N--CA 1.464 0.258 0 C-N-CA 123.133 0.573 . . . . 0.0 110.208 -170.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.79 -13.54 21.9 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 124.118 3.212 . . . . 0.0 114.161 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.2 m -132.15 147.8 52.44 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 -179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.467 ' N ' ' HD2' ' A' ' 82' ' ' PRO . 63.6 mt -62.51 -47.89 87.73 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 117.65 -1.167 . . . . 0.0 108.162 170.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 81' ' ' ILE . 19.3 Cg_endo -61.76 -31.75 85.88 Favored 'Trans proline' 0 C--N 1.353 0.79 0 CA-C-N 120.918 1.364 . . . . 0.0 113.096 -175.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.2 -40.72 94.54 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.209 1.004 . . . . 0.0 112.128 175.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -67.42 -43.08 82.09 Favored 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 20.7 mm -52.8 -41.47 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-O 117.468 -1.253 . . . . 0.0 110.089 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -66.57 -41.29 88.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 120.749 1.613 . . . . 0.0 110.981 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -73.43 -3.3 26.58 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.46 -36.56 9.52 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 119.968 -1.708 . . . . 0.0 109.539 167.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.31 -28.09 34.74 Favored 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 121.021 -1.049 . . . . 0.0 111.339 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.9 t -80.29 -29.32 38.21 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 176.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 74.4 p -98.9 -35.19 10.17 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.076 0.951 . . . . 0.0 109.524 -166.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 68.17 36.8 3.08 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 126.221 1.808 . . . . 0.0 109.737 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -61.9 162.45 17.07 Favored Pre-proline 0 CA--C 1.535 0.393 0 C-N-CA 125.515 1.526 . . . . 0.0 110.211 174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.61 155.6 27.76 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.271 2.648 . . . . 0.0 112.485 166.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.45 -37.2 23.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.861 0.864 . . . . 0.0 111.206 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -157.05 148.08 21.81 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.55 -8.42 0.84 Allowed 'General case' 0 C--N 1.333 -0.152 0 C-N-CA 125.352 1.461 . . . . 0.0 113.918 166.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 16.1 mmtp -87.52 -15.87 36.28 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 120.363 1.438 . . . . 0.0 114.504 175.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.96 -8.37 0.25 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 63.04 -0.32 2.54 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 126.462 1.982 . . . . 0.0 116.702 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.437 ' HA ' ' CE2' ' A' ' 55' ' ' TRP . 21.0 t -32.29 130.29 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 130.017 3.327 . . . . 0.0 112.888 173.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.13 137.9 55.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 120.695 1.589 . . . . 0.0 110.518 174.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 72.1 mt -59.07 142.5 51.22 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -148.39 -33.81 0.23 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 117.663 -1.161 . . . . 0.0 112.734 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -144.0 145.9 32.53 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 120.802 1.637 . . . . 0.0 110.208 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -113.1 117.35 31.71 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 123.875 0.87 . . . . 0.0 109.532 -175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.404 HG21 HD23 ' A' ' 32' ' ' LEU . 20.4 t -65.21 119.22 57.21 Favored Pre-proline 0 N--CA 1.469 0.5 0 CA-C-N 119.116 0.871 . . . . 0.0 108.975 176.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -83.1 108.81 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.867 1.711 . . . . 0.0 111.58 176.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -78.66 -36.19 44.15 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 123.62 0.768 . . . . 0.0 110.876 167.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 102.42 169.58 26.81 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 124.965 1.269 . . . . 0.0 111.675 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.67 -1.73 11.89 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 123.945 3.097 . . . . 0.0 116.879 -162.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.73 157.17 46.51 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 121.292 1.86 . . . . 0.0 110.21 170.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.3 t -142.06 171.96 13.34 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 126.399 1.88 . . . . 0.0 109.431 -166.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.239 -1.312 . . . . 0.0 109.972 -169.819 . . . . . . . . 0 0 . 1 stop_ save_